pathwayRes	pathway	pathwayTitle	TotalGenesinPW	GenesInPWs.ileum_Ensembl_BridgeDb_CD	probabilities.ileum_Ensembl_BridgeDb_CD	GenesInPWs.ileum_Ensembl_Hs_CD	probabilities.ileum_Ensembl_Hs_CD	GenesInPWs.ileum_Ensembl_PriID_BridgeDb_CD	probabilities.ileum_Ensembl_PriID_BridgeDb_CD	GenesInPWs.ileum_ENTREZ_BridgeDb_CD	probabilities.ileum_ENTREZ_BridgeDb_CD	GenesInPWs.ileum_ENTREZ_Hs_CD	probabilities.ileum_ENTREZ_Hs_CD	GenesInPWs.ileum_ENTREZ_PriID_BridgeDb_CD	probabilities.ileum_ENTREZ_PriID_BridgeDb_CD	GenesInPWs.ileum_HGNC_CD	probabilities.ileum_HGNC_CD	GenesInPWs.ileum_HGNC_PriID_BridgeDb_CD	probabilities.ileum_HGNC_PriID_BridgeDb_CD
<https://identifiers.org/wikipathways/WP106_r114258>	WP106	Alanine and aspartate metabolism	40	1	5.96635301543865e-79	1	1.18748080220594e-78	1	6.40401632497158e-80	1	1.53427399274202e-77	1	5.7012152252919e-79	1	1.64417375804362e-78	1	7.91612419219972e-81	1	7.91612419219972e-81
<https://identifiers.org/wikipathways/WP107_r117851>	WP107	Translation factors	50	3	4.44214731869238e-89	3	1.0162215738143e-88	3	3.03483680422717e-90	3	2.20277170513869e-87	3	4.20587905478294e-89	3	1.50278501959046e-88	3	2.45626548688868e-91	3	2.45626548688868e-91
<https://identifiers.org/wikipathways/WP117_r117743>	WP117	GPCRs, other	114	7	5.39200103811663e-165	7	3.43554821670285e-164	12	3.46033532266969e-156	7	3.33799252464857e-161	7	4.77117556346024e-165	12	1.44825497721203e-152	7	4.73302301989026e-170	12	1.59759646153497e-158
<https://identifiers.org/wikipathways/WP12_r116896>	WP12	Osteoclast signaling	16	5	5.05474386030476e-25	5	6.14760497557653e-25	5	2.68005095122612e-25	5	1.27304535565028e-24	5	4.98982662698619e-25	5	6.74371883175417e-25	5	1.47954886070745e-25	5	1.47954886070745e-25
<https://identifiers.org/wikipathways/WP127_r120669>	WP127	IL-5 signaling pathway	40	3	2.98817034519324e-73	3	5.74327464948511e-73	3	3.5920020833161e-74	3	6.51762660664804e-72	3	2.86197203499503e-73	3	7.82191002782899e-73	3	4.93740540053761e-75	3	4.93740540053761e-75
<https://identifiers.org/wikipathways/WP129_r117774>	WP129	Matrix metalloproteinases	31	11	4.75205240151423e-39	11	6.77686518622637e-39	11	1.50366462154776e-39	11	2.53649661188208e-38	11	4.64195934574007e-39	11	8.01514618821102e-39	11	5.11881680867565e-40	11	5.11881680867565e-40
<https://identifiers.org/wikipathways/WP134_r118339>	WP134	Pentose phosphate metabolism	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP138_r122133>	WP138	Androgen receptor signaling pathway	88	7	1.46398422735961e-132	7	6.01001903533167e-132	7	1.49927337230321e-134	7	1.14263774424194e-129	7	1.3335979018791e-132	7	1.17166345021209e-131	7	2.04614555394374e-136	7	2.04614555394374e-136
<https://identifiers.org/wikipathways/WP1403_r121114>	WP1403	AMP-activated protein kinase (AMPK) signaling	68	10	1.28651932282357e-98	10	3.56051646864479e-98	10	4.73813637020072e-100	10	1.56566555905224e-96	10	1.20286612326092e-98	10	5.76117196675027e-98	10	2.14843695403712e-101	10	2.14843695403712e-101
<https://identifiers.org/wikipathways/WP1422_r118359>	WP1422	Sphingolipid pathway	36	2	2.11986276115425e-69	2	3.86619461528409e-69	2	3.02081545229101e-70	2	3.61048539169628e-68	2	2.03738106251225e-69	2	5.13652311678547e-69	2	4.8700270483056e-71	2	4.8700270483056e-71
<https://identifiers.org/wikipathways/WP1423_r117518>	WP1423	Ganglio sphingolipid metabolism	18	3	3.63070543215484e-34	3	4.73993491799039e-34	3	1.52989087595523e-34	3	1.27743319437309e-33	3	3.56734354696044e-34	3	5.37670328987387e-34	3	6.81086670754278e-35	3	6.81086670754278e-35
<https://identifiers.org/wikipathways/WP1425_r116437>	WP1425	Bone morphogenic protein (BMP) signaling and regulation	12	1	1.38866589568813e-27	1	1.68890246581776e-27	1	7.36277733853336e-28	1	3.4973773506876e-27	1	1.3708314909303e-27	1	1.85267000872368e-27	1	4.06469467227321e-28	1	4.06469467227321e-28
<https://identifiers.org/wikipathways/WP143_r116506>	WP143	Fatty acid beta-oxidation	34	4	1.2486128928552e-60	4	2.12310110065586e-60	4	2.23332504871665e-61	4	1.52808694553388e-59	4	1.20559760436325e-60	4	2.72878648610951e-60	4	4.45510416772833e-62	4	4.45510416772833e-62
<https://identifiers.org/wikipathways/WP1433_r122867>	WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	41	12	1.22280023338848e-53	12	2.04304991142171e-53	12	2.31521489938714e-54	12	1.37764449824625e-52	12	1.18204310051496e-53	12	2.60420919252464e-53	12	4.871388250641e-55	12	4.871388250641e-55
<https://identifiers.org/wikipathways/WP1434_r117813>	WP1434	Osteopontin signaling	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP1455_r117827>	WP1455	Serotonin transporter activity	11	3	9.5595681568104e-20	3	1.10234199495745e-19	3	6.02368530969556e-20	3	1.87261283248844e-19	3	9.47004385986179e-20	3	1.17916427965518e-19	3	3.90898497540816e-20	3	3.90898497540816e-20
<https://identifiers.org/wikipathways/WP1471_r120934>	WP1471	Target of rapamycin (TOR) signaling	36	2	2.11986276115425e-69	2	3.86619461528409e-69	2	3.02081545229101e-70	2	3.61048539169628e-68	2	2.03738106251225e-69	2	5.13652311678547e-69	2	4.8700270483056e-71	2	4.8700270483056e-71
<https://identifiers.org/wikipathways/WP15_r121694>	WP15	Selenium micronutrient network	89	14	2.34387548909013e-118	14	8.68597347346435e-118	15	4.17433341483528e-118	14	1.12931577783554e-115	14	2.14961136202921e-118	15	1.85646486131651e-115	14	6.2386492454182e-122	15	8.19758510847956e-120
<https://identifiers.org/wikipathways/WP1528_r121714>	WP1528	Physiological and pathological hypertrophy of the heart	24	3	1.39012004762813e-45	3	2.01771417464122e-45	3	4.15417151480801e-46	3	8.06381444219644e-45	3	1.35633366754257e-45	3	2.40637631202491e-45	3	1.34040439621149e-46	3	1.34040439621149e-46
<https://identifiers.org/wikipathways/WP1530_r118120>	WP1530	miRNA regulation of DNA damage response	96	9	3.42361187087979e-138	9	1.55642532236177e-137	9	2.51754218011802e-140	9	4.32128176323895e-135	9	3.09774753870047e-138	9	3.18413385103174e-137	9	2.51781196176905e-142	9	2.51781196176905e-142
<https://identifiers.org/wikipathways/WP1531_r118354>	WP1531	Vitamin D metabolism	11	1	1.97422001503664e-25	1	2.35883377725878e-25	1	1.10871155422748e-25	1	4.57282088602404e-25	1	1.95115015542411e-25	1	2.56594796208229e-25	1	6.45947728335421e-26	1	6.45947728335421e-26
<https://identifiers.org/wikipathways/WP1533_r121695>	WP1533	Vitamin B12 metabolism	57	11	1.54990600772235e-80	11	3.48462802035051e-80	11	1.12027573963458e-81	11	7.08123128971409e-79	11	1.46915465032113e-80	11	5.1109166302887e-80	11	9.55899776923682e-83	11	9.55899776923682e-83
<https://identifiers.org/wikipathways/WP1539_r118358>	WP1539	Angiogenesis	24	10	9.94809657704991e-29	10	1.27595256044367e-28	10	4.43947661104607e-29	10	3.21973246923259e-28	10	9.78591779218959e-29	10	1.435304132741e-28	10	2.08552756996318e-29	10	2.08552756996318e-29
<https://identifiers.org/wikipathways/WP1541_r117711>	WP1541	Energy metabolism	47	3	1.99334194564169e-84	3	4.32843568691597e-84	3	1.61286036696366e-85	3	7.72992162553449e-83	3	1.8938321132177e-84	3	6.24503550163201e-84	3	1.52973268383357e-86	3	1.52973268383357e-86
<https://identifiers.org/wikipathways/WP1544_r121713>	WP1544	MicroRNAs in cardiomyocyte hypertrophy	104	9	3.42679662845231e-148	9	1.78390254497243e-147	9	1.62296347956059e-150	9	8.18884200284917e-145	9	3.07299907832444e-148	9	3.89078416327434e-147	9	1.07397362706247e-152	9	1.07397362706247e-152
<https://identifiers.org/wikipathways/WP1545_r118363>	WP1545	miRNAs involved in DNA damage response	69	2	1.00422914276761e-119	2	3.24493384264783e-119	2	2.2370667674097e-121	2	2.53652385434614e-117	2	9.29372071977506e-120	2	5.64937031224198e-119	2	6.32991987653062e-123	2	6.32991987653062e-123
<https://identifiers.org/wikipathways/WP1584_r122869>	WP1584	Type II diabetes mellitus	22	1	1.51100005176967e-47	1	2.19316758113179e-47	1	4.51540382044357e-48	1	8.76501569803979e-47	1	1.47427572558972e-47	1	2.61562642611399e-47	1	1.4569613002299e-48	1	1.4569613002299e-48
<https://identifiers.org/wikipathways/WP1589_r122870>	WP1589	Folate-alcohol and cancer pathway hypotheses	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP1591_r118366>	WP1591	Heart development	47	4	8.66605410867746e-82	4	1.84932414723489e-81	4	7.41915768803284e-83	4	3.09583361102658e-80	4	8.24290427278025e-82	4	2.64633379381664e-81	4	7.41920351659334e-84	4	7.41920351659334e-84
<https://identifiers.org/wikipathways/WP1600_r119518>	WP1600	Nicotine metabolism in liver cells	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP1601_r120496>	WP1601	Fluoropyrimidine activity	34	1	5.8178455778344e-69	1	1.04264518275675e-68	1	8.77474964713104e-70	1	9.12363927552419e-68	1	5.59794701461703e-69	1	1.37381610345768e-68	1	1.49192892114763e-70	1	1.49192892114763e-70
<https://identifiers.org/wikipathways/WP1602_r117165>	WP1602	Nicotine effect on dopaminergic neurons	21	3	5.77407969083068e-40	3	7.94872457920117e-40	3	2.04866083881391e-40	3	2.60915325531949e-39	3	5.65347559529853e-40	3	9.2455122721665e-40	3	7.76355226248898e-41	3	7.76355226248898e-41
<https://identifiers.org/wikipathways/WP167_r120547>	WP167	Eicosanoid synthesis	28	4	3.36789184289053e-50	4	5.15368216335023e-50	4	8.47933157731652e-51	4	2.50680325739565e-49	4	3.27458681665794e-50	4	6.30191438333841e-50	4	2.33016244282508e-51	4	2.33016244282508e-51
<https://identifiers.org/wikipathways/WP170_r116552>	WP170	Nuclear receptors	38	2	9.9529058420668e-73	2	1.8798179718122e-72	2	1.26618073436896e-73	2	1.99915662261611e-71	2	9.54357597823368e-73	2	2.53911233211064e-72	2	1.83538550754607e-74	2	1.83538550754607e-74
<https://identifiers.org/wikipathways/WP1742_r116592>	WP1742	TP53 network	22	1	1.51100005176967e-47	1	2.19316758113179e-47	1	4.51540382044357e-48	1	8.76501569803979e-47	1	1.47427572558972e-47	1	2.61562642611399e-47	1	1.4569613002299e-48	1	1.4569613002299e-48
<https://identifiers.org/wikipathways/WP176_r121696>	WP176	Folate metabolism	75	12	5.83948231852192e-104	12	1.76152843812852e-103	12	1.62603000415048e-105	12	1.06670780019668e-101	12	5.42879610533032e-104	12	2.96874343035479e-103	12	5.67216610650785e-107	12	5.67216610650785e-107
<https://identifiers.org/wikipathways/WP1772_r120736>	WP1772	Apoptosis modulation and signaling	97	11	5.37986369390038e-135	11	2.40459222712219e-134	11	4.18028724309756e-137	11	6.268412041375e-132	11	4.87326378251843e-135	11	4.88000354009089e-134	11	4.4027604423477e-139	11	4.4027604423477e-139
<https://identifiers.org/wikipathways/WP179_r122978>	WP179	Cell cycle	120	9	1.8575570661709e-167	9	1.26564465039054e-166	9	3.67027433142653e-170	9	1.57703666146004e-163	9	1.63641433842307e-167	9	3.13476685406076e-166	9	1.06872909083537e-172	9	1.06872909083537e-172
<https://identifiers.org/wikipathways/WP183_r117060>	WP183	Proteasome degradation	65	9	1.31402818439148e-96	9	3.51320726766177e-96	9	5.41333687533018e-98	9	1.35889290267807e-94	9	1.23139207081253e-96	9	5.59259173987315e-96	9	2.72660210424891e-99	9	2.72660210424891e-99
<https://identifiers.org/wikipathways/WP185_r116785>	WP185	Integrin-mediated cell adhesion	101	10	3.20902450634708e-142	10	1.56123949366406e-141	10	1.89332553605146e-144	10	5.5752669933198e-139	10	2.89060438363945e-142	10	3.29799461429864e-141	10	1.53992078411643e-146	10	1.53992078411643e-146
<https://identifiers.org/wikipathways/WP186_r118416>	WP186	Homologous recombination	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP195_r120702>	WP195	IL-1 signaling pathway	55	7	1.26654936878303e-86	7	2.94820446863798e-86	7	8.1790144994655e-88	7	6.81632832213129e-85	7	1.19780990802259e-86	7	4.39572010219074e-86	7	6.27921853426977e-89	7	6.27921853426977e-89
<https://identifiers.org/wikipathways/WP1971_r117762>	WP1971	Integrated cancer pathway	49	5	2.3441701280747e-82	5	5.09024036781337e-82	5	1.89672379154924e-83	5	9.09038783162833e-81	5	2.22714656514392e-82	5	7.34416174991947e-82	5	1.79896563618833e-84	5	1.79896563618833e-84
<https://identifiers.org/wikipathways/WP1982_r116442>	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	69	6	2.67962540754303e-109	6	8.08331304291655e-109	6	7.46153695633038e-111	6	4.8949156242241e-107	6	2.49116945351007e-109	6	1.3622988974936e-108	6	2.60284723640538e-112	6	2.60284723640538e-112
<https://identifiers.org/wikipathways/WP1991_r117830>	WP1991	SRF and miRs in smooth muscle differentiation and proliferation	17	1	7.07326209264537e-38	1	9.39903810824989e-38	1	2.81436879314797e-38	1	2.7052799541997e-37	1	6.94170762202852e-38	1	1.07512563284822e-37	1	1.18738959336519e-38	1	1.18738959336519e-38
<https://identifiers.org/wikipathways/WP1992_r105839>	WP1992	Genes targeted by miRNAs in adipocytes	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP1995_r116455>	WP1995	Effects of nitric oxide	8	3	4.76081819065963e-13	3	5.20462953639944e-13	3	3.56626923664813e-13	3	7.25029452226311e-13	3	4.7328791746736e-13	3	5.42865872899012e-13	3	2.72110344099487e-13	3	2.72110344099487e-13
<https://identifiers.org/wikipathways/WP2007_r106626>	WP2007	Iron metabolism in placenta	12	2	1.18453200902199e-24	2	1.41530026635527e-24	2	6.65226932536489e-25	2	2.74369253161439e-24	2	1.17069009325448e-24	2	1.53956877724938e-24	2	3.87568637001251e-25	2	3.87568637001251e-25
<https://identifiers.org/wikipathways/WP2011_r118441>	WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	18	2	6.36593588338078e-37	2	8.45913429742497e-37	2	2.5329319138332e-37	2	2.43475195877972e-36	2	6.24753685982565e-37	2	9.67613069563381e-37	2	1.06865063402868e-37	2	1.06865063402868e-37
<https://identifiers.org/wikipathways/WP2018_r120672>	WP2018	RANKL/RANK signaling pathway	55	4	5.00558990695236e-94	4	1.22739590324576e-93	4	2.73039393264164e-95	4	3.44280028612242e-92	4	4.71768156273077e-94	4	1.87558406752482e-93	4	1.78935495223003e-96	4	1.78935495223003e-96
<https://identifiers.org/wikipathways/WP2032_r122774>	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	64	6	3.31746112456581e-102	6	9.18126510698789e-102	6	1.2217914594966e-103	6	4.03727680889228e-100	6	3.10175022728556e-102	6	1.48559478995502e-101	6	5.54003033390586e-105	6	5.54003033390586e-105
<https://identifiers.org/wikipathways/WP2034_r120670>	WP2034	Leptin signaling pathway	76	11	1.72024648382733e-107	11	5.37085466748222e-107	11	4.28414415820266e-109	11	3.69548070841757e-105	11	1.59563336538783e-107	11	9.19996333083133e-107	11	1.3458916965353e-110	11	1.3458916965353e-110
<https://identifiers.org/wikipathways/WP2035_r120721>	WP2035	Follicle stimulating hormone (FSH) signaling pathway	27	2	8.39175708361454e-54	2	1.30693545985214e-53	2	1.99560639616765e-54	2	6.78676091705344e-53	2	8.14979297326518e-54	2	1.61146804892732e-53	2	5.19854787571575e-55	2	5.19854787571575e-55
<https://identifiers.org/wikipathways/WP2036_r120940>	WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	42	2	2.96082417653763e-79	2	5.99660393372014e-79	2	3.00319066220078e-80	2	8.26664522998068e-78	2	2.82599096659547e-79	2	8.37157661546776e-79	2	3.52054903382426e-81	2	3.52054903382426e-81
<https://identifiers.org/wikipathways/WP2037_r122570>	WP2037	Prolactin signaling pathway	76	11	1.72024648382733e-107	11	5.37085466748222e-107	11	4.28414415820266e-109	11	3.69548070841757e-105	11	1.59563336538783e-107	11	9.19996333083133e-107	11	1.3458916965353e-110	11	1.3458916965353e-110
<https://identifiers.org/wikipathways/WP2038_r117173>	WP2038	Microtubule cytoskeleton regulation	46	4	3.20459617891091e-80	4	6.72052264569606e-80	4	2.90294276346642e-81	4	1.05455949175607e-78	4	3.0516283903483e-80	4	9.53806265260692e-80	4	3.06081608907947e-82	4	3.06081608907947e-82
<https://identifiers.org/wikipathways/WP205_r120718>	WP205	IL-7 signaling pathway	25	3	2.0240536511766e-47	3	2.99009213787967e-47	3	5.71255708856996e-48	3	1.27592000667664e-46	3	1.97256205285421e-47	3	3.59590004785544e-47	3	1.74713815981685e-48	3	1.74713815981685e-48
<https://identifiers.org/wikipathways/WP2059_r119468>	WP2059	Alzheimer's disease and miRNA effects	280	24	5.38822816145839e-294	24	3.79191143646318e-292	24	5.35276526364275e-300	24	2.69341667473144e-285	24	4.06791257728528e-294	24	2.82892344556151e-291	24	1.22657708763712e-305	24	1.22657708763712e-305
<https://identifiers.org/wikipathways/WP206_r117723>	WP206	Fatty acid omega-oxidation	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP2064_r117162>	WP2064	Neural crest differentiation	101	8	9.03906430769706e-147	8	4.54905728717717e-146	8	4.7778647747839e-149	8	1.8419471372675e-143	8	8.12396034511115e-147	8	9.76446794013812e-146	8	3.50501375701381e-151	8	3.50501375701381e-151
<https://identifiers.org/wikipathways/WP2112_r117960>	WP2112	IL-17 signaling pathway	32	3	7.67863543734494e-60	3	1.28294344585086e-59	3	1.45385081602734e-60	3	8.65098777008135e-59	3	7.42269897588374e-60	3	1.63532623285206e-59	3	3.05901270126375e-61	3	3.05901270126375e-61
<https://identifiers.org/wikipathways/WP2113_r105848>	WP2113	Type III interferon signaling	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP2118_r119252>	WP2118	Arrhythmogenic right ventricular cardiomyopathy	74	9	3.31977391615822e-109	9	1.03648072530358e-108	9	8.2676466210929e-111	9	7.13162943729705e-107	9	3.07929245952048e-109	9	1.77543151998493e-108	9	2.59733485296283e-112	9	2.59733485296283e-112
<https://identifiers.org/wikipathways/WP2197_r117710>	WP2197	Endothelin pathways	33	8	3.3194434319945e-49	8	5.16971390499114e-49	8	7.89382066068095e-50	8	2.68457114834965e-48	8	3.22373210850477e-49	8	6.37432301433681e-49	8	2.05633759771817e-50	8	2.05633759771817e-50
<https://identifiers.org/wikipathways/WP22_r120719>	WP22	IL-9 signaling pathway	17	1	7.07326209264537e-38	1	9.39903810824989e-38	1	2.81436879314797e-38	1	2.7052799541997e-37	1	6.94170762202852e-38	1	1.07512563284822e-37	1	1.18738959336519e-38	1	1.18738959336519e-38
<https://identifiers.org/wikipathways/WP2203_r120724>	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	47	8	4.69041105880143e-72	8	9.33530596055661e-72	9	1.02647398868989e-70	8	1.20615989100326e-70	8	4.48197464550284e-72	9	2.42713462943203e-69	8	6.22321145896987e-74	9	1.33799046367853e-71
<https://identifiers.org/wikipathways/WP2249_r107453>	WP2249	Metastatic brain tumor	22	2	1.29643804441838e-44	2	1.84884027089407e-44	2	4.10224437087301e-45	2	6.9199798936023e-44	2	1.26640284828159e-44	2	2.18666369223131e-44	2	1.39649740627035e-45	2	1.39649740627035e-45
<https://identifiers.org/wikipathways/WP2261_r118379>	WP2261	Glioblastoma signaling pathways	83	8	1.21124994864765e-123	8	4.48867056832125e-123	8	1.7294333919614e-125	8	5.83599122170653e-121	8	1.11085962713876e-123	8	8.33751129553032e-123	8	3.22396117597386e-127	8	3.22396117597386e-127
<https://identifiers.org/wikipathways/WP2267_r117179>	WP2267	Synaptic vesicle pathway	51	3	1.29976771803391e-90	3	3.0255283283438e-90	3	8.39352912232031e-92	3	6.99510317322995e-89	3	1.22922539709986e-90	3	4.51100859323806e-90	3	6.44390636992394e-93	3	6.44390636992394e-93
<https://identifiers.org/wikipathways/WP2272_r118427>	WP2272	Pathogenic Escherichia coli infection	71	3	9.43660207894649e-120	3	3.1020044620041e-119	3	1.98823709478301e-121	3	2.58436317263218e-117	3	8.72328460383045e-120	3	5.44451627920151e-119	3	5.33939269965327e-123	3	5.33939269965327e-123
<https://identifiers.org/wikipathways/WP2289_r120498>	WP2289	Drug induction of bile acid pathway	17	1	7.07326209264537e-38	1	9.39903810824989e-38	1	2.81436879314797e-38	1	2.7052799541997e-37	1	6.94170762202852e-38	1	1.07512563284822e-37	1	1.18738959336519e-38	1	1.18738959336519e-38
<https://identifiers.org/wikipathways/WP2290_r79988>	WP2290	RalA downstream regulated genes	12	1	1.38866589568813e-27	1	1.68890246581776e-27	1	7.36277733853336e-28	1	3.4973773506876e-27	1	1.3708314909303e-27	1	1.85267000872368e-27	1	4.06469467227321e-28	1	4.06469467227321e-28
<https://identifiers.org/wikipathways/WP23_r120701>	WP23	B cell receptor signaling pathway	97	7	4.21118519321522e-144	7	2.01439155816546e-143	7	2.62510721102826e-146	7	6.7551683697232e-141	7	3.79757206263694e-144	7	4.22131678988105e-143	7	2.24825775494734e-148	7	2.24825775494734e-148
<https://identifiers.org/wikipathways/WP231_r120699>	WP231	TNF-alpha signaling pathway	93	8	1.14071186866351e-136	8	5.01266121450791e-136	8	9.3662665346684e-139	8	1.2268744374512e-133	8	1.03445601997356e-136	8	1.00916161684803e-135	8	1.0388897809574e-140	8	1.0388897809574e-140
<https://identifiers.org/wikipathways/WP2324_r120674>	WP2324	AGE/RAGE pathway	66	13	2.70860288506688e-89	13	6.87567940461617e-89	13	1.32041617534522e-90	13	2.19338474011112e-87	13	2.54697785403758e-89	13	1.06801339643026e-88	13	7.78789543269055e-92	13	7.78789543269055e-92
<https://identifiers.org/wikipathways/WP2328_r120805>	WP2328	Allograft rejection	102	19	9.95119083621453e-125	19	4.2266798732614e-124	20	8.57261038073155e-125	19	9.11830213136737e-122	19	9.04454647542191e-125	20	7.25992552548751e-122	19	1.1225928826022e-128	20	1.11080565733488e-126
<https://identifiers.org/wikipathways/WP2332_r120725>	WP2332	Interleukin-11 signaling pathway	44	7	1.15899175008666e-69	7	2.22758650554924e-69	7	1.39319392803494e-70	7	2.52792665565438e-68	7	1.11004447349316e-69	7	3.03380602339367e-69	7	1.91502205865254e-71	7	1.91502205865254e-71
<https://identifiers.org/wikipathways/WP2355_r120664>	WP2355	Corticotropin-releasing hormone signaling pathway	92	8	2.18329798518391e-135	8	9.43242701654734e-135	9	3.9571972546254e-135	8	2.16747817283044e-132	8	1.9821512124654e-135	9	3.63148676640558e-132	8	2.21294694201787e-139	9	4.86848327243939e-137
<https://identifiers.org/wikipathways/WP2359_r119918>	WP2359	Parkin-ubiquitin proteasomal system pathway	73	9	7.89567850329472e-108	9	2.42312385780432e-107	9	2.07920140025055e-109	9	1.56413980766667e-105	9	7.33204501847963e-108	9	4.11708174093814e-107	9	6.88293736035147e-111	9	6.88293736035147e-111
<https://identifiers.org/wikipathways/WP236_r105873>	WP236	Adipogenesis	131	18	4.08110908349387e-161	18	2.87531361345252e-160	18	7.23280647225484e-164	18	4.05640664677186e-157	18	3.58730870708246e-161	18	7.23514051658702e-160	18	1.90158876594787e-166	18	1.90158876594787e-166
<https://identifiers.org/wikipathways/WP2361_r117731>	WP2361	Gastric cancer network 1	29	1	2.66894505927068e-60	1	4.38166572030529e-60	1	5.34935028074568e-61	1	2.76796725627406e-59	1	2.58297952265631e-60	1	5.53900820804739e-60	1	1.18721763103484e-61	1	1.18721763103484e-61
<https://identifiers.org/wikipathways/WP2363_r117737>	WP2363	Gastric cancer network 2	32	1	1.54741003321976e-65	1	2.67770797681344e-65	1	2.61475964948432e-66	1	2.05703913002685e-64	1	1.49237176218465e-65	1	3.47025947733412e-65	1	4.94532152743953e-67	1	4.94532152743953e-67
<https://identifiers.org/wikipathways/WP2369_r118380>	WP2369	Histone modifications	67	1	7.5424200748357e-120	1	2.39566300744492e-119	1	1.77649419764887e-121	1	1.75696984795922e-117	1	6.98811736985639e-120	1	4.13709215534167e-119	1	5.29651863496566e-123	1	5.29651863496566e-123
<https://identifiers.org/wikipathways/WP2371_r119919>	WP2371	Parkinson's disease pathway	47	5	3.0123204081762e-79	5	6.31729128695431e-79	5	2.72876619765849e-80	5	9.9128592225069e-78	5	2.8685306869274e-79	5	8.96577889345096e-79	5	2.87716712373475e-81	5	2.87716712373475e-81
<https://identifiers.org/wikipathways/WP2374_r120781>	WP2374	Oncostatin M signaling pathway	65	13	7.17369370166166e-88	13	1.78976018441377e-87	13	3.69916592153529e-89	13	5.35385275199856e-86	13	6.75335037055404e-88	13	2.75741640532897e-87	13	2.29978912095663e-90	13	2.29978912095663e-90
<https://identifiers.org/wikipathways/WP2380_r120727>	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	144	11	2.74215871541386e-190	11	2.69456274412535e-189	11	1.64861988579487e-193	11	1.30554531565405e-185	11	2.35795483952734e-190	11	7.93431761557373e-189	11	1.56968202783708e-196	11	1.56968202783708e-196
<https://identifiers.org/wikipathways/WP24_r113974>	WP24	Peptide GPCRs	75	17	1.31299977094919e-93	17	3.63380263697194e-93	18	4.98073135333881e-93	17	1.59789167869386e-91	17	1.22762473622069e-93	18	5.58250001965811e-91	17	2.192658266771e-96	18	2.38025236292799e-94
<https://identifiers.org/wikipathways/WP2406_r119249>	WP2406	Cardiac progenitor differentiation	53	7	1.29482540327681e-83	7	2.9111345199252e-83	7	9.35902873546024e-85	7	5.91581561379641e-82	7	1.2273639518138e-83	7	4.26977162095965e-83	7	7.98579596427489e-86	7	7.98579596427489e-86
<https://identifiers.org/wikipathways/WP241_r120901>	WP241	One-carbon metabolism	29	3	1.3197960007544e-54	3	2.09192113818244e-54	3	2.96456713078699e-55	3	1.15969062808239e-53	3	1.28025380040459e-54	3	2.60089854050687e-54	3	7.32088254436557e-56	3	7.32088254436557e-56
<https://identifiers.org/wikipathways/WP2431_r120812>	WP2431	Spinal cord injury	117	28	5.128301183407e-126	28	2.41185933802258e-125	29	2.19549803223356e-126	28	7.5949400062882e-123	28	4.629792621597e-126	29	3.00835392689835e-123	28	3.04618521889314e-130	29	2.08506126189757e-128
<https://identifiers.org/wikipathways/WP2435_r120750>	WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	17	2	6.0511757202581e-35	2	7.89989152998412e-35	2	2.54981812659205e-35	2	2.12905532395515e-34	2	5.94557257826735e-35	2	8.96117214978988e-35	2	1.13514445125714e-35	2	1.13514445125714e-35
<https://identifiers.org/wikipathways/WP2436_r107129>	WP2436	Dopamine metabolism	13	1	1.05756629431435e-29	1	1.30922671768818e-29	1	5.2940323783702e-30	1	2.89591755152473e-29	1	1.04276239801604e-29	1	1.44826879816044e-29	1	2.76944605553207e-30	1	2.76944605553207e-30
<https://identifiers.org/wikipathways/WP244_r120686>	WP244	Alpha 6 beta 4 signaling pathway	33	5	2.18426463650708e-56	5	3.58595522549777e-56	5	4.37790826976221e-57	5	2.26530440253468e-55	5	2.11391044134192e-56	5	4.53312431746599e-56	5	9.71618909238888e-58	5	9.71618909238888e-58
<https://identifiers.org/wikipathways/WP2446_r116593>	WP2446	Retinoblastoma gene in cancer	90	12	6.9001323436911e-124	12	2.69146097575147e-123	12	8.34267441598881e-126	12	4.23229746881483e-121	12	6.30685923431283e-124	12	5.12176949941827e-123	12	1.33052586734229e-127	12	1.33052586734229e-127
<https://identifiers.org/wikipathways/WP2447_r113794>	WP2447	Amyotrophic lateral sclerosis (ALS)	38	4	2.48377253515231e-67	4	4.52989135757441e-67	4	3.539388771601e-68	4	4.2302853839373e-66	4	2.38713147824357e-67	4	6.0182929185002e-67	4	5.70604835826508e-69	4	5.70604835826508e-69
<https://identifiers.org/wikipathways/WP2453_r117835>	WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	16	1	7.11903025912711e-36	1	9.29399003527545e-36	1	2.99978603128478e-36	1	2.50477096935903e-35	1	6.99479126854986e-36	1	1.05425554703409e-35	1	1.33546406030252e-36	1	1.33546406030252e-36
<https://identifiers.org/wikipathways/WP2456_r119185>	WP2456	HIF1A and PPARG regulation of glycolysis	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP247_r118104>	WP247	Small ligand GPCRs	19	3	4.03175939280781e-36	3	5.35745172170245e-36	3	1.60419021209435e-36	3	1.54200957389379e-35	3	3.9567733445562e-36	3	6.12821610723476e-36	3	6.76812068218155e-37	3	6.76812068218155e-37
<https://identifiers.org/wikipathways/WP2485_r117161>	WP2485	NAD biosynthesis II (from tryptophan)	8	2	8.39650474543144e-16	2	9.34403866498999e-16	2	5.93718518864845e-16	2	1.39072145567707e-15	2	8.33742661422241e-16	2	9.82859154313241e-16	2	4.29196126339885e-16	2	4.29196126339885e-16
<https://identifiers.org/wikipathways/WP2507_r110715>	WP2507	Nanomaterial induced apoptosis	21	1	1.17858004038033e-45	1	1.68076388263097e-45	1	3.72931306442996e-46	1	6.29089081236571e-45	1	1.15127531661962e-45	1	1.98787608384662e-45	1	1.26954309660941e-46	1	1.26954309660941e-46
<https://identifiers.org/wikipathways/WP2509_r101755>	WP2509	Nanoparticle triggered autophagic cell death	23	2	1.7376500595351e-46	2	2.52214271830156e-46	2	5.1927143935101e-47	2	1.00797680527456e-45	2	1.69541708442819e-46	2	3.00797039003113e-46	2	1.67550549526437e-47	2	1.67550549526437e-47
<https://identifiers.org/wikipathways/WP2513_r119820>	WP2513	Nanoparticle triggered regulated necrosis	14	1	8.66857618290436e-32	1	1.0923226488459e-31	1	4.09709526242026e-32	1	2.58070310129512e-31	1	8.53723600714867e-32	1	1.21849538306767e-31	1	2.0310238228103e-32	1	2.0310238228103e-32
<https://identifiers.org/wikipathways/WP2516_r116808>	WP2516	ATM signaling pathway	41	4	3.06287460382302e-72	4	5.88685651572201e-72	4	3.68180213539894e-73	4	6.68056727181408e-71	4	2.93352133586983e-72	4	8.01745777852447e-72	4	5.06084053555118e-74	4	5.06084053555118e-74
<https://identifiers.org/wikipathways/WP2525_r116582>	WP2525	Trans-sulfuration and one-carbon metabolism	31	3	4.13686484186948e-58	3	6.79158186647299e-58	3	8.29149293515588e-59	3	4.29034924722474e-57	3	4.00361826011728e-58	3	8.58546272247344e-58	3	1.84018732810397e-59	3	1.84018732810397e-59
<https://identifiers.org/wikipathways/WP2526_r121697>	WP2526	PDGF pathway	41	4	3.06287460382302e-72	4	5.88685651572201e-72	4	3.68180213539894e-73	4	6.68056727181408e-71	4	2.93352133586983e-72	4	8.01745777852447e-72	4	5.06084053555118e-74	4	5.06084053555118e-74
<https://identifiers.org/wikipathways/WP2533_r120261>	WP2533	Glycerophospholipid biosynthetic pathway	44	1	2.13778701416652e-85	1	4.56200838047485e-85	1	1.8301961610935e-86	1	7.63696234604156e-84	1	2.03340222578596e-85	1	6.52811296655358e-85	1	1.83020746631962e-87	1	1.83020746631962e-87
<https://identifiers.org/wikipathways/WP254_r118382>	WP254	Apoptosis	87	8	6.55548846353512e-129	8	2.60101501367588e-128	8	7.49903318291118e-131	8	4.35741333023719e-126	8	5.98510024513449e-129	8	4.98970854655272e-128	8	1.13542244404126e-132	8	1.13542244404126e-132
<https://identifiers.org/wikipathways/WP2542_r117834>	WP2542	Sulindac metabolic pathway	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP2572_r119251>	WP2572	Primary focal segmental glomerulosclerosis (FSGS)	73	9	7.89567850329472e-108	9	2.42312385780432e-107	9	2.07920140025055e-109	9	1.56413980766667e-105	9	7.33204501847963e-108	9	4.11708174093814e-107	9	6.88293736035147e-111	9	6.88293736035147e-111
<https://identifiers.org/wikipathways/WP2583_r117181>	WP2583	T cell receptor and co-stimulatory signaling	32	1	1.54741003321976e-65	1	2.67770797681344e-65	1	2.61475964948432e-66	1	2.05703913002685e-64	1	1.49237176218465e-65	1	3.47025947733412e-65	1	4.94532152743953e-67	1	4.94532152743953e-67
<https://identifiers.org/wikipathways/WP2586_r121728>	WP2586	Aryl hydrocarbon receptor pathway	48	6	2.40985632654102e-78	6	5.05383302956351e-78	6	2.18301295812671e-79	6	7.93028737800562e-77	6	2.29482454954198e-78	6	7.17262311476061e-78	6	2.30173369898781e-80	6	2.30173369898781e-80
<https://identifiers.org/wikipathways/WP2596_r122782>	WP2596	Gastric acid production	14	3	4.212286550254e-26	3	5.12300414631387e-26	3	2.23337579268843e-26	3	1.06087112970856e-25	3	4.15818885582187e-26	3	5.61976569312849e-26	3	1.23295738392287e-26	3	1.23295738392287e-26
<https://identifiers.org/wikipathways/WP2597_r117821>	WP2597	Secretion of hydrochloric acid in parietal cells	5	1	1.4452483793074e-11	1	1.55209487960484e-11	1	1.14693765985773e-11	1	2.02360898898162e-11	1	1.43845720630258e-11	1	1.60533193842994e-11	1	9.23717435952005e-12	1	9.23717435952005e-12
<https://identifiers.org/wikipathways/WP26_r118660>	WP26	S1P receptor signal transduction	25	4	8.68825029767572e-45	4	1.26107135915079e-44	4	2.59635719675506e-45	4	5.03988402637277e-44	4	8.47708542214096e-45	4	1.50398519501555e-44	4	8.3775274763218e-46	4	8.3775274763218e-46
<https://identifiers.org/wikipathways/WP262_r116630>	WP262	Ebstein-Barr virus LMP1 signaling	24	1	2.82754875600926e-51	1	4.25131583584796e-51	2	6.8550685062838e-49	1	1.93688046554334e-50	1	2.75241216677333e-51	2	4.3150800574265e-48	1	2.18506075224617e-52	2	2.0965657917802e-49
<https://identifiers.org/wikipathways/WP2636_r116781>	WP2636	Common pathways underlying drug addiction	41	2	1.2231023681649e-77	2	2.43433564452212e-77	2	1.31282334661918e-78	2	3.14526168512116e-76	2	1.16874912118485e-77	2	3.37055620398945e-77	2	1.62280545940091e-79	2	1.62280545940091e-79
<https://identifiers.org/wikipathways/WP2637_r117962>	WP2637	Interleukin-1 (IL-1) structural pathway	51	5	1.97324626043634e-85	5	4.4364169026437e-85	5	1.42626707869862e-86	5	9.01539389620671e-84	5	1.87043853324308e-85	5	6.50690885632483e-85	5	1.21699357946131e-87	5	1.21699357946131e-87
<https://identifiers.org/wikipathways/WP2643_r110709>	WP2643	Nanoparticle-mediated activation of receptor signaling	28	1	1.58572149555976e-58	1	2.55798622912988e-58	1	3.36455686623448e-59	1	1.51379174774157e-57	1	1.53642747468347e-58	1	3.20689475217635e-58	1	7.87657490383101e-60	1	7.87657490383101e-60
<https://identifiers.org/wikipathways/WP268_r117167>	WP268	Notch signaling	46	5	1.11327671255368e-77	5	2.29438643124056e-77	5	1.06712175985024e-78	5	3.37459037361939e-76	5	1.06135635416312e-77	5	3.22958801417271e-77	5	1.18637231612721e-79	5	1.18637231612721e-79
<https://identifiers.org/wikipathways/WP272_r120902>	WP272	Blood clotting cascade	23	5	1.46084216178016e-38	5	2.01102731853791e-38	5	5.18311192219926e-39	5	6.60115773595832e-38	5	1.43032932561056e-38	5	2.33911460485811e-38	5	1.96417872240973e-39	5	1.96417872240973e-39
<https://identifiers.org/wikipathways/WP2795_r117670>	WP2795	Cardiac hypertrophic response	54	4	1.58904726864335e-92	4	3.8294752181268e-92	4	9.16915926107123e-94	4	1.00717557461291e-90	4	1.49936497666424e-92	4	5.80408015077681e-92	4	6.33431653089449e-95	4	6.33431653089449e-95
<https://identifiers.org/wikipathways/WP2805_r106523>	WP2805	exRNA mechanism of action and biogenesis	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP2806_r116569>	WP2806	Complement system	136	27	1.10380157839354e-149	27	7.27288968967215e-149	27	2.43178967213919e-152	26	1.29543547018103e-147	26	1.45616088298798e-151	26	2.71849668766512e-150	27	7.84331804874366e-155	27	7.84331804874366e-155
<https://identifiers.org/wikipathways/WP2813_r102405>	WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	20	4	2.01587969640393e-35	4	2.67872586085122e-35	4	8.02095106047161e-36	4	7.71004786946909e-35	4	1.97838667227809e-35	4	3.06410805361739e-35	4	3.3840603410908e-36	4	3.3840603410908e-36
<https://identifiers.org/wikipathways/WP2814_r102407>	WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	14	4	1.79654021368333e-23	4	2.14653873730548e-23	4	1.00892751434701e-23	4	4.16126700628186e-23	4	1.77554664143593e-23	4	2.33501264549489e-23	4	5.87812432785232e-24	4	5.87812432785232e-24
<https://identifiers.org/wikipathways/WP2815_r102408>	WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	12	2	1.18453200902199e-24	2	1.41530026635527e-24	2	6.65226932536489e-25	2	2.74369253161439e-24	2	1.17069009325448e-24	2	1.53956877724938e-24	2	3.87568637001251e-25	2	3.87568637001251e-25
<https://identifiers.org/wikipathways/WP2817_r102410>	WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	38	4	2.48377253515231e-67	4	4.52989135757441e-67	4	3.539388771601e-68	4	4.2302853839373e-66	4	2.38713147824357e-67	4	6.0182929185002e-67	4	5.70604835826508e-69	4	5.70604835826508e-69
<https://identifiers.org/wikipathways/WP2828_r119245>	WP2828	Bladder cancer	40	5	4.47940480328055e-68	5	8.31368296213671e-68	6	1.84048216123253e-66	5	8.28530470677012e-67	5	4.30014446427244e-68	6	3.12951231762009e-65	5	9.21950848150505e-70	6	2.96714514629783e-67
<https://identifiers.org/wikipathways/WP2839_r117746>	WP2839	Hair follicle development: organogenesis - part 2 of 3	32	5	1.14045089960658e-54	5	1.83970369599021e-54	5	2.41978929819586e-55	5	1.08871902497575e-53	5	1.10499863979237e-54	5	2.30639870576527e-54	5	5.66483267083536e-56	5	5.66483267083536e-56
<https://identifiers.org/wikipathways/WP2840_r120866>	WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	88	18	6.19473127087883e-109	18	2.10738539337857e-108	19	1.1467951690258e-108	18	1.99416784801986e-106	18	5.713508960197e-109	19	3.40508041292602e-106	18	2.82485340276879e-112	19	2.92297988939123e-110
<https://identifiers.org/wikipathways/WP2846_r116729>	WP2846	PCSK9-mediated LDL receptor degradation	2	1	0.00117924528301885	1	0.00120048019207684	1	0.0011129660545353	1	0.00128287363694678	1	0.00117785630153122	1	0.00121065375302659	1	0.00105429625724823	1	0.00105429625724823
<https://identifiers.org/wikipathways/WP2848_r120814>	WP2848	Pluripotent stem cell differentiation pathway	50	13	1.0732628323486e-65	13	2.06281520301465e-65	13	1.29014141912735e-66	13	2.34093963327555e-64	13	1.02793611392412e-65	13	2.80939984708283e-65	13	1.77337068924418e-67	13	1.77337068924418e-67
<https://identifiers.org/wikipathways/WP2849_r117150>	WP2849	Hematopoietic stem cell differentiation	94	13	6.9463898865954e-127	13	2.85166565766693e-126	13	7.11383169024477e-129	13	5.42164807674126e-124	13	6.3277259449067e-127	13	5.55937078347154e-126	13	9.70865977706031e-131	13	9.70865977706031e-131
<https://identifiers.org/wikipathways/WP2853_r116557>	WP2853	Endoderm differentiation	145	14	6.08026762041947e-185	14	5.78018093900476e-184	14	4.07075682280794e-188	14	2.47706630222215e-180	14	5.23981129206435e-185	14	1.6756030529579e-183	14	4.28821993785535e-191	14	4.28821993785535e-191
<https://identifiers.org/wikipathways/WP2857_r118395>	WP2857	Mesodermal commitment pathway	153	16	1.6843777857297e-189	16	1.76824182464402e-188	16	8.16897376079041e-193	16	1.09465446143414e-184	16	1.44206686859958e-189	16	5.37184367098027e-188	16	6.35579920283731e-196	16	6.35579920283731e-196
<https://identifiers.org/wikipathways/WP2858_r116763>	WP2858	Ectoderm differentiation	142	23	9.1001576630558e-164	23	7.08714051552418e-163	23	1.16465905230988e-166	23	1.44987818481788e-159	23	7.94628492734681e-164	23	1.86978313171251e-162	23	2.25528687668875e-169	23	2.25528687668875e-169
<https://identifiers.org/wikipathways/WP286_r120663>	WP286	IL-3 signaling pathway	49	6	6.79418642120312e-80	6	1.44987013143215e-79	7	1.52810907068874e-78	6	2.42713355104484e-78	6	6.46243694985939e-80	7	5.02083618033247e-77	6	5.81665555700889e-82	7	1.6112135892915e-79
<https://identifiers.org/wikipathways/WP2864_r108133>	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	53	6	5.20308715438446e-86	6	1.19030032940868e-85	7	9.35902873546024e-85	6	2.58010649822888e-84	6	4.92634613686733e-86	7	4.26977162095965e-83	6	2.87702376479267e-88	7	7.98579596427489e-86
<https://identifiers.org/wikipathways/WP2865_r120807>	WP2865	IL1 and megakaryocytes in obesity	24	11	1.54557245910712e-26	11	1.9475675899863e-26	11	7.30495696908484e-27	11	4.60129040148512e-26	11	1.52215503113058e-26	11	2.17252852819434e-26	11	3.62123423511789e-27	11	3.62123423511789e-27
<https://identifiers.org/wikipathways/WP2870_r106411>	WP2870	Extracellular vesicle-mediated signaling in recipient cells	30	6	9.76688634438275e-49	6	1.49456782737159e-48	6	2.45900615742177e-49	6	7.26972944644747e-48	6	9.49630176830807e-49	6	1.82755517116811e-48	6	6.75747108419275e-50	6	6.75747108419275e-50
<https://identifiers.org/wikipathways/WP2873_r120645>	WP2873	Aryl hydrocarbon receptor pathway	46	6	3.22108062165516e-75	6	6.52370541949424e-75	6	3.26717112140826e-76	6	8.99328334569573e-74	6	3.07439557255917e-75	6	9.10743819996739e-75	6	3.83000529389744e-77	6	3.83000529389744e-77
<https://identifiers.org/wikipathways/WP2875_r117690>	WP2875	Constitutive androstane receptor pathway	32	1	1.54741003321976e-65	1	2.67770797681344e-65	1	2.61475964948432e-66	1	2.05703913002685e-64	1	1.49237176218465e-65	1	3.47025947733412e-65	1	4.94532152743953e-67	1	4.94532152743953e-67
<https://identifiers.org/wikipathways/WP2876_r116466>	WP2876	Pregnane X receptor pathway	33	2	2.55322655481262e-64	2	4.41821816174222e-64	2	4.31435342164911e-65	2	3.39411456454429e-63	2	2.46241340760472e-64	2	5.72592813760127e-64	2	8.15978052027538e-66	2	8.15978052027538e-66
<https://identifiers.org/wikipathways/WP2877_r119905>	WP2877	Vitamin D receptor pathway	186	33	8.94729290220057e-192	33	1.22177495648799e-190	33	1.84583243220373e-195	33	2.00461875777829e-186	33	7.52819232290328e-192	33	4.20256268255021e-190	33	6.42985586568932e-199	33	6.42985586568932e-199
<https://identifiers.org/wikipathways/WP2878_r116507>	WP2878	PPAR-alpha pathway	26	3	3.06317781901004e-49	3	4.60559215550192e-49	3	8.16528225963824e-50	3	2.09828717100526e-48	3	2.98177984733773e-49	3	5.58502994290572e-49	3	2.36714914826671e-50	3	2.36714914826671e-50
<https://identifiers.org/wikipathways/WP2879_r116462>	WP2879	Farnesoid X receptor pathway	19	1	8.24868527261532e-42	1	1.13553208274302e-41	1	2.92665834116278e-42	1	3.72736179331351e-41	1	8.07639370756939e-42	1	1.32078746745236e-41	1	1.10907889464129e-42	1	1.10907889464129e-42
<https://identifiers.org/wikipathways/WP2880_r117734>	WP2880	Glucocorticoid receptor pathway	71	10	8.16188688328566e-103	10	2.37876382891994e-102	10	2.5414364012076e-104	10	1.26756165174206e-100	10	7.60514729038608e-103	10	3.94426819833474e-102	10	9.84513454055089e-106	10	9.84513454055089e-106
<https://identifiers.org/wikipathways/WP2881_r117716>	WP2881	Estrogen receptor pathway	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP2882_r120815>	WP2882	Nuclear receptors meta-pathway	318	38	7.32754310900551e-300	38	7.46198061648858e-298	38	2.18408160979627e-306	38	2.07823917967779e-290	38	5.39849200843816e-300	38	6.62771069814624e-297	38	1.60825663608481e-312	38	1.60825663608481e-312
<https://identifiers.org/wikipathways/WP2884_r106658>	WP2884	NRF2 pathway	143	14	9.70411294619962e-183	14	8.9244554189573e-182	14	7.2357351598096e-186	14	3.38227743953873e-178	14	8.38107816165717e-183	14	2.54690219564212e-181	14	8.43411944215991e-189	14	8.43411944215991e-189
<https://identifiers.org/wikipathways/WP2889_r107138>	WP2889	Oxytocin signaling	5	1	1.4452483793074e-11	1	1.55209487960484e-11	1	1.14693765985773e-11	1	2.02360898898162e-11	1	1.43845720630258e-11	1	1.60533193842994e-11	1	9.23717435952005e-12	1	9.23717435952005e-12
<https://identifiers.org/wikipathways/WP289_r122789>	WP289	Myometrial relaxation and contraction pathways	156	21	8.6160065072857e-183	21	8.7511042558302e-182	21	4.65220856714049e-186	21	4.79305993303254e-178	21	7.39264573749862e-183	21	2.6173881510781e-181	21	4.00390670999743e-189	21	4.00390670999743e-189
<https://identifiers.org/wikipathways/WP2895_r118446>	WP2895	Differentiation of white and brown adipocyte	25	2	3.53443594501154e-50	2	5.31414479480991e-50	2	9.42147953035195e-51	2	2.42110058192915e-49	2	3.44051520846669e-50	2	6.44426531873737e-50	2	2.73132594030779e-51	2	2.73132594030779e-51
<https://identifiers.org/wikipathways/WP2911_r120808>	WP2911	miRNA targets in ECM and membrane receptors	41	14	1.99575241696117e-49	14	3.21942233464983e-49	14	4.23455349290106e-50	14	1.90522329916748e-48	14	1.93371210182321e-49	14	4.03612360084511e-49	14	9.91327509005437e-51	14	9.91327509005437e-51
<https://identifiers.org/wikipathways/WP2916_r104425>	WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	16	2	6.0867708715537e-33	2	7.80695162963131e-33	2	2.71630625132838e-33	2	1.97000236740087e-32	2	5.98754132587876e-33	2	8.78194870679401e-33	2	1.27603590961906e-33	2	1.27603590961906e-33
<https://identifiers.org/wikipathways/WP2942_r119083>	WP2942	DDX1 as a regulatory component of the Drosha microprocessor	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP299_r117807>	WP299	Nuclear receptors in lipid metabolism and toxicity	35	3	5.86438834245705e-65	3	1.03274005352058e-64	3	9.3619266443516e-66	3	8.46749755095944e-64	3	5.64926152891772e-65	3	1.3495453522966e-64	3	1.67879301852139e-66	3	1.67879301852139e-66
<https://identifiers.org/wikipathways/WP3_r120028>	WP3	Transcriptional activation by NRF2 in response to phytochemicals	15	2	6.50143213717833e-31	2	8.1924198663443e-31	2	3.07282144681519e-31	2	1.93552732597132e-30	2	6.40292700536153e-31	2	9.13871537300759e-31	2	1.52326786710774e-31	2	1.52326786710774e-31
<https://identifiers.org/wikipathways/WP304_r120696>	WP304	Kit receptor signaling pathway	58	5	6.06934472180194e-96	5	1.54067872899648e-95	5	2.95874341292209e-97	5	4.91486152092234e-94	5	5.70718087918136e-96	5	2.39316789706427e-95	5	1.74508497716444e-98	5	1.74508497716444e-98
<https://identifiers.org/wikipathways/WP306_r116784>	WP306	Focal adhesion	198	42	2.25691219463909e-188	42	3.23679543312716e-187	42	3.96970875433995e-192	42	6.36939108381328e-183	42	1.89280533649172e-188	42	1.13946020334103e-186	42	1.19026161038971e-195	42	1.19026161038971e-195
<https://identifiers.org/wikipathways/WP313_r118735>	WP313	Hepatocyte growth factor receptor signaling	34	2	5.02661857924887e-66	2	8.85205760160482e-66	2	8.02450855230155e-67	2	7.25785504367946e-65	2	4.84222416764384e-66	2	1.15675315911137e-65	2	1.43896544444691e-67	2	1.43896544444691e-67
<https://identifiers.org/wikipathways/WP314_r121827>	WP314	Fas ligand pathway and stress induction of heat shock proteins	43	4	1.84076906408827e-75	4	3.66367514500584e-75	4	1.97579913666185e-76	4	4.73361883610728e-74	4	1.75896742738324e-75	4	5.07268708700412e-75	4	2.44232221639833e-77	4	2.44232221639833e-77
<https://identifiers.org/wikipathways/WP322_r117584>	WP322	Osteoblast signaling	14	4	1.79654021368333e-23	4	2.14653873730548e-23	4	1.00892751434701e-23	4	4.16126700628186e-23	4	1.77554664143593e-23	4	2.33501264549489e-23	4	5.87812432785232e-24	4	5.87812432785232e-24
<https://identifiers.org/wikipathways/WP325_r116669>	WP325	Triacylglyceride synthesis	24	2	2.42886438141197e-48	2	3.58811056545563e-48	2	6.8550685062838e-49	2	1.53110400801198e-47	2	2.36707446342502e-48	2	4.3150800574265e-48	2	2.0965657917802e-49	2	2.0965657917802e-49
<https://identifiers.org/wikipathways/WP3286_r106367>	WP3286	Copper homeostasis	55	7	1.26654936878303e-86	7	2.94820446863798e-86	7	8.1790144994655e-88	7	6.81632832213129e-85	7	1.19780990802259e-86	7	4.39572010219074e-86	7	6.27921853426977e-89	7	6.27921853426977e-89
<https://identifiers.org/wikipathways/WP3287_r121705>	WP3287	Overview of nanoparticle effects	22	4	3.1757438299569e-39	4	4.37179851856077e-39	5	4.08789783776939e-37	4	1.43503429042571e-38	4	3.10941157741423e-39	5	1.69738359804703e-36	4	4.26995374436899e-40	5	1.63453829334445e-37
<https://identifiers.org/wikipathways/WP3298_r120642>	WP3298	Melatonin metabolism and effects	40	5	4.47940480328055e-68	5	8.31368296213671e-68	5	6.03107207394614e-69	5	8.28530470677012e-67	5	4.30014446427244e-68	5	1.11370545111036e-67	5	9.21950848150505e-70	5	9.21950848150505e-70
<https://identifiers.org/wikipathways/WP3300_r102277>	WP3300	Dual hijack model of Vif in HIV infection	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP3301_r120029>	WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	13	2	9.02632832197287e-27	2	1.09778660278152e-26	2	4.78580527004663e-27	2	2.27329527794692e-26	2	8.91040469104683e-27	2	1.20423550567039e-26	2	2.64205153697754e-27	2	2.64205153697754e-27
<https://identifiers.org/wikipathways/WP3303_r120561>	WP3303	RAC1/PAK1/p38/MMP2 pathway	68	10	1.28651932282357e-98	10	3.56051646864479e-98	10	4.73813637020072e-100	10	1.56566555905224e-96	10	1.20286612326092e-98	10	5.76117196675027e-98	10	2.14843695403712e-101	10	2.14843695403712e-101
<https://identifiers.org/wikipathways/WP334_r117741>	WP334	GPCRs, class B secretin-like	23	1	2.0240536511766e-49	1	2.99009213787971e-49	5	5.18311192219926e-39	1	1.27592000667665e-48	1	1.97256205285423e-49	5	2.33911460485811e-38	1	1.74713815981688e-50	5	1.96417872240973e-39
<https://identifiers.org/wikipathways/WP34_r116553>	WP34	Ovarian infertility	32	2	1.33541485866865e-62	2	2.27069636433784e-62	2	2.3885829398039e-63	2	1.63431758880631e-61	2	1.28940920252758e-62	2	2.91848822043801e-62	2	4.76481729168807e-64	2	4.76481729168807e-64
<https://identifiers.org/wikipathways/WP3408_r118453>	WP3408	Evolocumab mechanism to reduce LDL cholesterol	2	1	0.00117924528301885	1	0.00120048019207684	1	0.0011129660545353	1	0.00128287363694678	1	0.00117785630153122	1	0.00121065375302659	1	0.00105429625724823	1	0.00105429625724823
<https://identifiers.org/wikipathways/WP3413_r116601>	WP3413	NOTCH1 regulation of endothelial cell calcification	17	4	1.47365795109374e-29	4	1.85694850303806e-29	4	6.9650619461145e-30	4	4.3871952722017e-29	4	1.45133012121528e-29	4	2.07144215121504e-29	4	3.45274049877754e-30	4	3.45274049877754e-30
<https://identifiers.org/wikipathways/WP3414_r106735>	WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	32	2	1.33541485866865e-62	2	2.27069636433784e-62	2	2.3885829398039e-63	2	1.63431758880631e-61	2	1.28940920252758e-62	2	2.91848822043801e-62	2	4.76481729168807e-64	2	4.76481729168807e-64
<https://identifiers.org/wikipathways/WP35_r117729>	WP35	G protein signaling pathways	92	10	7.67322987956868e-131	10	3.20414515124358e-130	10	7.43557364144086e-133	10	6.48924180134613e-128	10	6.98197347859282e-131	10	6.29699805294704e-130	10	9.63472839615715e-135	10	9.63472839615715e-135
<https://identifiers.org/wikipathways/WP3527_r120810>	WP3527	Pre-implantation embryo	59	9	6.31379682466269e-88	9	1.52157389836328e-87	9	3.64320242511093e-89	9	4.00183309228885e-86	9	5.95746018100205e-88	9	2.30614806426411e-87	9	2.5168280634793e-90	9	2.5168280634793e-90
<https://identifiers.org/wikipathways/WP3529_r120882>	WP3529	Zinc homeostasis	37	1	5.23837149582477e-74	1	9.89377879901161e-74	1	6.66410912825738e-75	1	1.05218769611373e-72	1	5.022934725386e-74	1	1.3363749116372e-73	1	9.65992372392667e-76	1	9.65992372392667e-76
<https://identifiers.org/wikipathways/WP357_r121828>	WP357	Fatty acid biosynthesis	23	3	9.93935834054085e-44	3	1.41744420768547e-43	3	3.14505401766929e-44	3	5.3053179184285e-43	3	9.70908850349193e-44	3	1.67644216404401e-43	3	1.07064801147392e-44	3	1.07064801147392e-44
<https://identifiers.org/wikipathways/WP3584_r117155>	WP3584	MECP2 and associated Rett syndrome	73	6	7.28688750575001e-115	6	2.35458889490205e-114	6	1.62326038776782e-116	6	1.84055243919059e-112	6	6.74370962868297e-115	6	4.09929608596895e-114	6	4.59311646080794e-118	6	4.59311646080794e-118
<https://identifiers.org/wikipathways/WP3585_r106742>	WP3585	Cytosine methylation	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP3591_r88424>	WP3591	Sleep regulation	39	4	5.59925600410078e-69	4	1.03921037026708e-68	4	7.53884009243259e-70	4	1.03566308834621e-67	4	5.3751805803406e-69	4	1.39213181388792e-68	4	1.15243856018816e-70	4	1.15243856018816e-70
<https://identifiers.org/wikipathways/WP3593_r117786>	WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	8	2	8.39650474543144e-16	2	9.34403866498999e-16	2	5.93718518864845e-16	2	1.39072145567707e-15	2	8.33742661422241e-16	2	9.82859154313241e-16	2	4.29196126339885e-16	2	4.29196126339885e-16
<https://identifiers.org/wikipathways/WP3594_r117682>	WP3594	Circadian rhythm genes	209	19	3.89846894704528e-240	19	9.69400584393012e-239	20	1.13691748982011e-242	19	1.46524899038865e-233	19	3.15274017461649e-240	20	4.07367407456158e-236	19	6.37272316326898e-249	20	6.64675025928928e-247
<https://identifiers.org/wikipathways/WP3595_r89883>	WP3595	mir-124 predicted interactions with cell cycle and differentiation 	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP3599_r105845>	WP3599	Transcription factor regulation in adipogenesis	22	4	3.1757438299569e-39	4	4.37179851856077e-39	4	1.12676346134767e-39	4	1.43503429042571e-38	4	3.10941157741423e-39	4	5.08503174969152e-39	4	4.26995374436899e-40	4	4.26995374436899e-40
<https://identifiers.org/wikipathways/WP3601_r117687>	WP3601	Lipid particles composition	11	1	1.97422001503664e-25	1	2.35883377725878e-25	1	1.10871155422748e-25	1	4.57282088602404e-25	1	1.95115015542411e-25	1	2.56594796208229e-25	1	6.45947728335421e-26	1	6.45947728335421e-26
<https://identifiers.org/wikipathways/WP3611_r120501>	WP3611	Photodynamic therapy-induced AP-1 survival signaling	50	7	4.85299030085926e-79	7	1.03562152245155e-78	7	4.15472830529826e-80	7	1.73366682217486e-77	7	4.61602639275673e-79	7	1.48194692453732e-78	7	4.15475396929211e-81	7	4.15475396929211e-81
<https://identifiers.org/wikipathways/WP3612_r106540>	WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	23	1	2.0240536511766e-49	1	2.99009213787971e-49	1	5.71255708856993e-50	1	1.27592000667665e-48	1	1.97256205285423e-49	1	3.59590004785544e-49	1	1.74713815981688e-50	1	1.74713815981688e-50
<https://identifiers.org/wikipathways/WP3613_r106539>	WP3613	Photodynamic therapy-induced unfolded protein response	27	2	8.39175708361454e-54	2	1.30693545985214e-53	3	1.21133308247379e-51	2	6.78676091705344e-53	2	8.14979297326518e-54	3	9.00273483334063e-51	2	5.19854787571575e-55	3	3.32880348974998e-52
<https://identifiers.org/wikipathways/WP3614_r106542>	WP3614	Photodynamic therapy-induced HIF-1 survival signaling	37	11	3.08816426624522e-49	11	4.8948444328102e-49	11	6.93673133798591e-50	11	2.71353690683739e-48	11	2.99564026249073e-49	11	6.08579047696105e-49	11	1.71299866479106e-50	11	1.71299866479106e-50
<https://identifiers.org/wikipathways/WP3617_r106541>	WP3617	Photodynamic therapy-induced NF-kB survival signaling	35	12	9.83105478766539e-44	12	1.47813256316326e-43	13	3.66681041935374e-42	12	6.73430579523938e-43	12	9.56981369544121e-44	13	2.30815789811774e-41	12	7.59719949092166e-45	13	1.12146352485219e-42
<https://identifiers.org/wikipathways/WP3624_r122572>	WP3624	Lung fibrosis	64	20	2.41189160435066e-72	20	5.23729394049541e-72	22	1.42932281779142e-69	20	9.35300293643975e-71	20	2.29148731049698e-72	22	4.69625883033806e-68	20	1.85093652652321e-74	22	1.50705495548948e-70
<https://identifiers.org/wikipathways/WP363_r120695>	WP363	Wnt signaling pathway	51	7	1.42324614918817e-80	7	3.09050308045803e-80	7	1.15158230201203e-81	7	5.51916404063148e-79	7	1.35219612883739e-80	7	4.45895534816539e-80	7	1.09222913625714e-82	7	1.09222913625714e-82
<https://identifiers.org/wikipathways/WP3630_r121716>	WP3630	NAD metabolism, sirtuins and aging	11	4	4.06998614276199e-17	4	4.61054539390957e-17	4	2.7166820746727e-17	4	7.33127923919225e-17	4	4.0366061952661e-17	4	4.89058384986981e-17	4	1.86067684829429e-17	4	1.86067684829429e-17
<https://identifiers.org/wikipathways/WP364_r121718>	WP364	IL6 signaling pathway	44	10	8.34908546752962e-63	10	1.52270184035565e-62	10	1.18974901842606e-63	10	1.42199069047874e-61	10	8.02423106464665e-63	10	2.02302107918688e-62	10	1.91806152740506e-64	10	1.91806152740506e-64
<https://identifiers.org/wikipathways/WP3640_r122579>	WP3640	Imatinib and chronic myeloid leukemia	20	3	4.70999929066328e-38	3	6.37033498418848e-38	3	1.76965274362308e-38	3	1.95810739542073e-37	3	4.61700506949384e-38	3	7.34798094392669e-38	3	7.07592334781133e-39	3	7.07592334781133e-39
<https://identifiers.org/wikipathways/WP3644_r118983>	WP3644	NAD+ metabolism	16	2	6.0867708715537e-33	2	7.80695162963131e-33	2	2.71630625132838e-33	2	1.97000236740087e-32	2	5.98754132587876e-33	2	8.78194870679401e-33	2	1.27603590961906e-33	2	1.27603590961906e-33
<https://identifiers.org/wikipathways/WP3645_r118940>	WP3645	NAD+ biosynthetic pathways	22	4	3.1757438299569e-39	4	4.37179851856077e-39	4	1.12676346134767e-39	4	1.43503429042571e-38	4	3.10941157741423e-39	4	5.08503174969152e-39	4	4.26995374436899e-40	4	4.26995374436899e-40
<https://identifiers.org/wikipathways/WP3646_r116732>	WP3646	Hepatitis C and hepatocellular carcinoma	56	11	4.73401115692064e-79	11	1.04599974435432e-78	12	5.55408144260392e-78	11	1.99268333135118e-77	11	4.49252027282411e-79	12	2.15055416442014e-76	11	3.25676731015063e-81	12	5.26782112416854e-79
<https://identifiers.org/wikipathways/WP3651_r122573>	WP3651	Pathways affected in adenoid cystic carcinoma	66	7	1.15913896598688e-102	7	3.26380736733332e-102	7	4.03656939641175e-104	7	1.53016322202913e-100	7	1.08253404450496e-102	7	5.32431215447555e-102	7	1.73669931548824e-105	7	1.73669931548824e-105
<https://identifiers.org/wikipathways/WP3655_r117757>	WP3655	Hypothetical craniofacial development pathway	8	3	4.76081819065963e-13	3	5.20462953639944e-13	3	3.56626923664813e-13	3	7.25029452226311e-13	3	4.7328791746736e-13	3	5.42865872899012e-13	3	2.72110344099487e-13	3	2.72110344099487e-13
<https://identifiers.org/wikipathways/WP3656_r117955>	WP3656	Interleukin-1 induced activation of NF-kB	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP3657_r120797>	WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	20	3	4.70999929066328e-38	3	6.37033498418848e-38	3	1.76965274362308e-38	3	1.95810739542073e-37	3	4.61700506949384e-38	3	7.34798094392669e-38	3	7.07592334781133e-39	3	7.07592334781133e-39
<https://identifiers.org/wikipathways/WP3658_r116670>	WP3658	Wnt/beta-catenin signaling pathway in leukemia	27	4	2.06764502783173e-48	4	3.10877470496373e-48	4	5.51156552525577e-49	4	1.41634384042853e-47	4	2.01270139695299e-48	4	3.7698952114613e-48	4	1.59782567508e-49	4	1.59782567508e-49
<https://identifiers.org/wikipathways/WP366_r120697>	WP366	TGF-beta signaling pathway	132	14	2.03092185471251e-170	14	1.55551035744978e-169	14	2.74393992326496e-173	14	2.9913800412817e-166	14	1.77536229118209e-170	14	4.07166011231991e-169	14	5.59092745263504e-176	14	5.59092745263504e-176
<https://identifiers.org/wikipathways/WP3664_r118061>	WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	18	1	7.43684098525791e-40	1	1.0058423659245e-39	1	2.79418854256284e-40	1	3.0917485190854e-39	1	7.29000800446413e-40	1	1.1602075174621e-39	1	1.11725105491761e-40	1	1.11725105491761e-40
<https://identifiers.org/wikipathways/WP3668_r117756>	WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	25	6	8.52299977701394e-40	6	1.19419674497502e-39	7	7.40444560314181e-38	6	4.18589583764003e-39	6	8.33525248024795e-40	7	3.34159229265443e-37	6	1.025680794992e-40	7	2.80596960344246e-38
<https://identifiers.org/wikipathways/WP3670_r117829>	WP3670	Interactions between LOXL4 and oxidative stress pathway	18	6	1.51020466828087e-26	6	1.86957575285871e-26	6	7.55987823631261e-27	6	4.1353702635773e-26	6	1.48906470436687e-26	6	2.0681278437731e-26	6	3.95476896729978e-27	6	3.95476896729978e-27
<https://identifiers.org/wikipathways/WP3672_r117771>	WP3672	lncRNA-mediated mechanisms of therapeutic resistance	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP3676_r116809>	WP3676	BDNF-TrkB signaling	33	6	6.27247994783626e-54	6	1.01183703279462e-53	6	1.33088411400773e-54	6	5.98795463736667e-53	6	6.07749251885811e-54	6	1.26851928817093e-53	6	3.11565796895942e-55	6	3.11565796895942e-55
<https://identifiers.org/wikipathways/WP3678_r117647>	WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	17	3	3.44917016054713e-32	3	4.42393925679112e-32	3	1.53924020908608e-32	3	1.11633467486049e-31	3	3.39294008466459e-32	3	4.97643760051659e-32	3	7.23087015450791e-33	3	7.23087015450791e-33
<https://identifiers.org/wikipathways/WP3679_r117678>	WP3679	Cell-type dependent selectivity of CCK2R signaling	13	2	9.02632832197287e-27	2	1.09778660278152e-26	2	4.78580527004663e-27	2	2.27329527794692e-26	2	8.91040469104683e-27	2	1.20423550567039e-26	2	2.64205153697754e-27	2	2.64205153697754e-27
<https://identifiers.org/wikipathways/WP368_r117795>	WP368	Mitochondrial long chain fatty acid beta-oxidation	17	3	3.44917016054713e-32	3	4.42393925679112e-32	3	1.53924020908608e-32	3	1.11633467486049e-31	3	3.39294008466459e-32	3	4.97643760051659e-32	3	7.23087015450791e-33	3	7.23087015450791e-33
<https://identifiers.org/wikipathways/WP3680_r117651>	WP3680	Physico-chemical features and toxicity-associated pathways	67	7	4.42520289009226e-104	7	1.26768170209461e-103	7	1.45716675409253e-105	7	6.33627539406359e-102	7	4.12804672634205e-104	7	2.08491475365194e-103	7	5.94881667370721e-107	7	5.94881667370721e-107
<https://identifiers.org/wikipathways/WP382_r119087>	WP382	MAPK signaling pathway	249	27	1.31029855586254e-261	27	5.41991780909011e-260	27	7.34516458123837e-267	27	5.39018150445209e-254	27	1.02460005542795e-261	27	3.14634801232297e-259	27	8.59610705724208e-272	27	8.59610705724208e-272
<https://identifiers.org/wikipathways/WP383_r118423>	WP383	Striated muscle contraction pathway	38	3	5.74282667087255e-70	3	1.06585679001753e-69	3	7.73214368454602e-71	3	1.06221855214998e-68	3	5.51300572342621e-70	3	1.42782750142356e-69	3	1.18198826685962e-71	3	1.18198826685962e-71
<https://identifiers.org/wikipathways/WP384_r121706>	WP384	Apoptosis modulation by HSP70	20	2	8.24868527261528e-41	2	1.13553208274304e-40	2	2.92665834116277e-41	2	3.72736179331358e-40	2	8.07639370756934e-41	2	1.32078746745235e-40	2	1.10907889464128e-41	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP3844_r107714>	WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	30	5	3.40705337594743e-51	5	5.30615796699976e-51	5	8.10216196844094e-52	5	2.75542493232372e-50	5	3.30881594714564e-51	5	6.54256027864477e-51	5	2.11061043754064e-52	5	2.11061043754064e-52
<https://identifiers.org/wikipathways/WP3845_r116460>	WP3845	Canonical and non-canonical Notch signaling	29	3	1.3197960007544e-54	3	2.09192113818244e-54	3	2.96456713078699e-55	3	1.15969062808239e-53	3	1.28025380040459e-54	3	2.60089854050687e-54	3	7.32088254436557e-56	3	7.32088254436557e-56
<https://identifiers.org/wikipathways/WP3850_r121711>	WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	39	2	2.24112775889497e-74	2	4.30745598711372e-74	2	2.69400156248706e-75	2	4.88821995498601e-73	2	2.14647902624631e-74	2	5.86643252087168e-74	2	3.7030540504033e-76	2	3.7030540504033e-76
<https://identifiers.org/wikipathways/WP3851_r121712>	WP3851	TLR4 signaling and tolerance	29	2	2.29929616856162e-57	2	3.70908003223837e-57	3	2.96456713078699e-55	2	2.1949980342253e-56	2	2.22781983829105e-57	3	2.60089854050687e-54	2	1.14210336105551e-58	3	7.32088254436557e-56
<https://identifiers.org/wikipathways/WP3853_r120593>	WP3853	ERK pathway in Huntington's disease	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP3858_r117850>	WP3858	Toll-like receptor signaling related to MyD88	31	2	7.19872072251074e-61	2	1.2027594804852e-60	2	1.36298514002564e-61	2	8.11030103445149e-60	2	6.95878028989097e-61	2	1.53311834329883e-60	2	2.86782440743483e-62	2	2.86782440743483e-62
<https://identifiers.org/wikipathways/WP3859_r117840>	WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	19	2	7.06499893599491e-39	2	9.55550247628267e-39	2	2.65447911543466e-39	2	2.93716109313104e-38	2	6.9255076042408e-39	2	1.10219714158899e-38	2	1.06138850217171e-39	2	1.06138850217171e-39
<https://identifiers.org/wikipathways/WP3863_r121717>	WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	66	4	4.49553523920749e-110	4	1.33297371246324e-109	4	1.323720006281e-111	4	7.57210580111022e-108	4	4.18412245503081e-110	4	2.22828979492298e-109	4	4.86599394598435e-113	4	4.86599394598435e-113
<https://identifiers.org/wikipathways/WP3865_r106524>	WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	60	2	7.83188487895129e-107	2	2.1675193366576e-106	3	1.78256761815581e-105	2	9.53123066237651e-105	2	7.32263311948849e-107	3	1.99793625824173e-103	2	1.30789414470468e-109	3	8.51875052917656e-107
<https://identifiers.org/wikipathways/WP3869_r118463>	WP3869	Cannabinoid receptor signaling	31	5	6.13705140350786e-53	5	9.72743329254822e-53	5	1.37852371581596e-53	5	5.39256142058309e-52	5	5.95318017188129e-53	5	1.20941782133564e-52	5	3.40421038313003e-54	5	3.40421038313003e-54
<https://identifiers.org/wikipathways/WP3872_r116648>	WP3872	Regulation of apoptosis by parathyroid hormone-related protein	22	2	1.29643804441838e-44	2	1.84884027089407e-44	2	4.10224437087301e-45	2	6.9199798936023e-44	2	1.26640284828159e-44	2	2.18666369223131e-44	2	1.39649740627035e-45	2	1.39649740627035e-45
<https://identifiers.org/wikipathways/WP3874_r116461>	WP3874	Canonical and non-canonical TGF-B signaling	17	3	3.44917016054713e-32	3	4.42393925679112e-32	3	1.53924020908608e-32	3	1.11633467486049e-31	3	3.39294008466459e-32	3	4.97643760051659e-32	3	7.23087015450791e-33	3	7.23087015450791e-33
<https://identifiers.org/wikipathways/WP3875_r117657>	WP3875	ATR signaling	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP3876_r116398>	WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP3877_r117828>	WP3877	MYD88 distinct input-output pathway	18	3	3.63070543215484e-34	3	4.73993491799039e-34	3	1.52989087595523e-34	3	1.27743319437309e-33	3	3.56734354696044e-34	3	5.37670328987387e-34	3	6.81086670754278e-35	3	6.81086670754278e-35
<https://identifiers.org/wikipathways/WP3878_r117656>	WP3878	ATM signaling in development and disease 	46	2	1.27234592274999e-85	2	2.76283128952081e-85	2	1.02948534061509e-86	2	4.93399252693674e-84	2	1.20882900843683e-85	2	3.98619287338225e-85	2	9.76425117340639e-88	2	9.76425117340639e-88
<https://identifiers.org/wikipathways/WP3879_r120671>	WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	18	4	1.55212657224619e-31	4	1.99077266555597e-31	4	6.92658094088733e-32	4	5.02350603687214e-31	4	1.52682303809906e-31	4	2.23939692023246e-31	4	3.25389156952851e-32	4	3.25389156952851e-32
<https://identifiers.org/wikipathways/WP3888_r116782>	WP3888	VEGFA-VEGFR2 signaling pathway	435	76	0	76	0	78	0	76	2.33301496591068e-314	76	0	78	1.09722098628424e-319	76	0	78	0
<https://identifiers.org/wikipathways/WP3890_r116457>	WP3890	Nanomaterial-induced inflammasome activation	10	3	1.47999496100436e-17	3	1.67656196142165e-17	3	9.87884390790066e-18	3	2.66591972334265e-17	3	1.46785679827857e-17	3	1.77839412722538e-17	3	6.76609763016104e-18	3	6.76609763016104e-18
<https://identifiers.org/wikipathways/WP3892_r120069>	WP3892	Development of pulmonary dendritic cells and macrophage subsets	13	1	1.05756629431435e-29	1	1.30922671768818e-29	1	5.2940323783702e-30	1	2.89591755152473e-29	1	1.04276239801604e-29	1	1.44826879816044e-29	1	2.76944605553207e-30	1	2.76944605553207e-30
<https://identifiers.org/wikipathways/WP3893_r118859>	WP3893	Development and heterogeneity of the ILC family	32	5	1.14045089960658e-54	5	1.83970369599021e-54	5	2.41978929819586e-55	5	1.08871902497575e-53	5	1.10499863979237e-54	5	2.30639870576527e-54	5	5.66483267083536e-56	5	5.66483267083536e-56
<https://identifiers.org/wikipathways/WP391_r117794>	WP391	Mitochondrial gene expression	19	1	8.24868527261532e-42	1	1.13553208274302e-41	1	2.92665834116278e-42	1	3.72736179331351e-41	1	8.07639370756939e-42	1	1.32078746745236e-41	1	1.10907889464129e-42	1	1.10907889464129e-42
<https://identifiers.org/wikipathways/WP3915_r122574>	WP3915	Angiopoietin-like protein 8 regulatory pathway	134	11	4.00242980486112e-179	11	3.3317728783895e-178	11	4.12547251827709e-182	11	8.72625610083603e-175	11	3.47958401564951e-179	11	9.07115723069704e-178	11	6.51874470471749e-185	11	6.51874470471749e-185
<https://identifiers.org/wikipathways/WP3924_r96137>	WP3924	Hfe effect on hepcidin production	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP3925_r117062>	WP3925	Amino acid metabolism	94	8	6.02060166504043e-138	8	2.69097746524123e-137	9	9.78254504731932e-138	8	7.01497549394243e-135	8	5.45366606155427e-138	9	1.05401324426348e-134	8	4.92712610544857e-142	9	1.08506266011106e-139
<https://identifiers.org/wikipathways/WP3926_r106298>	WP3926	ApoE and miR-146 in inflammation and atherosclerosis	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP3927_r117666>	WP3927	BMP signaling in eyelid development	20	3	4.70999929066328e-38	3	6.37033498418848e-38	3	1.76965274362308e-38	3	1.95810739542073e-37	3	4.61700506949384e-38	3	7.34798094392669e-38	3	7.07592334781133e-39	3	7.07592334781133e-39
<https://identifiers.org/wikipathways/WP3929_r119247>	WP3929	Chemokine signaling pathway	166	27	4.32045763190133e-182	27	4.68771759888089e-181	27	1.88227079468803e-185	27	3.27960396648671e-177	27	3.69086954695558e-182	27	1.44647867641478e-180	27	1.32405750662573e-188	27	1.32405750662573e-188
<https://identifiers.org/wikipathways/WP3931_r117717>	WP3931	Embryonic stem cell pluripotency pathways	116	12	4.42120216125811e-156	12	2.67855763212868e-155	12	1.27936790012496e-158	12	2.15871132893811e-152	12	3.92520050427011e-156	12	6.27616206375944e-155	12	5.33064952398083e-161	12	5.33064952398083e-161
<https://identifiers.org/wikipathways/WP3932_r120304>	WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	302	57	2.0737546685682e-256	57	1.23012357759501e-254	57	3.59430791320137e-262	57	4.64373034025953e-248	57	1.58339878014782e-256	57	8.46597033831476e-254	57	1.39183792638961e-267	57	1.39183792638961e-267
<https://identifiers.org/wikipathways/WP3933_r116372>	WP3933	Kennedy pathway from sphingolipids	14	1	8.66857618290436e-32	1	1.0923226488459e-31	1	4.09709526242026e-32	1	2.58070310129512e-31	1	8.53723600714867e-32	1	1.21849538306767e-31	1	2.0310238228103e-32	1	2.0310238228103e-32
<https://identifiers.org/wikipathways/WP3935_r118425>	WP3935	Leptin-insulin signaling overlap	17	4	1.47365795109374e-29	4	1.85694850303806e-29	4	6.9650619461145e-30	4	4.3871952722017e-29	4	1.45133012121528e-29	4	2.07144215121504e-29	4	3.45274049877754e-30	4	3.45274049877754e-30
<https://identifiers.org/wikipathways/WP3937_r120792>	WP3937	Microglia pathogen phagocytosis pathway	40	11	3.57892751235664e-54	11	5.97965827733189e-54	11	6.77623872991367e-55	11	4.03213023876946e-53	11	3.45963834297066e-54	11	7.62207568543791e-54	11	1.42577217091932e-55	11	1.42577217091932e-55
<https://identifiers.org/wikipathways/WP3940_r119248>	WP3940	One-carbon metabolism and related pathways	52	4	1.68969803344414e-89	4	3.93318682684688e-89	4	1.09115878590161e-90	4	9.09363412519926e-88	4	1.59799301622978e-89	4	5.86431117120948e-89	4	8.3770782809013e-92	4	8.3770782809013e-92
<https://identifiers.org/wikipathways/WP3941_r117040>	WP3941	Oxidative damage response	40	8	6.89074007936328e-61	8	1.21348431631601e-60	8	1.10003975489222e-61	8	9.94943058662813e-60	8	6.63796300021444e-61	8	1.58573506816781e-60	8	1.97260577952004e-62	8	1.97260577952004e-62
<https://identifiers.org/wikipathways/WP3942_r106517>	WP3942	PPAR signaling pathway	68	9	7.3347737903281e-101	9	2.06526477299588e-100	9	2.55425141250705e-102	9	9.68253283272869e-99	9	6.8500348705063e-101	9	3.36910641330411e-100	9	1.0989447335228e-103	9	1.0989447335228e-103
<https://identifiers.org/wikipathways/WP3943_r117818>	WP3943	Robo4 and VEGF signaling pathways crosstalk	6	2	4.3357451379222e-11	2	4.65628463881452e-11	2	3.44081297957319e-11	2	6.07082696694489e-11	2	4.31537161890774e-11	2	4.81599581528983e-11	2	2.77115230785602e-11	2	2.77115230785602e-11
<https://identifiers.org/wikipathways/WP3944_r120596>	WP3944	Serotonin and anxiety-related events	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP3945_r116679>	WP3945	TYROBP causal network in microglia	60	12	8.73393254570849e-83	12	2.03303713180808e-82	12	5.64012447436932e-84	12	4.70043673323991e-81	12	8.2599156393742e-83	12	3.03122198065115e-82	12	4.33005396155784e-85	12	4.33005396155784e-85
<https://identifiers.org/wikipathways/WP3947_r106483>	WP3947	Serotonin and anxiety	17	2	6.0511757202581e-35	2	7.89989152998412e-35	2	2.54981812659205e-35	2	2.12905532395515e-34	2	5.94557257826735e-35	2	8.96117214978988e-35	2	1.13514445125714e-35	2	1.13514445125714e-35
<https://identifiers.org/wikipathways/WP395_r120704>	WP395	IL-4 signaling pathway	53	4	5.13497682181996e-91	4	1.21621296279393e-90	4	3.13449407332175e-92	4	2.9991450444029e-89	4	4.85072335968973e-91	4	1.82828524749467e-90	4	2.28269999428157e-93	4	2.28269999428157e-93
<https://identifiers.org/wikipathways/WP3953_r106206>	WP3953	mRNA, protein, and metabolite inducation pathway by cyclosporin A	8	2	8.39650474543144e-16	2	9.34403866498999e-16	2	5.93718518864845e-16	2	1.39072145567707e-15	2	8.33742661422241e-16	2	9.82859154313241e-16	2	4.29196126339885e-16	2	4.29196126339885e-16
<https://identifiers.org/wikipathways/WP3958_r117148>	WP3958	GPR40 pathway	15	3	3.70148203010017e-28	3	4.58229351190859e-28	3	1.85291133242956e-28	3	1.01357114303365e-27	3	3.64966839305608e-28	3	5.06894079356153e-28	3	9.6930611943622e-29	3	9.6930611943622e-29
<https://identifiers.org/wikipathways/WP3959_r118468>	WP3959	DNA IR-double strand breaks and cellular response via ATM	57	5	1.82917492650164e-94	5	4.56359664899302e-94	5	9.43226994912602e-96	5	1.36514515693208e-92	5	1.72199423078746e-94	5	7.03096223551319e-94	5	5.864087276713e-97	5	5.864087276713e-97
<https://identifiers.org/wikipathways/WP3965_r117154>	WP3965	Lipid metabolism pathway	29	2	2.29929616856162e-57	2	3.70908003223837e-57	2	4.87860745604008e-58	2	2.1949980342253e-56	2	2.22781983829105e-57	2	4.64999739065581e-57	2	1.14210336105551e-58	2	1.14210336105551e-58
<https://identifiers.org/wikipathways/WP3967_r108139>	WP3967	miR-509-3p alteration of YAP1/ECM axis	18	9	1.48779194553177e-19	9	1.74636258699356e-19	9	8.85031215585193e-20	9	3.16922095198423e-19	9	1.47213108536656e-19	9	1.88382148773827e-19	9	5.44179955631633e-20	9	5.44179955631633e-20
<https://identifiers.org/wikipathways/WP3969_r106437>	WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	15	2	6.50143213717833e-31	2	8.1924198663443e-31	2	3.07282144681519e-31	2	1.93552732597132e-30	2	6.40292700536153e-31	2	9.13871537300759e-31	2	1.52326786710774e-31	2	1.52326786710774e-31
<https://identifiers.org/wikipathways/WP3971_r117820>	WP3971	OSX and miRNAs in tooth development	36	4	5.27794950821126e-64	4	9.29466048168511e-64	4	8.42573397991631e-65	4	7.62074779586338e-63	4	5.08433537602599e-64	4	1.21459081706692e-63	4	1.51091371666923e-65	4	1.51091371666923e-65
<https://identifiers.org/wikipathways/WP3972_r108157>	WP3972	PDGFR-beta pathway	29	3	1.3197960007544e-54	3	2.09192113818244e-54	3	2.96456713078699e-55	3	1.15969062808239e-53	3	1.28025380040459e-54	3	2.60089854050687e-54	3	7.32088254436557e-56	3	7.32088254436557e-56
<https://identifiers.org/wikipathways/WP3981_r108114>	WP3981	miRNA regulation of prostate cancer signaling pathways	35	5	8.74029024998649e-60	5	1.48617077045911e-59	5	1.56332753410167e-60	5	1.06966086187373e-58	5	8.43918323054291e-60	5	1.91015054027665e-59	5	3.11857291740985e-61	5	3.11857291740985e-61
<https://identifiers.org/wikipathways/WP3982_r108115>	WP3982	miRNA regulation of p53 pathway in prostate cancer	34	2	5.02661857924887e-66	2	8.85205760160482e-66	2	8.02450855230155e-67	2	7.25785504367946e-65	2	4.84222416764384e-66	2	1.15675315911137e-65	2	1.43896544444691e-67	2	1.43896544444691e-67
<https://identifiers.org/wikipathways/WP399_r119242>	WP399	Wnt signaling pathway and pluripotency	101	14	1.35454545284454e-133	14	6.15796685666803e-133	14	9.96060722136432e-136	14	1.70970681946831e-130	14	1.22561785648006e-133	14	1.25979643482637e-132	14	9.96167460727822e-138	14	9.96167460727822e-138
<https://identifiers.org/wikipathways/WP3995_r119304>	WP3995	Prion disease pathway	33	3	1.46895634453555e-61	3	2.49776600077157e-61	3	2.62744123378428e-62	3	1.79774934768694e-60	3	1.41835012278032e-61	3	3.21033704248181e-61	3	5.24129902085691e-63	3	5.24129902085691e-63
<https://identifiers.org/wikipathways/WP3996_r107156>	WP3996	Ethanol effects on histone modifications	31	1	8.34634286667934e-64	1	1.41918522771117e-63	1	1.49286433737747e-64	1	1.02144849300395e-62	1	8.05880751579743e-64	1	1.82405513777375e-63	1	2.97801080730502e-65	1	2.97801080730502e-65
<https://identifiers.org/wikipathways/WP3998_r119303>	WP3998	Prader-Willi and Angelman syndrome	74	3	6.67526834077041e-124	3	2.31010224066987e-123	3	1.19020139513152e-125	3	2.32957974810626e-121	3	6.1497520898446e-124	3	4.15435793947444e-123	3	2.73293002201386e-127	3	2.73293002201386e-127
<https://identifiers.org/wikipathways/WP400_r116725>	WP400	p38 MAPK signaling pathway	34	6	1.23774996068736e-55	6	2.03204129444872e-55	6	2.48081468619862e-56	6	1.28367249476964e-54	6	1.19788258342709e-55	6	2.56877044656405e-55	6	5.50584048568706e-57	6	5.50584048568706e-57
<https://identifiers.org/wikipathways/WP4008_r117805>	WP4008	NO/cGMP/PKG mediated neuroprotection	47	6	8.72066758167033e-77	6	1.7972693711385e-76	6	8.35912045216038e-78	6	2.64342912600185e-75	6	8.31395810761129e-77	6	2.52984394443534e-76	6	9.29324980966354e-79	6	9.29324980966354e-79
<https://identifiers.org/wikipathways/WP4016_r120667>	WP4016	DNA IR-damage and cellular response via ATR	83	7	5.47148480473253e-126	7	2.06257119739059e-125	7	7.39074099128785e-128	7	2.85727844391999e-123	7	5.0123389831414e-126	7	3.86219399908763e-125	7	1.30789500039509e-129	7	1.30789500039509e-129
<https://identifiers.org/wikipathways/WP4018_r117168>	WP4018	Clear cell renal cell carcinoma pathways	86	13	1.50789722156924e-116	13	5.40012028051491e-116	13	2.40578107499717e-118	13	6.18383423365037e-114	13	1.38604819607133e-116	13	9.86968282219524e-116	13	4.97713618074086e-120	13	4.97713618074086e-120
<https://identifiers.org/wikipathways/WP4022_r120306>	WP4022	Pyrimidine metabolism	99	5	1.68085805300062e-151	5	8.60346646379594e-151	5	8.40988299191913e-154	5	3.70924075301392e-148	5	1.50900303274213e-151	5	1.86153435722221e-150	5	5.85941898779347e-156	5	5.85941898779347e-156
<https://identifiers.org/wikipathways/WP4030_r93221>	WP4030	SCFA and skeletal muscle substrate metabolism	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP405_r118377>	WP405	Eukaryotic transcription initiation	41	1	1.40991627454169e-80	1	2.85552568272392e-80	1	1.43009079152415e-81	1	3.93649772856209e-79	1	1.34570998409307e-80	1	3.98646505498462e-80	1	1.67645192086866e-82	1	1.67645192086866e-82
<https://identifiers.org/wikipathways/WP408_r116900>	WP408	Oxidative stress response	33	2	2.55322655481262e-64	2	4.41821816174222e-64	2	4.31435342164911e-65	2	3.39411456454429e-63	2	2.46241340760472e-64	2	5.72592813760127e-64	2	8.15978052027538e-66	2	8.15978052027538e-66
<https://identifiers.org/wikipathways/WP410_r117108>	WP410	Exercise-induced circadian regulation	48	4	2.39201033477013e-83	4	5.19412282429946e-83	4	1.93543244035641e-84	4	9.27590595064114e-82	4	2.27259853586122e-83	4	7.49404260195863e-83	4	1.83567922060038e-85	4	1.83567922060038e-85
<https://identifiers.org/wikipathways/WP411_r122796>	WP411	mRNA processing	127	3	2.21284397839469e-190	3	1.87294410704001e-189	3	2.1608879063232e-193	3	5.21749128584056e-186	3	1.92166265617399e-190	3	5.13953829621304e-189	3	3.24543094443831e-196	3	3.24543094443831e-196
<https://identifiers.org/wikipathways/WP4136_r120387>	WP4136	Fibrin complement receptor 3 signaling pathway	43	8	9.87148833522982e-66	8	1.83212788278087e-65	8	1.32909750829583e-66	8	1.82587402475446e-64	8	9.47644336314048e-66	8	2.45432838788449e-65	8	2.03174918161169e-67	8	2.03174918161169e-67
<https://identifiers.org/wikipathways/WP4141_r122432>	WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	22	4	3.1757438299569e-39	4	4.37179851856077e-39	4	1.12676346134767e-39	4	1.43503429042571e-38	4	3.10941157741423e-39	4	5.08503174969152e-39	4	4.26995374436899e-40	4	4.26995374436899e-40
<https://identifiers.org/wikipathways/WP4142_r119292>	WP4142	Metabolism of spingolipids in ER and Golgi apparatus	31	3	4.13686484186948e-58	3	6.79158186647299e-58	3	8.29149293515588e-59	3	4.29034924722474e-57	3	4.00361826011728e-58	3	8.58546272247344e-58	3	1.84018732810397e-59	3	1.84018732810397e-59
<https://identifiers.org/wikipathways/WP4146_r107552>	WP4146	Macrophage markers	9	4	1.07118409289841e-12	4	1.17104164568987e-12	4	8.02410578245827e-13	4	1.6313162675092e-12	4	1.06489781430156e-12	4	1.22144821402278e-12	4	6.12248274223845e-13	4	6.12248274223845e-13
<https://identifiers.org/wikipathways/WP4147_r94394>	WP4147	PTF1A related regulatory pathway	11	2	1.68302256281873e-22	2	1.9755232884542e-22	2	1.00116653346741e-22	2	3.58509157464281e-22	2	1.66530665765446e-22	2	2.13101978250936e-22	2	6.15588185103648e-23	2	6.15588185103648e-23
<https://identifiers.org/wikipathways/WP4148_r110682>	WP4148	Splicing factor NOVA regulated synaptic proteins	42	2	2.96082417653763e-79	2	5.99660393372014e-79	2	3.00319066220078e-80	2	8.26664522998068e-78	2	2.82599096659547e-79	2	8.37157661546776e-79	2	3.52054903382426e-81	2	3.52054903382426e-81
<https://identifiers.org/wikipathways/WP4149_r107159>	WP4149	White fat cell differentiation	32	3	7.67863543734494e-60	3	1.28294344585086e-59	3	1.45385081602734e-60	3	8.65098777008135e-59	3	7.42269897588374e-60	3	1.63532623285206e-59	3	3.05901270126375e-61	3	3.05901270126375e-61
<https://identifiers.org/wikipathways/WP4150_r116677>	WP4150	Wnt signaling in kidney disease	37	6	1.12418565208399e-60	6	1.94534145661509e-60	6	1.89960981155211e-61	6	1.49442864276883e-59	6	1.08420062336836e-60	6	2.52112615898585e-60	6	3.59275136307724e-62	6	3.59275136307724e-62
<https://identifiers.org/wikipathways/WP4155_r119086>	WP4155	Endometrial cancer	63	5	3.11011980428037e-103	5	8.60743603780098e-103	5	1.14542949327807e-104	5	3.78494700833642e-101	5	2.90789083808012e-103	5	1.39274511558285e-102	5	5.19377843803687e-106	5	5.19377843803687e-106
<https://identifiers.org/wikipathways/WP4157_r120415>	WP4157	GABA metabolism (aka GHB)	12	1	1.38866589568813e-27	1	1.68890246581776e-27	1	7.36277733853336e-28	1	3.4973773506876e-27	1	1.3708314909303e-27	1	1.85267000872368e-27	1	4.06469467227321e-28	1	4.06469467227321e-28
<https://identifiers.org/wikipathways/WP4172_r122580>	WP4172	PI3K-Akt signaling pathway	340	57	3.01136177393764e-286	57	3.21056025050999e-284	57	7.72959574119811e-293	57	1.05941626225909e-276	57	2.21187020735702e-286	57	2.91402011349471e-283	57	4.94317818090976e-299	57	4.94317818090976e-299
<https://identifiers.org/wikipathways/WP4186_r105819>	WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	9	2	4.4399848830131e-18	2	5.02968588426499e-18	2	2.96365317237024e-18	2	7.99775917002785e-18	2	4.40357039483576e-18	2	5.33518238167616e-18	2	2.02982928904833e-18	2	2.02982928904833e-18
<https://identifiers.org/wikipathways/WP4191_r106347>	WP4191	Caloric restriction and aging	9	2	4.4399848830131e-18	2	5.02968588426499e-18	2	2.96365317237024e-18	2	7.99775917002785e-18	2	4.40357039483576e-18	2	5.33518238167616e-18	2	2.02982928904833e-18	2	2.02982928904833e-18
<https://identifiers.org/wikipathways/WP4197_r120647>	WP4197	Immune response to tuberculosis	23	6	4.17070437188237e-36	6	5.64093162849879e-36	6	1.56702750447824e-36	6	1.73390409864504e-35	6	4.08835798903678e-36	6	6.50663712584686e-36	6	6.26573012448694e-37	6	6.26573012448694e-37
<https://identifiers.org/wikipathways/WP4204_r108297>	WP4204	Tumor suppressor activity of SMARCB1	31	4	1.78195453063529e-55	4	2.87453702498469e-55	4	3.78092077843101e-56	4	1.70112347652466e-54	4	1.72656037467559e-55	4	3.60374797775818e-55	4	8.85130104817997e-57	4	8.85130104817997e-57
<https://identifiers.org/wikipathways/WP4205_r118937>	WP4205	MET in type 1 papillary renal cell carcinoma	59	3	1.33631796809937e-102	3	3.57280159832173e-102	3	5.50516299407121e-104	3	1.38194372399437e-100	3	1.25228010292937e-102	3	5.68745854846149e-102	3	2.77285329724695e-105	3	2.77285329724695e-105
<https://identifiers.org/wikipathways/WP4206_r119286>	WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	20	2	8.24868527261528e-41	2	1.13553208274304e-40	2	2.92665834116277e-41	2	3.72736179331358e-40	2	8.07639370756934e-41	2	1.32078746745235e-40	2	1.10907889464128e-41	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP4210_r95880>	WP4210	Tryptophan catabolism leading to NAD+ production	16	4	1.48059281204007e-27	4	1.83291740476345e-27	4	7.41164532971821e-28	4	4.05428457213461e-27	4	1.45986735722243e-27	4	2.02757631742461e-27	4	3.87722447774487e-28	4	3.87722447774487e-28
<https://identifiers.org/wikipathways/WP4211_r107570>	WP4211	Transcriptional cascade regulating adipogenesis	13	2	9.02632832197287e-27	2	1.09778660278152e-26	2	4.78580527004663e-27	2	2.27329527794692e-26	2	8.91040469104683e-27	2	1.20423550567039e-26	2	2.64205153697754e-27	2	2.64205153697754e-27
<https://identifiers.org/wikipathways/WP4216_r119088>	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	73	6	7.28688750575001e-115	6	2.35458889490205e-114	6	1.62326038776782e-116	6	1.84055243919059e-112	6	6.74370962868297e-115	6	4.09929608596895e-114	6	4.59311646080794e-118	6	4.59311646080794e-118
<https://identifiers.org/wikipathways/WP4217_r120623>	WP4217	Ebola virus infection in host	140	21	2.29981009764563e-165	21	1.79107636642454e-164	21	2.94334971765473e-168	21	3.66416123023601e-161	21	2.00820106544682e-165	21	4.72535343445459e-164	21	5.69960623116813e-171	21	5.69960623116813e-171
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	52	5	5.89028734458625e-87	5	1.34750980687774e-86	5	4.02419360240507e-88	5	2.9208752810139e-85	5	5.57699562664212e-87	5	1.99269293597697e-86	5	3.25700803561438e-89	5	3.25700803561438e-89
<https://identifiers.org/wikipathways/WP4223_r119284>	WP4223	Ras signaling	184	15	8.67151984506593e-224	15	1.53673834524893e-222	15	7.6645138230597e-228	15	6.62404510918224e-218	15	7.17154019704171e-224	15	5.97846695492676e-222	15	1.20304695755642e-231	15	1.20304695755642e-231
<https://identifiers.org/wikipathways/WP4224_r120400>	WP4224	Purine metabolism and related disorders	24	3	1.39012004762813e-45	3	2.01771417464122e-45	3	4.15417151480801e-46	3	8.06381444219644e-45	3	1.35633366754257e-45	3	2.40637631202491e-45	3	1.34040439621149e-46	3	1.34040439621149e-46
<https://identifiers.org/wikipathways/WP4225_r120401>	WP4225	Pyrimidine metabolism and related diseases	24	2	2.42886438141197e-48	2	3.58811056545563e-48	2	6.8550685062838e-49	2	1.53110400801198e-47	2	2.36707446342502e-48	2	4.3150800574265e-48	2	2.0965657917802e-49	2	2.0965657917802e-49
<https://identifiers.org/wikipathways/WP4239_r118997>	WP4239	Epithelial to mesenchymal transition in colorectal cancer	161	26	1.10899764898918e-178	26	1.12638657335817e-177	26	5.9880274686457e-182	26	6.16932240325244e-174	26	9.51534418615125e-179	26	3.36893583307157e-177	26	5.15357448303229e-185	26	5.15357448303229e-185
<https://identifiers.org/wikipathways/WP4240_r106495>	WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP4241_r106520>	WP4241	Type 2 papillary renal cell carcinoma	34	7	3.04663311752047e-53	7	4.91463701643101e-53	7	6.46429426803744e-54	7	2.90843510957813e-52	7	2.95192493773105e-53	7	6.16137939968718e-53	7	1.51331958492312e-54	7	1.51331958492312e-54
<https://identifiers.org/wikipathways/WP4249_r117749>	WP4249	Hedgehog signaling pathway	43	5	6.38378711425794e-73	5	1.24858048941797e-72	5	7.25118283154916e-74	5	1.51191785625269e-71	5	6.10713490787453e-73	5	1.71456823540742e-72	5	9.45178697746178e-75	5	9.45178697746178e-75
<https://identifiers.org/wikipathways/WP4255_r119279>	WP4255	Non-small cell lung cancer	72	9	1.90253403935558e-106	9	5.73915226047082e-106	9	5.29769123899455e-108	9	3.47539009319912e-104	9	1.76873031199214e-106	9	9.67232217220383e-106	9	1.84802153784783e-109	9	1.84802153784783e-109
<https://identifiers.org/wikipathways/WP4258_r117770>	WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	98	16	1.0086142479119e-125	16	4.21171593011578e-125	16	9.7737532093549e-128	16	8.52983924854117e-123	16	9.17751460542363e-126	16	8.27714281333757e-125	16	1.26644509387115e-129	16	1.26644509387115e-129
<https://identifiers.org/wikipathways/WP4259_r119256>	WP4259	Disorders of folate metabolism and transport	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP4262_r108103>	WP4262	Breast cancer pathway	156	17	1.09750322432393e-190	17	1.19079635025344e-189	17	4.78143391794386e-194	17	8.33100619052022e-186	17	9.37572260501704e-191	17	3.67441402401277e-189	17	3.36343393806797e-197	17	3.36343393806797e-197
<https://identifiers.org/wikipathways/WP4263_r105482>	WP4263	Pancreatic adenocarcinoma pathway	89	9	3.21393337379687e-129	9	1.29711235830045e-128	9	3.47858492588015e-131	9	2.31496819986534e-126	9	2.93098887762711e-129	9	2.50846635449014e-128	9	5.00035345351488e-133	9	5.00035345351488e-133
<https://identifiers.org/wikipathways/WP4271_r120408>	WP4271	Vitamin B12 disorders	16	1	7.11903025912711e-36	1	9.29399003527545e-36	1	2.99978603128478e-36	1	2.50477096935903e-35	1	6.99479126854986e-36	1	1.05425554703409e-35	1	1.33546406030252e-36	1	1.33546406030252e-36
<https://identifiers.org/wikipathways/WP428_r116549>	WP428	Wnt signaling	116	19	1.04936157623992e-141	19	5.65036213839019e-141	19	4.45356114580001e-144	19	2.94008175228822e-138	19	9.38923307261118e-142	19	1.25219863010703e-140	19	2.65868816368885e-146	19	2.65868816368885e-146
<https://identifiers.org/wikipathways/WP4288_r120407>	WP4288	MTHFR deficiency	27	2	8.39175708361454e-54	2	1.30693545985214e-53	3	1.21133308247379e-51	2	6.78676091705344e-53	2	8.14979297326518e-54	3	9.00273483334063e-51	2	5.19854787571575e-55	3	3.32880348974998e-52
<https://identifiers.org/wikipathways/WP4290_r118611>	WP4290	Metabolic reprogramming in colon cancer	42	5	2.57281466721137e-71	5	4.94495947320648e-71	5	3.09271379373513e-72	5	5.6116765083239e-70	5	2.46415792213074e-71	5	6.73466453396078e-71	5	4.25110604986296e-73	5	4.25110604986296e-73
<https://identifiers.org/wikipathways/WP4297_r120409>	WP4297	Thiamine metabolic pathways	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP4298_r121698>	WP4298	Acute viral myocarditis	98	12	4.39355535001879e-134	12	1.96375031881644e-133	12	3.41390124852979e-136	12	5.11920316712287e-131	12	3.97983208905696e-134	12	3.98533622440792e-133	12	3.59558769458402e-138	12	3.59558769458402e-138
<https://identifiers.org/wikipathways/WP43_r122562>	WP43	Oxidation by cytochrome P450	64	6	3.31746112456581e-102	6	9.18126510698789e-102	6	1.2217914594966e-103	6	4.03727680889228e-100	6	3.10175022728556e-102	6	1.48559478995502e-101	6	5.54003033390586e-105	6	5.54003033390586e-105
<https://identifiers.org/wikipathways/WP430_r122069>	WP430	Statin inhibition of cholesterol production	31	3	4.13686484186948e-58	3	6.79158186647299e-58	3	8.29149293515588e-59	3	4.29034924722474e-57	3	4.00361826011728e-58	3	8.58546272247344e-58	3	1.84018732810397e-59	3	1.84018732810397e-59
<https://identifiers.org/wikipathways/WP4300_r105311>	WP4300	Extracellular vesicles in the crosstalk of cardiac cells	25	5	2.98180750216227e-42	5	4.25233262305644e-42	5	9.43516205300799e-43	5	1.59159537552852e-41	5	2.91272655104765e-42	5	5.02932649213194e-42	5	3.21194403442183e-43	5	3.21194403442183e-43
<https://identifiers.org/wikipathways/WP4304_r119229>	WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	31	7	4.32533538108378e-48	7	6.61880037835994e-48	7	1.08898844114392e-48	7	3.21945161199811e-47	7	4.20550506882215e-48	7	8.09345861517305e-48	7	2.99259433728526e-49	7	2.99259433728526e-49
<https://identifiers.org/wikipathways/WP4312_r119230>	WP4312	Rett syndrome causing genes	49	4	6.7361210576859e-85	4	1.48837437655364e-84	4	5.15134109600562e-86	4	2.83542976657155e-83	4	6.39249875184856e-85	4	2.16514202533002e-84	4	4.6341206496351e-87	4	4.6341206496351e-87
<https://identifiers.org/wikipathways/WP4313_r120500>	WP4313	Ferroptosis	65	6	1.22938981241033e-103	6	3.46161387444424e-103	6	4.28120996589089e-105	6	1.62290038700056e-101	6	1.14814216841435e-103	6	5.64699773959528e-103	6	1.84195381945718e-106	6	1.84195381945718e-106
<https://identifiers.org/wikipathways/WP4320_r116686>	WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	26	2	5.3458600680803e-52	2	8.1804478783338e-52	2	1.34592564719308e-52	2	3.97905278951686e-51	2	5.19775685183789e-52	2	1.00030387037117e-51	2	3.69867054416676e-53	2	3.69867054416676e-53
<https://identifiers.org/wikipathways/WP4321_r106178>	WP4321	Thermogenesis	108	13	2.56846554930837e-144	13	1.33707737192298e-143	13	1.21644971587367e-146	13	6.1377317808752e-141	13	2.30328587351795e-144	13	2.91623523852917e-143	13	8.0496876852064e-149	13	8.0496876852064e-149
<https://identifiers.org/wikipathways/WP4329_r101725>	WP4329	miRNAs involvement in the immune response in sepsis	66	9	4.9501061740775e-98	9	1.34652543359852e-97	10	3.57280233771763e-97	9	5.55337037626943e-96	9	4.63351634399212e-98	10	3.69111054831611e-95	9	9.21432354738472e-101	10	1.79955738880422e-98
<https://identifiers.org/wikipathways/WP4331_r107654>	WP4331	Neovascularisation processes	41	10	5.42125147554982e-58	10	9.38117758625773e-58	10	9.16064217218498e-59	10	7.20670422158103e-57	10	5.2284284346911e-58	10	1.21578307676426e-57	10	1.73256157399446e-59	10	1.73256157399446e-59
<https://identifiers.org/wikipathways/WP4336_r108198>	WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	93	14	1.66396652572214e-123	14	6.60210438891317e-123	14	1.90346459475205e-125	14	1.10603351078739e-120	14	1.51918602502192e-123	14	1.26652774095441e-122	14	2.88202008126095e-127	14	2.88202008126095e-127
<https://identifiers.org/wikipathways/WP4337_r108190>	WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	18	3	3.63070543215484e-34	3	4.73993491799039e-34	3	1.52989087595523e-34	3	1.27743319437309e-33	3	3.56734354696044e-34	3	5.37670328987387e-34	3	6.81086670754278e-35	3	6.81086670754278e-35
<https://identifiers.org/wikipathways/WP4341_r122900>	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	93	13	1.31242430197798e-125	13	5.29681727477272e-125	14	1.90346459475205e-125	13	9.45327786997728e-123	13	1.19688263085579e-125	14	1.26652774095441e-122	13	2.04191706162215e-129	14	2.88202008126095e-127
<https://identifiers.org/wikipathways/WP4352_r102218>	WP4352	Ciliary landscape	214	12	2.02122776672286e-259	12	6.08897788359321e-258	12	3.17977363934779e-264	12	1.87270639098458e-252	12	1.61399346950898e-259	12	3.04331470087579e-257	12	9.83411289178496e-269	12	9.83411289178496e-269
<https://identifiers.org/wikipathways/WP4357_r98705>	WP4357	NRF2-ARE regulation	23	2	1.7376500595351e-46	2	2.52214271830156e-46	2	5.1927143935101e-47	2	1.00797680527456e-45	2	1.69541708442819e-46	2	3.00797039003113e-46	2	1.67550549526437e-47	2	1.67550549526437e-47
<https://identifiers.org/wikipathways/WP437_r120689>	WP437	EGF/EGFR signaling pathway	162	19	4.64334579088239e-193	19	5.38114376271497e-192	19	1.6329776221701e-196	19	4.80619943745597e-188	19	3.94947314256589e-193	19	1.7129330992579e-191	19	9.39250261774583e-200	19	9.39250261774583e-200
<https://identifiers.org/wikipathways/WP4389_r116629>	WP4389	Bile acids synthesis and enterohepatic circulation 	13	1	1.05756629431435e-29	1	1.30922671768818e-29	1	5.2940323783702e-30	1	2.89591755152473e-29	1	1.04276239801604e-29	1	1.44826879816044e-29	1	2.76944605553207e-30	1	2.76944605553207e-30
<https://identifiers.org/wikipathways/WP4396_r98945>	WP4396	Nonalcoholic fatty liver disease	155	10	1.79152852592666e-204	10	2.14560467192266e-203	11	9.99028945083905e-206	10	2.16481026027483e-199	10	1.52050552849817e-204	11	1.13259728540089e-200	10	2.9451024412009e-211	11	5.46450371135518e-209
<https://identifiers.org/wikipathways/WP4397_r108140>	WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	3	2	0.00176886792452827	2	0.00180072028811527	2	0.00166944908180295	2	0.00192431045542016	2	0.00176678445229683	2	0.00181598062953988	2	0.00158144438587235	2	0.00158144438587235
<https://identifiers.org/wikipathways/WP4462_r102079>	WP4462	Platelet-mediated interactions with vascular and circulating cells	19	9	1.65794996862776e-21	9	1.98094860614192e-21	9	9.31095963240239e-22	9	3.84025498008295e-21	9	1.63857590052518e-21	9	2.15488309855671e-21	9	5.42466902256087e-22	9	5.42466902256087e-22
<https://identifiers.org/wikipathways/WP4478_r121699>	WP4478	LTF danger signal response pathway	19	5	5.89808097453552e-31	5	7.56493612911274e-31	6	7.94017061857046e-29	5	1.90893229401143e-30	5	5.80192754477645e-31	6	2.36144405238514e-28	5	1.23647879642085e-31	6	3.9361241686064e-29
<https://identifiers.org/wikipathways/WP4479_r121700>	WP4479	Supression of HMGB1 mediated inflammation by THBD	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP4480_r121701>	WP4480	Altered glycosylation of MUC1 in tumor microenvironment	9	2	4.4399848830131e-18	2	5.02968588426499e-18	2	2.96365317237024e-18	2	7.99775917002785e-18	2	4.40357039483576e-18	2	5.33518238167616e-18	2	2.02982928904833e-18	2	2.02982928904833e-18
<https://identifiers.org/wikipathways/WP4481_r121702>	WP4481	Resistin as a regulator of inflammation	33	4	6.33487423580948e-59	4	1.05842834282695e-58	5	4.37790826976221e-57	4	7.13706491031721e-58	4	6.12372665510397e-59	5	4.53312431746599e-56	4	2.52368547854254e-60	5	9.71618909238888e-58
<https://identifiers.org/wikipathways/WP4482_r121703>	WP4482	Vitamin D in inflammatory diseases	22	1	1.51100005176967e-47	1	2.19316758113179e-47	1	4.51540382044357e-48	1	8.76501569803979e-47	1	1.47427572558972e-47	1	2.61562642611399e-47	1	1.4569613002299e-48	1	1.4569613002299e-48
<https://identifiers.org/wikipathways/WP4483_r107927>	WP4483	Relationship between inflammation, COX-2 and EGFR	26	3	3.06317781901004e-49	3	4.60559215550192e-49	3	8.16528225963824e-50	3	2.09828717100526e-48	3	2.98177984733773e-49	3	5.58502994290572e-49	3	2.36714914826671e-50	3	2.36714914826671e-50
<https://identifiers.org/wikipathways/WP4484_r107333>	WP4484	Control of immune tolerance by vasoactive intestinal peptide	15	3	3.70148203010017e-28	3	4.58229351190859e-28	3	1.85291133242956e-28	3	1.01357114303365e-27	3	3.64966839305608e-28	3	5.06894079356153e-28	3	9.6930611943622e-29	3	9.6930611943622e-29
<https://identifiers.org/wikipathways/WP4493_r120800>	WP4493	Cells and molecules involved in local acute inflammatory response 	17	4	1.47365795109374e-29	4	1.85694850303806e-29	5	2.51995941210423e-27	4	4.3871952722017e-29	4	1.45133012121528e-29	5	6.8937594792436e-27	4	3.45274049877754e-30	5	1.31825632243325e-27
<https://identifiers.org/wikipathways/WP4494_r103559>	WP4494	Selective expression of chemokine receptors during T-cell polarization	29	10	9.6395127478027e-38	10	1.35063651856672e-37	10	3.2298069333374e-38	10	4.7342481923709e-37	10	9.4271705551603e-38	10	1.58415486113446e-37	10	1.16004497913597e-38	10	1.16004497913597e-38
<https://identifiers.org/wikipathways/WP4495_r117759>	WP4495	IL-10 anti-inflammatory signaling pathway 	13	3	5.1329720390952e-24	3	6.13296782087275e-24	3	2.88265004099145e-24	3	1.18893343036624e-23	3	5.0729904041027e-24	3	6.67146470141401e-24	3	1.67946409367207e-24	3	1.67946409367207e-24
<https://identifiers.org/wikipathways/WP4496_r102693>	WP4496	Signal transduction through IL1R	33	9	6.34382522558959e-47	9	9.70757388826112e-47	9	1.59718304701112e-47	9	4.721862364264e-46	9	6.16807410093909e-47	9	1.18704059689206e-46	9	4.38913836135186e-48	9	4.38913836135186e-48
<https://identifiers.org/wikipathways/WP45_r106424>	WP45	G1 to S cell cycle control	66	7	1.15913896598688e-102	7	3.26380736733332e-102	7	4.03656939641175e-104	7	1.53016322202913e-100	7	1.08253404450496e-102	7	5.32431215447555e-102	7	1.73669931548824e-105	7	1.73669931548824e-105
<https://identifiers.org/wikipathways/WP4507_r119314>	WP4507	Molybdenum cofactor (Moco) biosynthesis	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP4518_r122628>	WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP4519_r119988>	WP4519	Cerebral organic acidurias, including diseases	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP4521_r119311>	WP4521	Glycosylation and related congenital defects	25	1	4.11220005236946e-53	1	6.29265221410297e-53	1	1.03532742091776e-53	1	3.06080983808996e-52	1	3.99827450141385e-53	1	7.69464515670135e-53	1	2.84513118782057e-54	1	2.84513118782057e-54
<https://identifiers.org/wikipathways/WP4522_r119310>	WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	20	4	2.01587969640393e-35	4	2.67872586085122e-35	4	8.02095106047161e-36	4	7.71004786946909e-35	4	1.97838667227809e-35	4	3.06410805361739e-35	4	3.3840603410908e-36	4	3.3840603410908e-36
<https://identifiers.org/wikipathways/WP4523_r121849>	WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	25	1	4.11220005236946e-53	1	6.29265221410297e-53	1	1.03532742091776e-53	1	3.06080983808996e-52	1	3.99827450141385e-53	1	7.69464515670135e-53	1	2.84513118782057e-54	1	2.84513118782057e-54
<https://identifiers.org/wikipathways/WP453_r116780>	WP453	Inflammatory response pathway	33	11	1.70316828153368e-42	11	2.51605489070882e-42	11	4.8069111379765e-43	10	7.46998626026546e-44	10	1.06152555277163e-44	10	1.98829299979421e-44	11	1.47015386451213e-43	11	1.47015386451213e-43
<https://identifiers.org/wikipathways/WP4532_r103287>	WP4532	Intraflagellar transport proteins binding to dynein	27	1	9.75218719769264e-57	1	1.54575453560279e-56	1	2.19056684540914e-57	1	8.56914257203722e-56	1	9.46000345126562e-57	1	1.92184621219714e-56	1	5.40951912145245e-58	1	5.40951912145245e-58
<https://identifiers.org/wikipathways/WP4533_r103380>	WP4533	Transcription co-factors SKI and SKIL protein partners	18	5	5.3051686239375e-29	5	6.68501461093702e-29	5	2.50742230060121e-29	5	1.5793902979926e-28	5	5.22478843637499e-29	5	7.4571917443741e-29	5	1.24298657955991e-29	5	1.24298657955991e-29
<https://identifiers.org/wikipathways/WP4534_r103303>	WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	46	4	3.20459617891091e-80	4	6.72052264569606e-80	4	2.90294276346642e-81	4	1.05455949175607e-78	4	3.0516283903483e-80	4	9.53806265260692e-80	4	3.06081608907947e-82	4	3.06081608907947e-82
<https://identifiers.org/wikipathways/WP4535_r109210>	WP4535	Envelope proteins and their potential roles in EDMD physiopathology	46	3	7.37536519887454e-83	3	1.57389289126377e-82	4	2.90294276346642e-81	3	2.6347520093843e-81	3	7.01523767896176e-83	4	9.53806265260692e-80	3	6.31421575880253e-85	4	3.06081608907947e-82
<https://identifiers.org/wikipathways/WP4536_r110928>	WP4536	Genes related to primary cilium development (based on CRISPR)	103	7	1.32462181231243e-151	7	7.01311444753946e-151	8	1.40448762654286e-151	7	3.42756850644794e-148	7	1.18653703311679e-151	8	3.36702475667994e-148	7	3.73253114132014e-156	8	9.29400254188737e-154
<https://identifiers.org/wikipathways/WP4537_r103300>	WP4537	Hippo-Yap signaling pathway	23	5	1.46084216178016e-38	5	2.01102731853791e-38	5	5.18311192219926e-39	5	6.60115773595832e-38	5	1.43032932561056e-38	5	2.33911460485811e-38	5	1.96417872240973e-39	5	1.96417872240973e-39
<https://identifiers.org/wikipathways/WP4538_r104390>	WP4538	Regulatory circuits of the STAT3 signaling pathway	78	13	6.62294896273543e-106	13	2.0677790469806e-105	13	1.64939550090797e-107	13	1.42276007274081e-103	13	6.14318845674316e-106	13	3.54198588236987e-105	13	5.18168303166079e-109	13	5.18168303166079e-109
<https://identifiers.org/wikipathways/WP4539_r113659>	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	50	9	2.03482243572311e-74	9	4.19362853265652e-74	9	1.95046143883743e-75	9	6.16800129400448e-73	9	1.93992355844258e-74	9	5.90296920368241e-74	9	2.16842495558811e-76	9	2.16842495558811e-76
<https://identifiers.org/wikipathways/WP4540_r120395>	WP4540	Hippo signaling regulation pathways	98	17	1.05429854031729e-123	17	4.32815748818382e-123	17	1.07971226630403e-125	17	8.22878609859302e-121	17	9.60399910767582e-124	17	8.43781676206707e-123	17	1.47354611510417e-127	17	1.47354611510417e-127
<https://identifiers.org/wikipathways/WP4541_r116745>	WP4541	Hippo-Merlin signaling dysregulation	120	22	1.24873123088097e-140	22	6.83829884290447e-140	23	4.13146129660686e-141	22	3.78811521423773e-137	22	1.11606572834039e-140	23	1.16163447779998e-137	22	2.84489572988991e-145	23	2.46640090669615e-143
<https://identifiers.org/wikipathways/WP4542_r120673>	WP4542	Leukocyte-intrinsic Hippo pathway functions	36	9	5.33160795566081e-52	9	8.60061477875417e-52	9	1.13125149690658e-52	9	5.08976144176162e-51	9	5.16586864102922e-52	9	1.07824139494526e-51	9	2.64830927361548e-53	9	2.64830927361548e-53
<https://identifiers.org/wikipathways/WP4545_r121824>	WP4545	Oxysterols derived from cholesterol	52	6	1.71014675904486e-84	6	3.84489464895783e-84	6	1.23609813487215e-85	6	7.81334137671229e-83	6	1.62104672881069e-84	6	5.63932100881499e-84	6	1.05472776886646e-86	6	1.05472776886646e-86
<https://identifiers.org/wikipathways/WP4549_r119333>	WP4549	Fragile X syndrome	112	9	6.10950949088631e-158	9	3.63968362560191e-157	9	1.86716998598612e-160	9	2.75588059596061e-154	9	5.43013173362747e-158	9	8.46069573323802e-157	9	8.18926513880362e-163	9	8.18926513880362e-163
<https://identifiers.org/wikipathways/WP455_r117740>	WP455	GPCRs, class A rhodopsin-like	262	35	1.07184317026923e-258	35	4.79679131466952e-257	35	4.6498295434533e-264	35	6.384308928001e-251	35	8.33785970484954e-259	35	2.89007918039476e-256	35	4.27430484358233e-269	35	4.27430484358233e-269
<https://identifiers.org/wikipathways/WP4553_r103606>	WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	35	1	1.17770153397459e-70	1	2.14788589738007e-70	2	1.53558118824795e-68	1	2.00582521760901e-69	1	1.13187836806236e-70	2	2.40417818105096e-67	1	2.70557058239211e-72	2	2.61087561200844e-69
<https://identifiers.org/wikipathways/WP4558_r107928>	WP4558	Overview of interferons-mediated signaling pathway	37	3	2.61449740542356e-68	3	4.76830669218362e-68	3	3.72567239115895e-69	3	4.4529319830919e-67	3	2.51276997709854e-68	3	6.33504517736881e-68	3	6.00636669291056e-70	3	6.00636669291056e-70
<https://identifiers.org/wikipathways/WP4559_r104316>	WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	50	8	1.05431214286167e-76	8	2.211051950434e-76	8	9.55068169180447e-78	8	3.46950072787742e-75	8	1.00398574042457e-76	8	3.1380226127078e-76	8	1.00700849330713e-78	8	1.00700849330713e-78
<https://identifiers.org/wikipathways/WP4560_r108134>	WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	18	3	3.63070543215484e-34	3	4.73993491799039e-34	3	1.52989087595523e-34	3	1.27743319437309e-33	3	3.56734354696044e-34	3	5.37670328987387e-34	3	6.81086670754278e-35	3	6.81086670754278e-35
<https://identifiers.org/wikipathways/WP4561_r107544>	WP4561	Cell migration and invasion through p75NTR	30	5	3.40705337594743e-51	5	5.30615796699976e-51	5	8.10216196844094e-52	5	2.75542493232372e-50	5	3.30881594714564e-51	5	6.54256027864477e-51	5	2.11061043754064e-52	5	2.11061043754064e-52
<https://identifiers.org/wikipathways/WP4564_r117803>	WP4564	Neural crest cell migration during development	39	7	1.37814801587271e-61	7	2.42696863263204e-61	7	2.20007950978452e-62	7	1.98988611732563e-60	7	1.32759260004289e-61	7	3.17147013633566e-61	7	3.94521155904015e-63	7	3.94521155904015e-63
<https://identifiers.org/wikipathways/WP4565_r117804>	WP4565	Neural crest cell migration in cancer	42	8	3.97155228370869e-64	8	7.24329628076167e-64	8	5.65948264579008e-65	8	6.76422632891588e-63	8	3.81702323371147e-64	8	9.62325037668187e-64	8	9.12397132486551e-66	8	9.12397132486551e-66
<https://identifiers.org/wikipathways/WP4566_r104315>	WP4566	Translation inhibitors in chronically activated PDGFRA cells	46	7	7.98367839795977e-73	7	1.58898824860537e-72	7	8.56932311272193e-74	7	2.05303811234598e-71	7	7.62889301362192e-73	7	2.20009685659205e-72	7	1.05927003556933e-74	7	1.05927003556933e-74
<https://identifiers.org/wikipathways/WP4577_r118444>	WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	44	3	1.07562967396484e-79	3	2.21679848429051e-79	3	1.03103551676351e-80	3	3.26047379093658e-78	3	1.02546507648611e-79	3	3.12037489292049e-79	3	1.14625344553353e-81	3	1.14625344553353e-81
<https://identifiers.org/wikipathways/WP4582_r108125>	WP4582	Cancer immunotherapy by CTLA4 blockade	16	2	6.0867708715537e-33	2	7.80695162963131e-33	2	2.71630625132838e-33	2	1.97000236740087e-32	2	5.98754132587876e-33	2	8.78194870679401e-33	2	1.27603590961906e-33	2	1.27603590961906e-33
<https://identifiers.org/wikipathways/WP4584_r119306>	WP4584	Biomarkers for pyrimidine metabolism disorders	19	3	4.03175939280781e-36	3	5.35745172170245e-36	3	1.60419021209435e-36	3	1.54200957389379e-35	3	3.9567733445562e-36	3	6.12821610723476e-36	3	6.76812068218155e-37	3	6.76812068218155e-37
<https://identifiers.org/wikipathways/WP4585_r108119>	WP4585	Cancer immunotherapy by PD-1 blockade	25	4	8.68825029767572e-45	4	1.26107135915079e-44	4	2.59635719675506e-45	4	5.03988402637277e-44	4	8.47708542214096e-45	4	1.50398519501555e-44	4	8.3775274763218e-46	4	8.3775274763218e-46
<https://identifiers.org/wikipathways/WP4586_r119267>	WP4586	Metabolism of alpha-linolenic acid	6	2	4.3357451379222e-11	2	4.65628463881452e-11	2	3.44081297957319e-11	2	6.07082696694489e-11	2	4.31537161890774e-11	2	4.81599581528983e-11	2	2.77115230785602e-11	2	2.77115230785602e-11
<https://identifiers.org/wikipathways/WP4589_r119266>	WP4589	Major receptors targeted by epinephrine and norepinephrine	21	1	1.17858004038033e-45	1	1.68076388263097e-45	1	3.72931306442996e-46	1	6.29089081236571e-45	1	1.15127531661962e-45	1	1.98787608384662e-45	1	1.26954309660941e-46	1	1.26954309660941e-46
<https://identifiers.org/wikipathways/WP4595_r121755>	WP4595	Urea cycle and associated pathways	24	4	5.96361500432459e-43	4	8.50466524611258e-43	4	1.88703241060154e-43	4	3.18319075105702e-42	4	5.82545310209528e-43	4	1.00586529842639e-42	4	6.42388806884351e-44	4	6.42388806884351e-44
<https://identifiers.org/wikipathways/WP4630_r120771>	WP4630	Measles virus infection	150	13	1.61163546772563e-192	13	1.69187771547212e-191	13	7.81618468217094e-196	13	1.0473802076339e-187	13	1.37978910192063e-192	13	5.13985274596768e-191	13	6.0813147191903e-199	13	6.0813147191903e-199
<https://identifiers.org/wikipathways/WP465_r122957>	WP465	Tryptophan metabolism	56	7	4.06690164288137e-88	7	9.63240666532856e-88	7	2.48251930607083e-89	7	2.37532287516712e-86	7	3.84177290087425e-88	7	1.44800191601578e-87	7	1.80789839547106e-90	7	1.80789839547106e-90
<https://identifiers.org/wikipathways/WP4655_r105163>	WP4655	Cytosolic DNA-sensing pathway	74	7	7.70328107750755e-114	7	2.48913683175354e-113	7	1.71601812421176e-115	7	1.94572686428724e-111	7	7.12906446460797e-114	7	4.33354157659585e-113	7	4.85558025856857e-117	7	4.85558025856857e-117
<https://identifiers.org/wikipathways/WP4656_r120396>	WP4656	Joubert syndrome	76	5	1.90245147711948e-121	5	6.58379138590908e-121	5	3.39207397612458e-123	5	6.63930228210253e-119	5	1.75267934560565e-121	5	1.18399201275021e-120	5	7.78885056273924e-125	5	7.78885056273924e-125
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	154	12	5.44581843317066e-199	12	6.20811344749921e-198	12	2.02043399008827e-202	12	5.21666232335504e-194	12	4.63706956882412e-199	12	1.96087298729387e-197	12	1.22203930417227e-205	12	1.22203930417227e-205
<https://identifiers.org/wikipathways/WP4658_r119261>	WP4658	Small cell lung cancer	96	16	3.34855686190394e-123	16	1.35144509324918e-122	16	3.62429399384565e-125	16	2.41193632511143e-120	16	3.05376054101194e-123	16	2.61353962489271e-122	16	5.20980553151024e-127	16	5.20980553151024e-127
<https://identifiers.org/wikipathways/WP4659_r116555>	WP4659	Gastrin signaling pathway	114	12	1.07202618839658e-153	12	6.2799365980398e-153	13	5.05208957109763e-154	12	4.46724110784323e-150	12	9.53876686262664e-154	13	1.95291613465599e-150	12	1.59759646153497e-158	13	2.45538286934378e-156
<https://identifiers.org/wikipathways/WP466_r117096>	WP466	DNA replication	42	3	1.71234331543093e-76	3	3.40806990233108e-76	3	1.83795268526684e-77	3	4.40336635916965e-75	3	1.63624876965883e-76	3	4.71877868558539e-76	3	2.27192764316124e-78	3	2.27192764316124e-78
<https://identifiers.org/wikipathways/WP4661_r117646>	WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	6	1	5.10087663284958e-14	1	5.57638878899941e-14	1	3.82100275355155e-14	1	7.76817270242475e-14	1	5.07094197286457e-14	1	5.81642006677515e-14	1	2.91546797249452e-14	1	2.91546797249452e-14
<https://identifiers.org/wikipathways/WP4666_r119241>	WP4666	Hepatitis B infection	152	12	7.79530010005297e-197	12	8.59851377868329e-196	13	4.79377789602628e-198	12	6.39473974558451e-192	12	6.65209888054053e-197	13	3.6839000666845e-193	12	2.15311998114608e-203	13	3.37211713970281e-201
<https://identifiers.org/wikipathways/WP4673_r119920>	WP4673	Male infertility	145	15	7.40171244992377e-183	15	6.9208033109684e-182	15	5.22956559836715e-186	15	2.78917665630196e-178	15	6.38558336126265e-183	15	1.99061642691412e-181	15	5.79481454268826e-189	15	5.79481454268826e-189
<https://identifiers.org/wikipathways/WP4674_r117748>	WP4674	Head and neck squamous cell carcinoma	74	6	3.0585914658282e-116	6	1.00542168622479e-115	6	6.44427407161056e-118	6	8.37643791513571e-114	6	2.8273910057935e-116	6	1.76467661641485e-115	6	1.73060396181161e-119	6	1.73060396181161e-119
<https://identifiers.org/wikipathways/WP4685_r119240>	WP4685	Melanoma	68	6	6.82721951660973e-108	6	2.02434274466086e-107	6	2.01028944953879e-109	6	1.14995046766194e-105	6	6.35428730170669e-108	6	3.38402943522315e-107	6	7.38982280596844e-111	6	7.38982280596844e-111
<https://identifiers.org/wikipathways/WP4686_r122622>	WP4686	Leucine, isoleucine and valine metabolism	25	2	3.53443594501154e-50	2	5.31414479480991e-50	2	9.42147953035195e-51	2	2.42110058192915e-49	2	3.44051520846669e-50	2	6.44426531873737e-50	2	2.73132594030779e-51	2	2.73132594030779e-51
<https://identifiers.org/wikipathways/WP4688_r120418>	WP4688	Serine metabolism	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP4698_r119119>	WP4698	Vitamin D-sensitive calcium signaling in depression	37	3	2.61449740542356e-68	3	4.76830669218362e-68	3	3.72567239115895e-69	3	4.4529319830919e-67	3	2.51276997709854e-68	3	6.33504517736881e-68	3	6.00636669291056e-70	3	6.00636669291056e-70
<https://identifiers.org/wikipathways/WP47_r120579>	WP47	Hedgehog signaling pathway	16	1	7.11903025912711e-36	1	9.29399003527545e-36	1	2.99978603128478e-36	1	2.50477096935903e-35	1	6.99479126854986e-36	1	1.05425554703409e-35	1	1.33546406030252e-36	1	1.33546406030252e-36
<https://identifiers.org/wikipathways/WP4705_r119081>	WP4705	Pathways of nucleic acid metabolism and innate immune sensing	20	1	9.62507032977294e-44	1	1.34861292487293e-43	1	3.22496786904986e-44	1	4.7271550961491e-43	1	9.41304627921844e-44	1	1.5817813981465e-43	1	1.15830693957313e-44	1	1.15830693957313e-44
<https://identifiers.org/wikipathways/WP4707_r116586>	WP4707	Aspirin and miRNAs	11	4	4.06998614276199e-17	4	4.61054539390957e-17	4	2.7166820746727e-17	4	7.33127923919225e-17	4	4.0366061952661e-17	4	4.89058384986981e-17	4	1.86067684829429e-17	4	1.86067684829429e-17
<https://identifiers.org/wikipathways/WP4718_r119764>	WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	47	5	3.0123204081762e-79	5	6.31729128695431e-79	5	2.72876619765849e-80	5	9.9128592225069e-78	5	2.8685306869274e-79	5	8.96577889345096e-79	5	2.87716712373475e-81	5	2.87716712373475e-81
<https://identifiers.org/wikipathways/WP4719_r116307>	WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	30	6	9.76688634438275e-49	6	1.49456782737159e-48	6	2.45900615742177e-49	6	7.26972944644747e-48	6	9.49630176830807e-49	6	1.82755517116811e-48	6	6.75747108419275e-50	6	6.75747108419275e-50
<https://identifiers.org/wikipathways/WP4721_r116526>	WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	29	1	2.66894505927068e-60	1	4.38166572030529e-60	1	5.34935028074568e-61	1	2.76796725627406e-59	1	2.58297952265631e-60	1	5.53900820804739e-60	1	1.18721763103484e-61	1	1.18721763103484e-61
<https://identifiers.org/wikipathways/WP4722_r117144>	WP4722	Glycerolipids and glycerophospholipids	22	1	1.51100005176967e-47	1	2.19316758113179e-47	1	4.51540382044357e-48	1	8.76501569803979e-47	1	1.47427572558972e-47	1	2.61562642611399e-47	1	1.4569613002299e-48	1	1.4569613002299e-48
<https://identifiers.org/wikipathways/WP4723_r120315>	WP4723	Omega-3 / omega-6 fatty acid synthesis	14	4	1.79654021368333e-23	4	2.14653873730548e-23	4	1.00892751434701e-23	4	4.16126700628186e-23	4	1.77554664143593e-23	4	2.33501264549489e-23	4	5.87812432785232e-24	4	5.87812432785232e-24
<https://identifiers.org/wikipathways/WP4724_r117812>	WP4724	Omega-9 fatty acid synthesis	14	3	4.212286550254e-26	3	5.12300414631387e-26	3	2.23337579268843e-26	3	1.06087112970856e-25	3	4.15818885582187e-26	3	5.61976569312849e-26	3	1.23295738392287e-26	3	1.23295738392287e-26
<https://identifiers.org/wikipathways/WP4725_r117175>	WP4725	Sphingolipid metabolism overview	23	2	1.7376500595351e-46	2	2.52214271830156e-46	2	5.1927143935101e-47	2	1.00797680527456e-45	2	1.69541708442819e-46	2	3.00797039003113e-46	2	1.67550549526437e-47	2	1.67550549526437e-47
<https://identifiers.org/wikipathways/WP4726_r120323>	WP4726	Sphingolipid metabolism: integrated pathway	26	2	5.3458600680803e-52	2	8.1804478783338e-52	2	1.34592564719308e-52	2	3.97905278951686e-51	2	5.19775685183789e-52	2	1.00030387037117e-51	2	3.69867054416676e-53	2	3.69867054416676e-53
<https://identifiers.org/wikipathways/WP474_r117098>	WP474	Endochondral ossification	64	13	1.92806813796969e-86	13	4.72772036405903e-86	13	1.05170132661496e-87	13	1.32610814318733e-84	13	1.81717073816907e-86	13	7.22443098196168e-86	13	6.8922910886513e-89	13	6.8922910886513e-89
<https://identifiers.org/wikipathways/WP4746_r120402>	WP4746	Thyroid hormones production and peripheral downstream signaling effects	95	9	6.35507953532029e-137	9	2.84047621331015e-136	9	4.9380540887106e-139	9	7.40469635471682e-134	9	5.75664750941857e-137	9	5.76460899280537e-136	9	5.20085533352943e-141	9	5.20085533352943e-141
<https://identifiers.org/wikipathways/WP4747_r116543>	WP4747	Netrin-UNC5B signaling pathway	52	10	3.10670644763243e-75	10	6.51523308061225e-75	11	4.70238521436081e-74	10	1.0223462144812e-73	10	2.95841131511785e-75	11	1.42315221165147e-72	10	2.96731836027852e-77	11	5.22787543838151e-75
<https://identifiers.org/wikipathways/WP4752_r119239>	WP4752	Base excision repair	31	4	1.78195453063529e-55	4	2.87453702498469e-55	4	3.78092077843101e-56	4	1.70112347652466e-54	4	1.72656037467559e-55	4	3.60374797775818e-55	4	8.85130104817997e-57	4	8.85130104817997e-57
<https://identifiers.org/wikipathways/WP4753_r119238>	WP4753	Nucleotide excision repair	43	3	4.24384798637068e-78	3	8.59513230499894e-78	3	4.30457328248771e-79	3	1.18488581629715e-76	3	4.05058705212015e-78	3	1.19992598155034e-77	3	5.04612028181485e-80	3	5.04612028181485e-80
<https://identifiers.org/wikipathways/WP4754_r115147>	WP4754	IL-18 signaling pathway	185	49	2.18090301013555e-164	49	2.25199707927224e-163	54	7.87487268457222e-160	49	1.31134852299336e-159	49	1.86920144402217e-164	54	3.24145147604841e-155	49	9.13227380921946e-171	54	8.29555473931791e-163
<https://identifiers.org/wikipathways/WP4756_r120634>	WP4756	Renin-angiotensin-aldosterone system (RAAS)	44	2	1.85773691531074e-82	2	3.8959551569254e-82	2	1.68286537012542e-83	2	6.11338835800628e-81	2	1.76905993643381e-82	2	5.52931168267092e-82	2	1.77438613859685e-84	2	1.77438613859685e-84
<https://identifiers.org/wikipathways/WP4758_r108284>	WP4758	Nephrotic syndrome	49	5	2.3441701280747e-82	5	5.09024036781337e-82	6	5.81661962741762e-81	5	9.09038783162833e-81	5	2.22714656514392e-82	6	2.07472569435228e-79	5	1.79896563618833e-84	6	5.81665555700889e-82
<https://identifiers.org/wikipathways/WP4760_r108400>	WP4760	PKC-gamma calcium signaling pathway in ataxia	22	3	7.41130415392509e-42	3	1.03843195215218e-41	3	2.48322525916846e-42	3	3.63990942403476e-41	3	7.24804563499825e-42	3	1.21797167657282e-41	3	8.91896343471333e-43	3	8.91896343471333e-43
<https://identifiers.org/wikipathways/WP4767_r116441>	WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	27	3	4.81127406127233e-51	3	7.36240309050039e-51	3	1.21133308247379e-51	3	3.58114751056529e-50	3	4.67798116665423e-51	3	9.00273483334063e-51	3	3.32880348974998e-52	3	3.32880348974998e-52
<https://identifiers.org/wikipathways/WP477_r117044>	WP477	Cytoplasmic ribosomal proteins	88	1	2.32370065391591e-148	1	1.05638918070871e-147	1	1.70872593939744e-150	1	2.93297419149722e-145	1	2.10252746304887e-148	1	2.16116025730948e-147	1	1.708909047712e-152	1	1.708909047712e-152
<https://identifiers.org/wikipathways/WP4784_r111633>	WP4784	Proteoglycan biosynthesis	18	5	5.3051686239375e-29	5	6.68501461093702e-29	5	2.50742230060121e-29	5	1.5793902979926e-28	5	5.22478843637499e-29	5	7.4571917443741e-29	5	1.24298657955991e-29	5	1.24298657955991e-29
<https://identifiers.org/wikipathways/WP4786_r117852>	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	33	8	3.3194434319945e-49	8	5.16971390499114e-49	10	2.90687314556021e-45	8	2.68457114834965e-48	8	3.22373210850477e-49	10	1.98829299979421e-44	8	2.05633759771817e-50	10	8.42714565379531e-46
<https://identifiers.org/wikipathways/WP4787_r118872>	WP4787	Osteoblast differentiation and related diseases	118	15	4.02232130226968e-152	15	2.39626061676782e-151	15	1.22928978517736e-154	15	1.81439070422579e-148	15	3.57503897471362e-152	15	5.57027315050263e-151	15	5.39157123282654e-157	15	5.39157123282654e-157
<https://identifiers.org/wikipathways/WP4788_r117658>	WP4788	Autosomal recessive osteopetrosis pathways	11	1	1.97422001503664e-25	1	2.35883377725878e-25	1	1.10871155422748e-25	1	4.57282088602404e-25	1	1.95115015542411e-25	1	2.56594796208229e-25	1	6.45947728335421e-26	1	6.45947728335421e-26
<https://identifiers.org/wikipathways/WP4790_r116413>	WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	23	4	4.26149988850699e-41	4	5.97098372487506e-41	4	1.42785452402186e-41	4	2.09294791882001e-40	4	4.16762624012396e-41	4	7.0033371402938e-41	4	5.1284039749602e-42	4	5.1284039749602e-42
<https://identifiers.org/wikipathways/WP4792_r119117>	WP4792	Purine metabolism	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP4803_r110008>	WP4803	Ciliopathies	184	9	7.36663627518809e-237	9	1.4387109375638e-235	9	4.74689533464835e-241	9	8.88856201322677e-231	9	6.05337091300622e-237	9	5.85993701767415e-235	9	5.53460835210254e-245	9	5.53460835210254e-245
<https://identifiers.org/wikipathways/WP4806_r116801>	WP4806	EGFR tyrosine kinase inhibitor resistance	85	14	3.91258751032116e-113	14	1.35402454448248e-112	14	6.97614968512368e-115	14	1.36544093232445e-110	14	3.60456568784471e-113	14	2.43500158459763e-112	14	1.60185738233236e-116	14	1.60185738233236e-116
<https://identifiers.org/wikipathways/WP4808_r117708>	WP4808	Endochondral ossification with skeletal dysplasias	64	13	1.92806813796969e-86	13	4.72772036405903e-86	13	1.05170132661496e-87	13	1.32610814318733e-84	13	1.81717073816907e-86	13	7.22443098196168e-86	13	6.8922910886513e-89	13	6.8922910886513e-89
<https://identifiers.org/wikipathways/WP481_r120562>	WP481	Insulin signaling	161	14	3.48545367447224e-202	14	4.31372111299224e-201	14	9.89924781626966e-206	14	4.91592066436091e-197	14	2.95175802854389e-202	14	1.41645605821997e-200	14	4.65752615968078e-209	14	4.65752615968078e-209
<https://identifiers.org/wikipathways/WP4814_r116554>	WP4814	Somatic sex determination	14	2	7.40296406020034e-29	2	9.16458702381728e-29	2	3.70582266485915e-29	2	2.02714228606735e-28	2	7.29933678611217e-29	2	1.0137881587123e-28	2	1.93861223887245e-29	2	1.93861223887245e-29
<https://identifiers.org/wikipathways/WP4815_r110276>	WP4815	Glycosaminoglycan degradation	17	3	3.44917016054713e-32	3	4.42393925679112e-32	3	1.53924020908608e-32	3	1.11633467486049e-31	3	3.39294008466459e-32	3	4.97643760051659e-32	3	7.23087015450791e-33	3	7.23087015450791e-33
<https://identifiers.org/wikipathways/WP4816_r116440>	WP4816	TGF-beta receptor signaling in skeletal dysplasias	59	12	2.53720740452835e-81	12	5.80432101131209e-81	12	1.73339825512282e-82	12	1.25815023226394e-79	12	2.40225879845136e-81	12	8.58341024187686e-81	12	1.40293748354473e-83	12	1.40293748354473e-83
<https://identifiers.org/wikipathways/WP4823_r119116>	WP4823	Genes controlling nephrogenesis	44	8	2.50921713893762e-67	8	4.73919029055595e-67	9	6.49781004055736e-66	8	5.04005376971119e-66	8	2.40602139629649e-67	9	1.19989387852127e-64	8	4.62717204921926e-69	9	9.93299599899082e-67
<https://identifiers.org/wikipathways/WP4829_r109219>	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	38	4	2.48377253515231e-67	4	4.52989135757441e-67	4	3.539388771601e-68	4	4.2302853839373e-66	4	2.38713147824357e-67	4	6.0182929185002e-67	4	5.70604835826508e-69	4	5.70604835826508e-69
<https://identifiers.org/wikipathways/WP4830_r118773>	WP4830	GDNF/RET signaling axis	23	3	9.93935834054085e-44	3	1.41744420768547e-43	3	3.14505401766929e-44	3	5.3053179184285e-43	3	9.70908850349193e-44	3	1.67644216404401e-43	3	1.07064801147392e-44	3	1.07064801147392e-44
<https://identifiers.org/wikipathways/WP4838_r110282>	WP4838	Regucalcin in proximal tubule epithelial kidney cells	44	2	1.85773691531074e-82	2	3.8959551569254e-82	2	1.68286537012542e-83	2	6.11338835800628e-81	2	1.76905993643381e-82	2	5.52931168267092e-82	2	1.77438613859685e-84	2	1.77438613859685e-84
<https://identifiers.org/wikipathways/WP4842_r119114>	WP4842	Mammalian disorder of sexual development	25	3	2.0240536511766e-47	3	2.99009213787967e-47	3	5.71255708856996e-48	3	1.27592000667664e-46	3	1.97256205285421e-47	3	3.59590004785544e-47	3	1.74713815981685e-48	3	1.74713815981685e-48
<https://identifiers.org/wikipathways/WP4844_r120398>	WP4844	Influence of laminopathies on Wnt signaling	39	3	1.2938777594687e-71	3	2.44376336335589e-71	3	1.6460349546796e-72	3	2.59890360940083e-70	3	1.24066487717033e-71	3	3.30084603174383e-71	3	2.38600115980986e-73	3	2.38600115980986e-73
<https://identifiers.org/wikipathways/WP4846_r122702>	WP4846	SARS-CoV-2 and COVID-19 pathway	50	2	7.64569245902332e-92	2	1.77972254608463e-91	2	4.93737007195304e-93	2	4.11476657248814e-90	2	7.23073762999934e-92	2	2.65353446661058e-91	2	3.79053315877891e-94	2	3.79053315877891e-94
<https://identifiers.org/wikipathways/WP4853_r122756>	WP4853	Linoleic acid metabolism affected by SARS-CoV-2	13	1	1.05756629431435e-29	1	1.30922671768818e-29	1	5.2940323783702e-30	1	2.89591755152473e-29	1	1.04276239801604e-29	1	1.44826879816044e-29	1	2.76944605553207e-30	1	2.76944605553207e-30
<https://identifiers.org/wikipathways/WP4861_r118973>	WP4861	Endoplasmic reticulum stress response in coronavirus infection	54	2	6.25145224368308e-98	2	1.55967076178841e-97	2	3.22360558753453e-99	2	4.66556786374587e-96	2	5.88514774705226e-98	2	2.40292625957385e-97	2	2.00413098999077e-100	2	2.00413098999077e-100
<https://identifiers.org/wikipathways/WP4863_r116597>	WP4863	Host-pathogen interaction of human coronaviruses - autophagy	20	2	8.24868527261528e-41	2	1.13553208274304e-40	2	2.92665834116277e-41	2	3.72736179331358e-40	2	8.07639370756934e-41	2	1.32078746745235e-40	2	1.10907889464128e-41	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP4864_r116596>	WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	32	1	1.54741003321976e-65	1	2.67770797681344e-65	1	2.61475964948432e-66	1	2.05703913002685e-64	1	1.49237176218465e-65	1	3.47025947733412e-65	1	4.94532152743953e-67	1	4.94532152743953e-67
<https://identifiers.org/wikipathways/WP4868_r120021>	WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	42	2	2.96082417653763e-79	2	5.99660393372014e-79	2	3.00319066220078e-80	2	8.26664522998068e-78	2	2.82599096659547e-79	2	8.37157661546776e-79	2	3.52054903382426e-81	2	3.52054903382426e-81
<https://identifiers.org/wikipathways/WP4871_r120412>	WP4871	Kisspeptin/kisspeptin receptor system in the ovary	39	3	1.2938777594687e-71	3	2.44376336335589e-71	3	1.6460349546796e-72	3	2.59890360940083e-70	3	1.24066487717033e-71	3	3.30084603174383e-71	3	2.38600115980986e-73	3	2.38600115980986e-73
<https://identifiers.org/wikipathways/WP4872_r110081>	WP4872	MAP3K1 role in promoting and blocking gonadal determination	17	1	7.07326209264537e-38	1	9.39903810824989e-38	1	2.81436879314797e-38	1	2.7052799541997e-37	1	6.94170762202852e-38	1	1.07512563284822e-37	1	1.18738959336519e-38	1	1.18738959336519e-38
<https://identifiers.org/wikipathways/WP4874_r121708>	WP4874	CAMKK2 pathway	47	5	3.0123204081762e-79	5	6.31729128695431e-79	5	2.72876619765849e-80	5	9.9128592225069e-78	5	2.8685306869274e-79	5	8.96577889345096e-79	5	2.87716712373475e-81	5	2.87716712373475e-81
<https://identifiers.org/wikipathways/WP4875_r116427>	WP4875	Disruption of postsynaptic signaling by CNV	33	4	6.33487423580948e-59	4	1.05842834282695e-58	4	1.19942692322256e-59	4	7.13706491031721e-58	4	6.12372665510397e-59	4	1.349144142103e-58	4	2.52368547854254e-60	4	2.52368547854254e-60
<https://identifiers.org/wikipathways/WP4876_r120600>	WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	8	3	4.76081819065963e-13	3	5.20462953639944e-13	3	3.56626923664813e-13	3	7.25029452226311e-13	3	4.7328791746736e-13	3	5.42865872899012e-13	3	2.72110344099487e-13	3	2.72110344099487e-13
<https://identifiers.org/wikipathways/WP4877_r119237>	WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	42	6	7.42685833935028e-69	6	1.4027201705663e-68	6	9.44824063986075e-70	6	1.49177067179612e-67	6	7.12141639495775e-69	6	1.89468562222097e-68	6	1.36956466573082e-70	6	1.36956466573082e-70
<https://identifiers.org/wikipathways/WP4879_r120399>	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	59	5	2.04740616687427e-97	5	5.28796073361201e-97	5	9.43599250607581e-99	5	1.79886370802992e-95	5	1.92303638990122e-97	5	8.28134345611688e-97	5	5.28000070013855e-100	5	5.28000070013855e-100
<https://identifiers.org/wikipathways/WP4880_r119113>	WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	43	1	8.44425870595783e-84	1	1.77088870769329e-83	1	7.64938804602479e-85	1	2.77881289000282e-82	1	8.04118152924467e-84	1	2.51332349212314e-83	1	8.06539153907656e-86	1	8.06539153907656e-86
<https://identifiers.org/wikipathways/WP4884_r120646>	WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	32	2	1.33541485866865e-62	2	2.27069636433784e-62	3	1.45385081602734e-60	2	1.63431758880631e-61	4	3.20289460809377e-57	3	1.63532623285206e-59	2	4.76481729168807e-64	3	3.05901270126375e-61
<https://identifiers.org/wikipathways/WP4891_r120510>	WP4891	COVID-19 adverse outcome pathway	15	7	3.72823158115602e-18	7	4.29913378033406e-18	8	5.29753004561177e-16	7	7.30319004670483e-18	7	3.6933171053461e-18	8	9.53663850724619e-16	7	1.52450414040918e-18	8	3.62831985417391e-16
<https://identifiers.org/wikipathways/WP49_r120703>	WP49	IL-2 signaling pathway	42	8	3.97155228370869e-64	8	7.24329628076167e-64	8	5.65948264579008e-65	8	6.76422632891588e-63	8	3.81702323371147e-64	8	9.62325037668187e-64	8	9.12397132486551e-66	8	9.12397132486551e-66
<https://identifiers.org/wikipathways/WP4900_r110333>	WP4900	Purinergic signaling	33	7	1.5430300671677e-51	7	2.44575465641213e-51	7	3.46600248548015e-52	7	1.35584401431802e-50	7	1.49679958607302e-51	7	3.04082195078683e-51	7	8.55915753472712e-53	7	8.55915753472712e-53
<https://identifiers.org/wikipathways/WP4904_r120598>	WP4904	LDLRAD4 and what we know about it	7	2	1.78530682149736e-13	2	1.95173607614979e-13	2	1.33735096374305e-13	2	2.71886044584866e-13	2	1.7748296905026e-13	2	2.0357470233713e-13	2	1.02041379037308e-13	2	1.02041379037308e-13
<https://identifiers.org/wikipathways/WP4905_r115772>	WP4905	1q21.1 copy number variation syndrome	38	5	8.58888542655707e-65	5	1.53925708330381e-64	6	3.94886065858748e-63	4	4.2302853839373e-66	4	2.38713147824357e-67	5	2.0281647135346e-64	5	2.20253466629022e-66	6	7.08114895212332e-64
<https://identifiers.org/wikipathways/WP4906_r115773>	WP4906	3q29 copy number variation syndrome	75	5	4.42069645867521e-120	5	1.50387655867604e-119	5	8.33289751766389e-122	5	1.42308202862438e-117	5	4.077285635567e-120	5	2.68267663941552e-119	5	2.01587750748796e-123	5	2.01587750748796e-123
<https://identifiers.org/wikipathways/WP4912_r115852>	WP4912	SARS coronavirus and innate immunity	32	1	1.54741003321976e-65	1	2.67770797681344e-65	1	2.61475964948432e-66	1	2.05703913002685e-64	1	1.49237176218465e-65	1	3.47025947733412e-65	1	4.94532152743953e-67	1	4.94532152743953e-67
<https://identifiers.org/wikipathways/WP4917_r119111>	WP4917	Proximal tubule transport	57	3	1.196613773743e-99	3	3.09056734869208e-99	3	5.51489918531602e-101	3	1.05135225483922e-97	3	1.12392541782654e-99	3	4.84006046529324e-99	3	3.0859150789822e-102	3	3.0859150789822e-102
<https://identifiers.org/wikipathways/WP4919_r111814>	WP4919	Neuroinflammation	18	1	7.43684098525791e-40	1	1.0058423659245e-39	1	2.79418854256284e-40	1	3.0917485190854e-39	1	7.29000800446413e-40	1	1.1602075174621e-39	1	1.11725105491761e-40	1	1.11725105491761e-40
<https://identifiers.org/wikipathways/WP4923_r110416>	WP4923	Autophagy	30	1	4.64433595000688e-62	1	7.75973858377543e-62	1	8.79345251629426e-63	1	5.23245228029124e-61	1	4.48953567089743e-62	1	9.89108608579918e-62	1	1.85020929511924e-63	1	1.85020929511924e-63
<https://identifiers.org/wikipathways/WP4925_r112845>	WP4925	Unfolded protein response	25	5	2.98180750216227e-42	5	4.25233262305644e-42	5	9.43516205300799e-43	5	1.59159537552852e-41	5	2.91272655104765e-42	5	5.02932649213194e-42	5	3.21194403442183e-43	5	3.21194403442183e-43
<https://identifiers.org/wikipathways/WP4932_r118797>	WP4932	7q11.23 copy number variation syndrome	117	7	1.43344882274795e-168	6	3.78557721951291e-170	7	2.99069070646491e-171	6	4.71695910705912e-167	6	4.8945593372575e-171	6	9.37617204604372e-170	7	9.16510163213267e-174	7	9.16510163213267e-174
<https://identifiers.org/wikipathways/WP4940_r115775>	WP4940	15q11.2 copy number variation syndrome	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP4941_r120578>	WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	36	3	1.22174757134522e-66	3	2.18955488378916e-66	3	1.8426974258975e-67	3	1.91596424786012e-65	3	1.17556887306956e-66	3	2.88501381726116e-66	3	3.13305073441006e-68	3	3.13305073441006e-68
<https://identifiers.org/wikipathways/WP4942_r115789>	WP4942	15q13.3 copy number variation syndrome	34	2	5.02661857924887e-66	2	8.85205760160482e-66	2	8.02450855230155e-67	2	7.25785504367946e-65	2	4.84222416764384e-66	2	1.15675315911137e-65	2	1.43896544444691e-67	2	1.43896544444691e-67
<https://identifiers.org/wikipathways/WP4946_r117703>	WP4946	DNA repair pathways, full network	119	11	8.27560434305438e-162	11	5.36207384811387e-161	11	1.9252767426393e-164	11	5.54441642107878e-158	11	7.31465200969126e-162	11	1.29690821942146e-160	11	6.53561375278903e-167	11	6.53561375278903e-167
<https://identifiers.org/wikipathways/WP4947_r118070>	WP4947	Nitric oxide metabolism in cystic fibrosis	14	2	7.40296406020034e-29	2	9.16458702381728e-29	2	3.70582266485915e-29	2	2.02714228606735e-28	2	7.29933678611217e-29	2	1.0137881587123e-28	2	1.93861223887245e-29	2	1.93861223887245e-29
<https://identifiers.org/wikipathways/WP4949_r115778>	WP4949	16p11.2 proximal deletion syndrome	82	2	1.67920307093491e-137	2	6.77710083589149e-137	3	1.13652904865916e-136	2	1.20951533781747e-134	2	1.53137136081118e-137	3	7.56223978368761e-134	2	2.61256469824792e-141	3	1.72080928124587e-138
<https://identifiers.org/wikipathways/WP4950_r115784>	WP4950	16p11.2 distal deletion syndrome	34	5	4.30771448035044e-58	5	7.19731273122346e-58	5	8.15610307791336e-59	5	4.85320413901559e-57	5	4.1641341254708e-58	5	9.17418016630012e-58	5	1.71610612540896e-59	5	1.71610612540896e-59
<https://identifiers.org/wikipathways/WP4961_r120610>	WP4961	STING pathway in Kawasaki-like disease and COVID-19	21	4	2.47274962759825e-37	4	3.34442586669895e-37	4	9.29067690402123e-38	4	1.02800638259588e-36	4	2.42392766148431e-37	4	3.85768999556144e-37	4	3.71485975760098e-38	4	3.71485975760098e-38
<https://identifiers.org/wikipathways/WP4962_r122013>	WP4962	Airway smooth muscle cell contraction	17	1	7.07326209264537e-38	1	9.39903810824989e-38	1	2.81436879314797e-38	1	2.7052799541997e-37	1	6.94170762202852e-38	1	1.07512563284822e-37	1	1.18738959336519e-38	1	1.18738959336519e-38
<https://identifiers.org/wikipathways/WP4963_r122690>	WP4963	p53 transcriptional gene network	98	13	6.0191708295254e-132	13	2.64502062172901e-131	13	4.94227857671762e-134	13	6.47382308211522e-129	13	5.45849278060641e-132	13	5.32502232445874e-131	13	5.48188831589639e-136	13	5.48188831589639e-136
<https://identifiers.org/wikipathways/WP4969_r120081>	WP4969	RAS and bradykinin pathways in COVID-19	31	5	6.13705140350786e-53	5	9.72743329254822e-53	5	1.37852371581596e-53	5	5.39256142058309e-52	5	5.95318017188129e-53	5	1.20941782133564e-52	5	3.40421038313003e-54	5	3.40421038313003e-54
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	37	2	4.53381052963613e-71	2	8.4146588685595e-71	2	6.10432396148366e-72	2	8.38593593802639e-70	2	4.35237293954699e-71	2	1.12723223796597e-70	2	9.33148631731329e-73	2	9.33148631731329e-73
<https://identifiers.org/wikipathways/WP4970_r113773>	WP4970	Galanin receptor pathway	20	2	8.24868527261528e-41	2	1.13553208274304e-40	2	2.92665834116277e-41	2	3.72736179331358e-40	2	8.07639370756934e-41	2	1.32078746745235e-40	2	1.10907889464128e-41	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP4971_r122106>	WP4971	Phosphoinositides metabolism	54	6	1.61197192390565e-87	6	3.75226023281196e-87	6	1.04096548175012e-88	6	8.67532695543949e-86	6	1.52448533748333e-87	6	5.59455285733373e-87	6	7.99173267997957e-90	6	7.99173267997957e-90
<https://identifiers.org/wikipathways/WP500_r121748>	WP500	Glycogen synthesis and degradation	45	3	2.786605372966e-81	3	5.84393273538776e-81	3	2.52429805518821e-82	3	9.17008253700916e-80	3	2.65358990465072e-81	3	8.2939675240065e-81	3	2.66157920789524e-83	3	2.66157920789524e-83
<https://identifiers.org/wikipathways/WP5031_r122564>	WP5031	Biotin metabolism, including IMDs	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP5033_r118996>	WP5033	Genes associated with the development of rheumatoid arthritis	18	2	6.36593588338078e-37	2	8.45913429742497e-37	2	2.5329319138332e-37	2	2.43475195877972e-36	2	6.24753685982565e-37	2	9.67613069563381e-37	2	1.06865063402868e-37	2	1.06865063402868e-37
<https://identifiers.org/wikipathways/WP5036_r119016>	WP5036	Angiotensin II receptor type 1 pathway	28	5	1.15788121558578e-47	5	1.74091383477974e-47	6	9.35716851107767e-46	5	7.93152550639976e-47	5	1.12711278229366e-47	6	5.89008427838727e-45	5	8.9478237804483e-49	6	2.86181230577999e-46
<https://identifiers.org/wikipathways/WP5038_r121595>	WP5038	Mitochondrial immune response to SARS-CoV-2	48	1	1.08787281274105e-91	1	2.48870589505544e-91	1	7.43225339810742e-93	1	5.39454295136023e-90	1	1.03001119708972e-91	1	3.68028984389498e-91	1	6.01534404952332e-94	1	6.01534404952332e-94
<https://identifiers.org/wikipathways/WP5039_r120358>	WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	86	20	2.05938932312414e-102	20	6.54114033743087e-102	21	4.30082642389565e-102	20	4.79724665298105e-100	20	1.90804200209361e-102	21	9.23578757646422e-100	20	1.44616632570869e-105	21	1.35113253859068e-103
<https://identifiers.org/wikipathways/WP5044_r119244>	WP5044	Kynurenine pathway and links to cell senescence	23	6	4.17070437188237e-36	6	5.64093162849879e-36	6	1.56702750447824e-36	6	1.73390409864504e-35	6	4.08835798903678e-36	6	6.50663712584686e-36	6	6.26573012448694e-37	6	6.26573012448694e-37
<https://identifiers.org/wikipathways/WP5046_r118987>	WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	28	4	3.36789184289053e-50	4	5.15368216335023e-50	4	8.47933157731652e-51	4	2.50680325739565e-49	4	3.27458681665794e-50	4	6.30191438333841e-50	4	2.33016244282508e-51	4	2.33016244282508e-51
<https://identifiers.org/wikipathways/WP5050_r119012>	WP5050	TCA cycle in senescence	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP5052_r118777>	WP5052	Nephrogenesis	19	3	4.03175939280781e-36	3	5.35745172170245e-36	3	1.60419021209435e-36	3	1.54200957389379e-35	3	3.9567733445562e-36	3	6.12821610723476e-36	3	6.76812068218155e-37	3	6.76812068218155e-37
<https://identifiers.org/wikipathways/WP5053_r118778>	WP5053	Development of ureteric collection system	61	8	3.90063779531521e-93	8	9.9016120458183e-93	8	1.90152098984043e-94	8	3.15867618103565e-91	8	3.66788285431679e-93	8	1.53803772527393e-92	8	1.1215287201455e-95	8	1.1215287201455e-95
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	109	39	1.51356159878193e-97	39	5.14898462221617e-97	40	1.33093575889442e-97	39	4.87235966227827e-95	39	1.39598432576139e-97	40	3.95183325312046e-95	39	6.90197757684593e-101	40	3.39232197901986e-99
<https://identifiers.org/wikipathways/WP5061_r115541>	WP5061	Fatty acid transporters	25	2	3.53443594501154e-50	2	5.31414479480991e-50	2	9.42147953035195e-51	2	2.42110058192915e-49	2	3.44051520846669e-50	2	6.44426531873737e-50	2	2.73132594030779e-51	2	2.73132594030779e-51
<https://identifiers.org/wikipathways/WP5063_r118833>	WP5063	FOXP3 in COVID-19	17	4	1.47365795109374e-29	4	1.85694850303806e-29	4	6.9650619461145e-30	4	4.3871952722017e-29	4	1.45133012121528e-29	4	2.07144215121504e-29	4	3.45274049877754e-30	4	3.45274049877754e-30
<https://identifiers.org/wikipathways/WP5064_r120384>	WP5064	7-oxo-C and 7-beta-HC pathways	29	4	5.67842229324571e-52	4	8.84359661166627e-52	4	1.35036032807347e-52	4	4.59237488720618e-51	4	5.51469324524266e-52	4	1.09042671310748e-51	4	3.51768406256771e-53	4	3.51768406256771e-53
<https://identifiers.org/wikipathways/WP5065_r118890>	WP5065	SARS-CoV-2 altering angiogenesis via NRP1	8	2	8.39650474543144e-16	2	9.34403866498999e-16	2	5.93718518864845e-16	2	1.39072145567707e-15	2	8.33742661422241e-16	2	9.82859154313241e-16	2	4.29196126339885e-16	2	4.29196126339885e-16
<https://identifiers.org/wikipathways/WP5066_r116631>	WP5066	FOXA2 pathway	21	1	1.17858004038033e-45	1	1.68076388263097e-45	1	3.72931306442996e-46	1	6.29089081236571e-45	1	1.15127531661962e-45	1	1.98787608384662e-45	1	1.26954309660941e-46	1	1.26954309660941e-46
<https://identifiers.org/wikipathways/WP5072_r115764>	WP5072	Modulators of TCR signaling and T cell activation	64	5	1.13482136530181e-104	5	3.19533588410245e-104	5	3.95188612236089e-106	5	1.49806189569287e-102	5	1.05982354007478e-104	5	5.21261329808776e-104	5	1.70026506411431e-107	5	1.70026506411431e-107
<https://identifiers.org/wikipathways/WP5074_r120388>	WP5074	Kallmann syndrome	25	2	3.53443594501154e-50	2	5.31414479480991e-50	2	9.42147953035195e-51	2	2.42110058192915e-49	2	3.44051520846669e-50	2	6.44426531873737e-50	2	2.73132594030779e-51	2	2.73132594030779e-51
<https://identifiers.org/wikipathways/WP5083_r120385>	WP5083	Neuroinflammation and glutamatergic signaling	140	26	5.69124349105248e-156	26	4.07733882687259e-155	26	9.55302706062581e-159	26	6.12030045588615e-152	26	4.99709759771303e-156	26	1.03411726943379e-154	26	2.38664637942844e-161	26	2.38664637942844e-161
<https://identifiers.org/wikipathways/WP5085_r119785>	WP5085	Vasopressin-regulated water reabsorption	44	3	1.07562967396484e-79	3	2.21679848429051e-79	3	1.03103551676351e-80	3	3.26047379093658e-78	3	1.02546507648611e-79	3	3.12037489292049e-79	3	1.14625344553353e-81	3	1.14625344553353e-81
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	438	79	0	79	1.91697470586404e-321	80	0	79	4.10343108597695e-312	79	0	80	7.2177062069656e-319	79	0	80	0
<https://identifiers.org/wikipathways/WP5088_r119639>	WP5088	Prostaglandin signaling	35	15	1.82283856222183e-37	15	2.59953597912682e-37	16	6.54657020718779e-36	15	9.72974084968107e-37	15	1.78060799518642e-37	16	3.21096004545328e-35	15	1.96352562712268e-38	16	2.35132193847945e-36
<https://identifiers.org/wikipathways/WP5089_r118192>	WP5089	Kinin-Kallikrein pathway	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP5090_r118898>	WP5090	Complement system in neuronal development and plasticity	113	23	1.90429906411758e-130	23	9.10908398225076e-130	23	1.18707417883763e-132	23	3.05468893297427e-127	23	1.71726309649126e-130	23	1.90888057482389e-129	23	1.01666275459434e-134	23	1.01666275459434e-134
<https://identifiers.org/wikipathways/WP5092_r119997>	WP5092	Interactions of natural killer cells in pancreatic cancer	38	10	4.35069111181595e-53	10	7.14262514998733e-53	10	8.72006362198817e-54	9	2.84316875810671e-54	9	2.43948857517163e-55	9	5.37454054742421e-55	10	1.93530293071902e-54	10	1.93530293071902e-54
<https://identifiers.org/wikipathways/WP5095_r120801>	WP5095	Overview of proinflammatory and profibrotic mediators	130	34	1.47668738850179e-130	34	7.8182146500532e-130	35	3.57879254271682e-131	34	3.82105076305609e-127	34	1.32275058171902e-130	35	8.579558027156e-128	34	4.16102287637511e-135	35	2.36821644849706e-133
<https://identifiers.org/wikipathways/WP5097_r119075>	WP5097	CCL18 signaling pathway	131	11	1.02060573356652e-175	11	8.08199429544048e-175	11	1.23733990188004e-178	11	1.75883571325751e-171	12	1.34793392485622e-173	11	2.1491087518918e-174	11	2.27717801101124e-181	11	2.27717801101124e-181
<https://identifiers.org/wikipathways/WP5098_r119538>	WP5098	T-cell activation SARS-CoV-2	92	10	7.67322987956868e-131	10	3.20414515124358e-130	10	7.43557364144086e-133	10	6.48924180134613e-128	10	6.98197347859282e-131	10	6.29699805294704e-130	10	9.63472839615715e-135	10	9.63472839615715e-135
<https://identifiers.org/wikipathways/WP51_r116716>	WP51	Regulation of actin cytoskeleton	151	14	1.73826396876126e-191	14	1.82481096454499e-190	14	8.43031347862747e-195	14	1.12967436680511e-186	14	1.48820110278591e-191	14	5.54369831886483e-190	14	6.55913230426973e-198	14	6.55913230426973e-198
<https://identifiers.org/wikipathways/WP5101_r119172>	WP5101	Congenital generalized lipodystrophy (CGL)	20	1	9.62507032977294e-44	1	1.34861292487293e-43	2	2.92665834116277e-41	1	4.7271550961491e-43	1	9.41304627921844e-44	2	1.32078746745235e-40	1	1.15830693957313e-44	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP5102_r119174>	WP5102	Familial partial lipodystrophy (FPLD)	31	2	7.19872072251074e-61	2	1.2027594804852e-60	2	1.36298514002564e-61	2	8.11030103445149e-60	2	6.95878028989097e-61	2	1.53311834329883e-60	2	2.86782440743483e-62	2	2.86782440743483e-62
<https://identifiers.org/wikipathways/WP5103_r119170>	WP5103	Progeria-associated lipodystrophy	25	1	4.11220005236946e-53	1	6.29265221410297e-53	1	1.03532742091776e-53	1	3.06080983808996e-52	1	3.99827450141385e-53	1	7.69464515670135e-53	1	2.84513118782057e-54	1	2.84513118782057e-54
<https://identifiers.org/wikipathways/WP5108_r120390>	WP5108	Familial  hyperlipidemia type 1	18	1	7.43684098525791e-40	1	1.0058423659245e-39	1	2.79418854256284e-40	1	3.0917485190854e-39	1	7.29000800446413e-40	1	1.1602075174621e-39	1	1.11725105491761e-40	1	1.11725105491761e-40
<https://identifiers.org/wikipathways/WP5109_r120391>	WP5109	Familial hyperlipidemia type 2	16	2	6.0867708715537e-33	2	7.80695162963131e-33	2	2.71630625132838e-33	2	1.97000236740087e-32	2	5.98754132587876e-33	2	8.78194870679401e-33	2	1.27603590961906e-33	2	1.27603590961906e-33
<https://identifiers.org/wikipathways/WP5110_r120392>	WP5110	Familial hyperlipidemia type 3	13	2	9.02632832197287e-27	2	1.09778660278152e-26	2	4.78580527004663e-27	2	2.27329527794692e-26	2	8.91040469104683e-27	2	1.20423550567039e-26	2	2.64205153697754e-27	2	2.64205153697754e-27
<https://identifiers.org/wikipathways/WP5111_r119173>	WP5111	Familial hyperlipidemia type 4	22	2	1.29643804441838e-44	2	1.84884027089407e-44	2	4.10224437087301e-45	2	6.9199798936023e-44	2	1.26640284828159e-44	2	2.18666369223131e-44	2	1.39649740627035e-45	2	1.39649740627035e-45
<https://identifiers.org/wikipathways/WP5112_r119153>	WP5112	Familial hyperlipidemia type 5	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	41	6	3.06092661557516e-67	6	5.68101669079338e-67	7	1.07799669443617e-65	6	5.66162488295951e-66	6	2.93843205058611e-67	7	1.83300007174893e-64	6	6.29999746236184e-69	7	1.7378992999744e-66
<https://identifiers.org/wikipathways/WP5114_r119169>	WP5114	Nucleotide excision repair in xeroderma pigmentosum 	61	6	7.13667292453306e-98	6	1.8753814229671e-97	6	3.10964636883097e-99	6	6.80289437010681e-96	6	6.69550341232745e-98	6	2.96108998137826e-97	6	1.65084593904897e-100	6	1.65084593904897e-100
<https://identifiers.org/wikipathways/WP5115_r120811>	WP5115	Network map of SARS-CoV-2 signaling pathway	285	53	1.1392548283229e-248	53	5.51503247468391e-247	54	1.43733255856914e-252	53	9.81566474945241e-241	55	1.10400774156685e-245	54	1.2024461985166e-244	54	1.08960792224334e-257	54	1.08960792224334e-257
<https://identifiers.org/wikipathways/WP5117_r119395>	WP5117	Cohesin complex - Cornelia de Lange syndrome	36	2	2.11986276115425e-69	2	3.86619461528409e-69	2	3.02081545229101e-70	2	3.61048539169628e-68	2	2.03738106251225e-69	2	5.13652311678547e-69	2	4.8700270483056e-71	2	4.8700270483056e-71
<https://identifiers.org/wikipathways/WP5118_r119397>	WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	11	2	1.68302256281873e-22	2	1.9755232884542e-22	2	1.00116653346741e-22	2	3.58509157464281e-22	2	1.66530665765446e-22	2	2.13101978250936e-22	2	6.15588185103648e-23	2	6.15588185103648e-23
<https://identifiers.org/wikipathways/WP5120_r120422>	WP5120	Inclusion body myositis	12	2	1.18453200902199e-24	2	1.41530026635527e-24	2	6.65226932536489e-25	2	2.74369253161439e-24	2	1.17069009325448e-24	2	1.53956877724938e-24	2	3.87568637001251e-25	2	3.87568637001251e-25
<https://identifiers.org/wikipathways/WP5121_r119472>	WP5121	Sphingolipid metabolism in senescence	30	4	9.89847000565773e-54	4	1.56894085363684e-53	4	2.22342534809024e-54	4	8.69767971061783e-53	4	9.60190350303431e-54	4	1.95067390538011e-53	4	5.49066190827421e-55	4	5.49066190827421e-55
<https://identifiers.org/wikipathways/WP5122_r119484>	WP5122	Prostaglandin and leukotriene metabolism in senescence 	32	8	1.73013415243352e-47	8	2.64752015134398e-47	8	4.35595376457577e-48	8	1.28778064479925e-46	8	1.68220202752887e-47	8	3.23738344606927e-47	8	1.19703773491412e-48	8	1.19703773491412e-48
<https://identifiers.org/wikipathways/WP5124_r119432>	WP5124	Alzheimer's disease	267	23	7.75877250783358e-285	23	4.531229107377e-283	23	1.41479069665978e-290	23	1.6147177925484e-276	23	5.93025602172978e-285	23	3.09562957467268e-282	23	5.74697417225154e-296	23	5.74697417225154e-296
<https://identifiers.org/wikipathways/WP5130_r122780>	WP5130	Th17 cell differentiation pathway	71	14	3.21927731902229e-94	14	8.75706224357603e-94	14	1.25394199195501e-95	14	3.61160723987641e-92	14	3.01338467276691e-94	14	1.40544243367929e-93	14	5.99249021396169e-97	14	5.99249021396169e-97
<https://identifiers.org/wikipathways/WP5133_r121511>	WP5133	Non-classical role of vitamin D	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP5143_r120629>	WP5143	GDNF signaling	135	1	2.90099657544619e-205	1	2.89818077354227e-204	2	1.5949933325706e-205	1	1.49300040561671e-200	1	2.49181314392708e-205	2	7.67622895027485e-201	1	1.49618046996548e-211	2	1.51862317701495e-208
<https://identifiers.org/wikipathways/WP5144_r120537>	WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	57	13	3.00973863168836e-76	13	6.53548686424471e-76	14	3.200615723628e-75	13	1.16713761967235e-74	13	2.8594891536525e-76	14	1.14162522305192e-73	13	2.30973695444313e-78	14	3.20063549401396e-76
<https://identifiers.org/wikipathways/WP5149_r120374>	WP5149	Lipid metabolism in senescent cells	20	4	2.01587969640393e-35	4	2.67872586085122e-35	4	8.02095106047161e-36	4	7.71004786946909e-35	4	1.97838667227809e-35	4	3.06410805361739e-35	4	3.3840603410908e-36	4	3.3840603410908e-36
<https://identifiers.org/wikipathways/WP5154_r122424>	WP5154	Docosahexaenoic acid (DHA) oxylipin metabolism	2	1	0.00117924528301885	1	0.00120048019207684	1	0.0011129660545353	1	0.00128287363694678	1	0.00117785630153122	1	0.00121065375302659	1	0.00105429625724823	1	0.00105429625724823
<https://identifiers.org/wikipathways/WP516_r117755>	WP516	Hypertrophy model	20	5	6.89834032109415e-33	5	9.00587634418181e-33	5	2.90679266431499e-33	5	2.42712306930887e-32	5	6.77795273922483e-33	5	1.02157362507604e-32	5	1.29406467443314e-33	5	1.29406467443314e-33
<https://identifiers.org/wikipathways/WP5166_r122169>	WP5166	Glyoxylate metabolism	14	2	7.40296406020034e-29	2	9.16458702381728e-29	2	3.70582266485915e-29	2	2.02714228606735e-28	2	7.29933678611217e-29	2	1.0137881587123e-28	2	1.93861223887245e-29	2	1.93861223887245e-29
<https://identifiers.org/wikipathways/WP5169_r122351>	WP5169	Hemesynthesis defects and porphyrias	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP5173_r122082>	WP5173	Disorders of galactose metabolism 	14	1	8.66857618290436e-32	1	1.0923226488459e-31	1	4.09709526242026e-32	1	2.58070310129512e-31	1	8.53723600714867e-32	1	1.21849538306767e-31	1	2.0310238228103e-32	1	2.0310238228103e-32
<https://identifiers.org/wikipathways/WP5174_r121476>	WP5174	Ulcerative colitis signaling	22	4	3.1757438299569e-39	4	4.37179851856077e-39	4	1.12676346134767e-39	4	1.43503429042571e-38	4	3.10941157741423e-39	4	5.08503174969152e-39	4	4.26995374436899e-40	4	4.26995374436899e-40
<https://identifiers.org/wikipathways/WP5176_r122283>	WP5176	Disorders of bile acid synthesis and biliary transport	20	3	4.70999929066328e-38	3	6.37033498418848e-38	3	1.76965274362308e-38	3	1.95810739542073e-37	3	4.61700506949384e-38	3	7.34798094392669e-38	3	7.07592334781133e-39	3	7.07592334781133e-39
<https://identifiers.org/wikipathways/WP5178_r122450>	WP5178	Disorders of fructose metabolism	14	1	8.66857618290436e-32	1	1.0923226488459e-31	1	4.09709526242026e-32	1	2.58070310129512e-31	1	8.53723600714867e-32	1	1.21849538306767e-31	1	2.0310238228103e-32	1	2.0310238228103e-32
<https://identifiers.org/wikipathways/WP5179_r121899>	WP5179	Biosynthesis and turnover of 1-deoxy-sphingoid bases	10	1	3.0600410233068e-23	1	3.59186052446223e-23	1	1.82030278812256e-23	1	6.51834831753246e-23	1	3.02783028664454e-23	1	3.87458142274426e-23	1	1.119251245643e-23	1	1.119251245643e-23
<https://identifiers.org/wikipathways/WP5180_r122423>	WP5180	DYRK1A	62	10	4.69706135227853e-90	10	1.17186678741374e-89	10	2.42207292481472e-91	10	3.50549882571314e-88	10	4.42183655214844e-90	10	1.8054512177749e-89	10	1.50581430538824e-92	10	1.50581430538824e-92
<https://identifiers.org/wikipathways/WP5181_r122326>	WP5181	Roles of ceramides in the development of insulin resistance	23	3	9.93935834054085e-44	3	1.41744420768547e-43	3	3.14505401766929e-44	3	5.3053179184285e-43	3	9.70908850349193e-44	3	1.67644216404401e-43	3	1.07064801147392e-44	3	1.07064801147392e-44
<https://identifiers.org/wikipathways/WP5183_r122816>	WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	33	3	1.46895634453555e-61	3	2.49776600077157e-61	3	2.62744123378428e-62	3	1.79774934768694e-60	3	1.41835012278032e-61	3	3.21033704248181e-61	3	5.24129902085691e-63	3	5.24129902085691e-63
<https://identifiers.org/wikipathways/WP5187_r122433>	WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	12	1	1.38866589568813e-27	1	1.68890246581776e-27	1	7.36277733853336e-28	1	3.4973773506876e-27	1	1.3708314909303e-27	1	1.85267000872368e-27	1	4.06469467227321e-28	1	4.06469467227321e-28
<https://identifiers.org/wikipathways/WP5188_r122585>	WP5188	Retinol metabolism	19	2	7.06499893599491e-39	2	9.55550247628267e-39	2	2.65447911543466e-39	2	2.93716109313104e-38	2	6.9255076042408e-39	2	1.10219714158899e-38	2	1.06138850217171e-39	2	1.06138850217171e-39
<https://identifiers.org/wikipathways/WP5190_r122630>	WP5190	Creatine pathway	5	1	1.4452483793074e-11	1	1.55209487960484e-11	1	1.14693765985773e-11	1	2.02360898898162e-11	1	1.43845720630258e-11	1	1.60533193842994e-11	1	9.23717435952005e-12	1	9.23717435952005e-12
<https://identifiers.org/wikipathways/WP5191_r122556>	WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	14	2	7.40296406020034e-29	2	9.16458702381728e-29	2	3.70582266485915e-29	2	2.02714228606735e-28	2	7.29933678611217e-29	2	1.0137881587123e-28	2	1.93861223887245e-29	2	1.93861223887245e-29
<https://identifiers.org/wikipathways/WP5192_r122557>	WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	14	3	4.212286550254e-26	3	5.12300414631387e-26	3	2.23337579268843e-26	3	1.06087112970856e-25	3	4.15818885582187e-26	3	5.61976569312849e-26	3	1.23295738392287e-26	3	1.23295738392287e-26
<https://identifiers.org/wikipathways/WP5194_r122165>	WP5194	Synthesis of ceramides and 1-deoxyceramides	22	2	1.29643804441838e-44	2	1.84884027089407e-44	2	4.10224437087301e-45	2	6.9199798936023e-44	2	1.26640284828159e-44	2	2.18666369223131e-44	2	1.39649740627035e-45	2	1.39649740627035e-45
<https://identifiers.org/wikipathways/WP5198_r121825>	WP5198	Inflammatory bowel disease signaling	43	10	3.28081108485429e-61	10	5.87970551537342e-61	10	4.94827432663566e-62	10	5.14502086191401e-60	10	3.15680544838714e-61	10	7.74725117824994e-61	10	8.41331533611773e-63	10	8.41331533611773e-63
<https://identifiers.org/wikipathways/WP5200_r122392>	WP5200	Dravet syndrome	20	1	9.62507032977294e-44	1	1.34861292487293e-43	1	3.22496786904986e-44	1	4.7271550961491e-43	1	9.41304627921844e-44	1	1.5817813981465e-43	1	1.15830693957313e-44	1	1.15830693957313e-44
<https://identifiers.org/wikipathways/WP5202_r122439>	WP5202	Alstrom syndrome	33	2	2.55322655481262e-64	2	4.41821816174222e-64	2	4.31435342164911e-65	2	3.39411456454429e-63	2	2.46241340760472e-64	2	5.72592813760127e-64	2	8.15978052027538e-66	2	8.15978052027538e-66
<https://identifiers.org/wikipathways/WP5205_r122560>	WP5205	Clock-controlled autophagy in bone metabolism	80	6	2.17780054109758e-124	6	7.93374147315951e-124	6	3.28691664718764e-126	6	9.68081404647731e-122	6	1.99955780702261e-124	6	1.46180111916641e-123	6	6.45486986354248e-128	6	6.45486986354248e-128
<https://identifiers.org/wikipathways/WP5211_r122576>	WP5211	Glucose metabolism in triple-negative breast cancer cells	8	1	9.86663307336237e-19	1	1.11770797428111e-18	1	6.58589593860051e-19	1	1.77727981556176e-18	1	9.78571198852386e-19	1	1.18559608481693e-18	1	4.51073175344072e-19	1	4.51073175344072e-19
<https://identifiers.org/wikipathways/WP5213_r122577>	WP5213	Amino acid metabolism in triple-negative breast cancer cells	9	2	4.4399848830131e-18	2	5.02968588426499e-18	2	2.96365317237024e-18	2	7.99775917002785e-18	2	4.40357039483576e-18	2	5.33518238167616e-18	2	2.02982928904833e-18	2	2.02982928904833e-18
<https://identifiers.org/wikipathways/WP5218_r122962>	WP5218	Extrafollicular B cell activation by SARS-CoV-2	76	11	1.72024648382733e-107	11	5.37085466748222e-107	11	4.28414415820266e-109	10	2.50309653895285e-107	10	9.9557385248246e-110	10	5.89397767263501e-109	11	1.3458916965353e-110	11	1.3458916965353e-110
<https://identifiers.org/wikipathways/WP5220_r122761>	WP5220	Metabolic reprogramming in pancreatic cancer	43	3	4.24384798637068e-78	3	8.59513230499894e-78	3	4.30457328248771e-79	3	1.18488581629715e-76	3	4.05058705212015e-78	3	1.19992598155034e-77	3	5.04612028181485e-80	3	5.04612028181485e-80
<https://identifiers.org/wikipathways/WP5221_r122738>	WP5221	2q11.2 copy number variation syndrome	65	6	1.22938981241033e-103	6	3.46161387444424e-103	6	4.28120996589089e-105	6	1.62290038700056e-101	6	1.14814216841435e-103	6	5.64699773959528e-103	6	1.84195381945718e-106	6	1.84195381945718e-106
<https://identifiers.org/wikipathways/WP5222_r122737>	WP5222	2q13 copy number variation syndrome	68	12	2.99335620404379e-94	12	8.00308615573342e-94	13	1.75677605819288e-93	12	3.09555803230069e-92	12	2.80511113731078e-94	13	1.67285001843979e-91	12	6.2111995934788e-97	13	9.32635508190082e-95
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	172	8	6.02959745095903e-227	8	9.85194473930823e-226	9	1.51145230633509e-228	8	3.14313755711655e-221	8	5.0134500409582e-227	9	7.43854560335951e-223	8	1.39660485747107e-234	9	3.19667334043344e-232
<https://identifiers.org/wikipathways/WP524_r117113>	WP524	G13 signaling pathway	38	1	1.14929628661279e-75	1	2.20895178826341e-75	1	1.38153926281386e-76	1	2.50677946409538e-74	1	1.10075847499807e-75	1	3.0084269337803e-75	1	1.89900207712991e-77	1	1.89900207712991e-77
<https://identifiers.org/wikipathways/WP528_r120525>	WP528	Acetylcholine synthesis	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP530_r117693>	WP530	Cytokines and inflammatory response	30	9	9.82641108667108e-42	9	1.42627170719952e-41	9	2.93647998952991e-42	9	5.70010883382761e-41	9	9.58758361244123e-42	9	1.7010072555626e-41	9	9.47498357572007e-43	9	9.47498357572007e-43
<https://identifiers.org/wikipathways/WP531_r117702>	WP531	DNA mismatch repair	23	4	4.26149988850699e-41	4	5.97098372487506e-41	4	1.42785452402186e-41	4	2.09294791882001e-40	4	4.16762624012396e-41	4	7.0033371402938e-41	4	5.1284039749602e-42	4	5.1284039749602e-42
<https://identifiers.org/wikipathways/WP534_r117147>	WP534	Glycolysis and gluconeogenesis	46	3	7.37536519887454e-83	3	1.57389289126377e-82	3	6.31417675577258e-84	3	2.6347520093843e-81	3	7.01523767896176e-83	3	2.25219897346099e-82	3	6.31421575880253e-85	3	6.31421575880253e-85
<https://identifiers.org/wikipathways/WP536_r116854>	WP536	Calcium regulation in cardiac cells	152	17	2.17226580908472e-186	17	2.20632662598392e-185	17	1.17291387820842e-189	17	1.20842529594379e-181	17	1.86383234050066e-186	17	6.59895368565757e-185	17	1.00946414577773e-192	17	1.00946414577773e-192
<https://identifiers.org/wikipathways/WP545_r116815>	WP545	Complement activation	22	7	7.58817435320352e-32	7	9.9064639786001e-32	7	3.19747193074649e-32	7	2.66983537623977e-31	7	7.45574801314735e-32	7	1.12373098758363e-31	7	1.42347114187643e-32	7	1.42347114187643e-32
<https://identifiers.org/wikipathways/WP550_r119093>	WP550	Biogenic amine synthesis	15	1	7.60846358944202e-34	1	9.75868953703897e-34	1	3.39538281416043e-34	1	2.46250295925109e-33	1	7.48442665734825e-34	1	1.09774358834925e-33	1	1.5950448870238e-34	1	1.5950448870238e-34
<https://identifiers.org/wikipathways/WP554_r121084>	WP554	ACE inhibitor pathway	17	2	6.0511757202581e-35	2	7.89989152998412e-35	2	2.54981812659205e-35	2	2.12905532395515e-34	2	5.94557257826735e-35	2	8.96117214978988e-35	2	1.13514445125714e-35	2	1.13514445125714e-35
<https://identifiers.org/wikipathways/WP558_r119232>	WP558	Complement and coagulation cascades	60	19	1.66071422644807e-68	19	3.42261734604204e-68	19	1.59186325192285e-69	19	5.03399575209765e-67	20	1.37585536664102e-66	19	4.81769060667784e-68	19	1.76975352222834e-70	19	1.76975352222834e-70
<https://identifiers.org/wikipathways/WP560_r117838>	WP560	TGF-beta receptor signaling	55	11	1.470924895186e-77	11	3.19403493365341e-77	11	1.19016030912946e-78	11	5.70405603599274e-76	11	1.39749469915344e-77	11	4.60833035232895e-77	11	1.12881881232182e-79	11	1.12881881232182e-79
<https://identifiers.org/wikipathways/WP561_r117151>	WP561	Heme biosynthesis	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP58_r113950>	WP58	Monoamine GPCRs	34	2	5.02661857924887e-66	2	8.85205760160482e-66	2	8.02450855230155e-67	2	7.25785504367946e-65	2	4.84222416764384e-66	2	1.15675315911137e-65	2	1.43896544444691e-67	2	1.43896544444691e-67
<https://identifiers.org/wikipathways/WP581_r117099>	WP581	EPO receptor signaling	26	4	1.3156348732648e-46	4	1.9435598896218e-46	4	3.71316210757049e-47	4	8.29348004339832e-46	4	1.28216533435523e-46	4	2.33733503110606e-46	4	1.13563980388094e-47	4	1.13563980388094e-47
<https://identifiers.org/wikipathways/WP585_r107188>	WP585	Interferon type I signaling pathways	54	5	5.54577496756556e-90	5	1.31350999981753e-89	5	3.38525359918741e-91	5	3.23907664795516e-88	5	5.2387812284649e-90	5	1.97454806729433e-89	5	2.46531599382415e-92	5	2.46531599382415e-92
<https://identifiers.org/wikipathways/WP61_r120637>	WP61	Notch signaling pathway	60	6	2.04740616687424e-96	6	5.287960733612e-96	6	9.43599250607545e-98	6	1.79886370802983e-94	6	1.92303638990115e-96	6	8.28134345611644e-96	6	5.28000070013831e-99	6	5.28000070013831e-99
<https://identifiers.org/wikipathways/WP619_r120967>	WP619	Type II interferon signaling	37	13	5.85983128704974e-45	13	8.96694709720575e-45	13	1.47532803272512e-45	13	4.36161398388541e-44	13	5.69748886708418e-45	13	1.09647687023407e-44	13	4.05427472832832e-46	13	4.05427472832832e-46
<https://identifiers.org/wikipathways/WP623_r107189>	WP623	Oxidative phosphorylation	62	2	9.62234911563768e-110	2	2.75650093521609e-109	2	3.1685252802694e-111	2	1.37778663371599e-107	2	8.9762001320804e-110	2	4.53352719282114e-109	2	1.29353596391016e-112	2	1.29353596391016e-112
<https://identifiers.org/wikipathways/WP673_r118930>	WP673	ErbB signaling pathway	92	11	1.23957540872669e-128	11	5.08876507202046e-128	11	1.26945520896603e-130	11	9.67486959473431e-126	11	1.12917552894698e-128	11	9.92063420523449e-128	11	1.73249934250902e-132	11	1.73249934250902e-132
<https://identifiers.org/wikipathways/WP678_r116938>	WP678	Arachidonate epoxygenase / epoxide hydrolase	7	1	2.09912618635786e-16	1	2.3360096662475e-16	1	1.4842962971621e-16	1	3.47680363919266e-16	1	2.08435665355559e-16	1	2.45714788578309e-16	1	1.07299031584971e-16	1	1.07299031584971e-16
<https://identifiers.org/wikipathways/WP69_r120966>	WP69	T-cell receptor signaling pathway	89	9	3.21393337379687e-129	9	1.29711235830045e-128	9	3.47858492588015e-131	9	2.31496819986534e-126	9	2.93098887762711e-129	9	2.50846635449014e-128	9	5.00035345351488e-133	9	5.00035345351488e-133
<https://identifiers.org/wikipathways/WP690_r117170>	WP690	Polyol pathway	4	1	4.91095399288653e-09	1	5.18089270812093e-09	1	4.12897557548781e-09	1	6.32175448157866e-09	1	4.89363141584126e-09	1	5.31364871620314e-09	1	3.51012625661768e-09	1	3.51012625661768e-09
<https://identifiers.org/wikipathways/WP691_r114497>	WP691	Tamoxifen metabolism	21	2	1.01063238462616e-42	2	1.41604357111659e-42	2	3.38621626250239e-43	2	4.96351285095656e-42	2	9.88369859317941e-43	2	1.66087046805387e-42	2	1.21622228655181e-43	2	1.21622228655181e-43
<https://identifiers.org/wikipathways/WP696_r106311>	WP696	Benzo(a)pyrene metabolism	9	2	4.4399848830131e-18	2	5.02968588426499e-18	2	2.96365317237024e-18	2	7.99775917002785e-18	2	4.40357039483576e-18	2	5.33518238167616e-18	2	2.02982928904833e-18	2	2.02982928904833e-18
<https://identifiers.org/wikipathways/WP697_r106826>	WP697	Estrogen metabolism	18	2	6.36593588338078e-37	2	8.45913429742497e-37	2	2.5329319138332e-37	2	2.43475195877972e-36	2	6.24753685982565e-37	2	9.67613069563381e-37	2	1.06865063402868e-37	2	1.06865063402868e-37
<https://identifiers.org/wikipathways/WP698_r106827>	WP698	Glucuronidation	26	1	6.21611635823294e-55	1	9.68100340631228e-55	1	1.47822696012422e-55	1	5.02723030892843e-54	1	6.03688368390008e-55	1	1.19368003624244e-54	1	3.85077620423401e-56	1	3.85077620423401e-56
<https://identifiers.org/wikipathways/WP702_r106643>	WP702	Metapathway biotransformation Phase I and II	190	9	7.40027159410531e-243	9	1.59226498703552e-241	9	3.47990458134901e-247	9	1.40826236964475e-236	9	6.04220545390615e-243	9	6.78889566410862e-241	9	3.01652324089429e-251	9	3.01652324089429e-251
<https://identifiers.org/wikipathways/WP704_r117787>	WP704	Methylation pathways	9	1	5.21430990371474e-21	1	6.01277451794975e-21	1	3.28564653256124e-21	1	1.02142518135732e-20	1	5.16547846901553e-21	1	6.43180516175554e-21	1	2.13217362294992e-21	1	2.13217362294992e-21
<https://identifiers.org/wikipathways/WP706_r117178>	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	166	23	1.59975952385027e-189	23	1.85395108856944e-188	24	4.54538294603513e-191	23	1.65586705575344e-184	23	1.36070143352601e-189	24	4.41138818665247e-186	23	3.23597384132628e-196	24	2.74922944269353e-194
<https://identifiers.org/wikipathways/WP707_r116541>	WP707	DNA damage response	68	8	3.76142245657859e-103	8	1.07752944678042e-102	8	1.23859174097866e-104	8	5.38583408495405e-101	8	3.5088397173909e-103	8	1.77217754060415e-102	8	5.056494172651e-106	8	5.056494172651e-106
<https://identifiers.org/wikipathways/WP710_r116542>	WP710	DNA damage response (only ATM dependent)	114	13	1.4818700465759e-151	13	8.53588305287366e-151	13	5.05208957109763e-154	13	5.70432326078424e-148	13	1.32001858352808e-151	13	1.95291613465599e-150	13	2.45538286934378e-156	13	2.45538286934378e-156
<https://identifiers.org/wikipathways/WP716_r116512>	WP716	Vitamin A and carotenoid metabolism	43	8	9.87148833522982e-66	8	1.83212788278087e-65	8	1.32909750829583e-66	8	1.82587402475446e-64	8	9.47644336314048e-66	8	2.45432838788449e-65	8	2.03174918161169e-67	8	2.03174918161169e-67
<https://identifiers.org/wikipathways/WP722_r120570>	WP722	Serotonin HTR1 group and FOS pathway	34	3	2.89365676212093e-63	3	5.00731391664115e-63	3	4.88960054453571e-64	3	3.84666317315019e-62	3	2.79073519528534e-63	3	6.48938522261475e-63	3	9.24775125631219e-65	3	9.24775125631219e-65
<https://identifiers.org/wikipathways/WP727_r116775>	WP727	Monoamine transport	32	6	3.27309408187088e-52	6	5.18796442269243e-52	6	7.35212648435166e-53	6	2.87603275764431e-51	6	3.17502942500335e-52	6	6.45022838045687e-52	6	1.81557887100275e-53	6	1.81557887100275e-53
<https://identifiers.org/wikipathways/WP732_r120591>	WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	20	2	8.24868527261528e-41	2	1.13553208274304e-40	2	2.92665834116277e-41	2	3.72736179331358e-40	2	8.07639370756934e-41	2	1.32078746745235e-40	2	1.10907889464128e-41	2	1.10907889464128e-41
<https://identifiers.org/wikipathways/WP733_r120590>	WP733	Serotonin receptor 2 and STAT3 signaling	4	1	4.91095399288653e-09	1	5.18089270812093e-09	1	4.12897557548781e-09	1	6.32175448157866e-09	1	4.89363141584126e-09	1	5.31364871620314e-09	1	3.51012625661768e-09	1	3.51012625661768e-09
<https://identifiers.org/wikipathways/WP734_r117826>	WP734	Serotonin receptor 4/6/7 and NR3C signaling	19	1	8.24868527261532e-42	1	1.13553208274302e-41	1	2.92665834116278e-42	1	3.72736179331351e-41	1	8.07639370756939e-42	1	1.32078746745236e-41	1	1.10907889464129e-42	1	1.10907889464129e-42
<https://identifiers.org/wikipathways/WP75_r119233>	WP75	Toll-like receptor signaling pathway	104	14	2.60663309411857e-137	14	1.24686506508596e-136	15	2.04302197755144e-137	14	4.18130398473849e-134	14	2.35061545897296e-137	15	3.03271096438851e-134	14	1.3916232127706e-141	15	1.84250913370821e-139
<https://identifiers.org/wikipathways/WP78_r119082>	WP78	TCA cycle (aka Krebs or citric acid cycle)	18	1	7.43684098525791e-40	1	1.0058423659245e-39	1	2.79418854256284e-40	1	3.0917485190854e-39	1	7.29000800446413e-40	1	1.1602075174621e-39	1	1.11725105491761e-40	1	1.11725105491761e-40
<https://identifiers.org/wikipathways/WP80_r111167>	WP80	Nucleotide GPCRs	11	2	1.68302256281873e-22	2	1.9755232884542e-22	2	1.00116653346741e-22	2	3.58509157464281e-22	2	1.66530665765446e-22	2	2.13101978250936e-22	2	6.15588185103648e-23	2	6.15588185103648e-23
<https://identifiers.org/wikipathways/WP98_r117172>	WP98	Prostaglandin synthesis and regulation	46	9	3.33210128149914e-68	9	6.40431120345416e-68	9	4.00543254310057e-69	9	7.26778913500655e-67	9	3.19137786129297e-68	9	8.72219231725709e-68	9	5.50568841862618e-70	9	5.50568841862618e-70
